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 A great deal of variation exists in recommendations of total daily protein intake 
and timing of supplementation for athletes.  The most widely accepted recommendations 
promote protein intakes for strength and power athletes of 1.6-1.8 grams/kg/day and 
post-exercise protein supplementation.  To our knowledge, no studies have investigated 
an interaction between supplementation timing and total daily needs in athletic 
populations.  In an effort to determine optimal protein intake and supplementation 
strategies for athletic populations in a stable training phase, a double blind randomized 
controlled trial was conducted on 46 young, trained males (21.8±3.1 yr, 182.2±6.2 cm, 
83.5±13.6 kg).  Subjects underwent a two-week familiarization period followed by the 
two-week intervention period, both consisting of concurrent sprint interval and 
resistance exercise with nutritional interventions of low (LO = 1.3 g/kg total mass/day, 
1.9 g/kg lean mass/day) and high (HI = 2.2 g/kg total mass/day, 2.7 g/kg lean mass/day) 
daily protein intake and whey protein supplementation either immediately (IPE) or three 
hours delayed (DPE) post-exercise.  An age and activity matched control group (CON) 
completed food and activity logs but continued their normal diet (1.6 g/kg total 
mass/day, 2.1 g/kg lean mass/day) and exercise regimens and did not perform exercise 
on the experimental day.  Tests of body composition, power, and strength were 
conducted before and after the intervention period.  Cumulative muscle protein synthesis 
(C-MPS) was determined using deuterium stable isotope labeling (70%2H2O, 3ml/kg) to 
measure myofibrillar fractional synthetic rates (myoFSR) during the 24-hour post-






A two-way ANOVA (total protein x timing) showed no difference in myoFSR 
among groups.  No differences in total body %fat or lean mass were found, but changes 
in thigh %fat (p=0.002), total thigh fat mass (p<0.001), and thigh cross section fat mass 
(p=0.049) were significantly greater in LO/DPE compared to CON.  Knee extension 
one-repetition-maximum was significantly greater at follow-up in LO/DPE compared to 
CON (p=0.006) and change in knee extension 1RM was greater in HI/DPE compared to 
CON (p=0.006).  Thus, trained individuals undergoing simulated elite athlete training 
exhibited no significant differences in muscle protein synthesis, lean mass accretion, or 
performance measures regardless of total daily protein intake or supplementation timing 
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CHAPTER I  
INTRODUCTION 
 
While a standard for total daily protein intake for athletes and active individuals 
is generally accepted, recommendations for athletes have in fact fluctuated between 
slightly above to intakes 3 times sedentary levels.  Two contrary hypotheses exist in the 
literature, the first being that active individuals and athletes have higher protein 
requirements than sedentary populations (61, 104), and the second proposing that 
adaptation occurs over time in such individuals, so that they do not have a significantly 
increased daily protein need (18, 19, 75, 85, 86, 102, 110).  The U.S. and Canadian 
dietary reference intakes state that the recommended allowance for protein (0.8 g-1⋅kg-
1⋅day-1) is sufficient to meet the requirement of 98% of healthy individuals, and there is 
a “lack of compelling evidence” to the contrary suggesting that healthy exercising adults 
do not need additional protein (50a).  However, the RDA only seeks to repair losses and 
prevent deficiency; an “athletically optimal” amount of protein seeks to (1) repair and 
replace damaged proteins, (2) remodel proteins within muscle, bone, tendon, and 
ligaments, (3) maintain optimal function of all metabolic pathways using amino acids, 
(4) support increments in lean mass, (5) support an optimally functioning immune 
system, (6) support the optimal rate of production of plasma protein, and (7) support 







There is also some evidence for varying levels of efficiency in protein and amino 
acid turnover based on intake levels (121).  While high efficiency can be obtained at 
optimal levels of protein and amino acid intake, low efficiency and low actual uptake 
may be associated with protein intakes higher than the optimal level.  For an elite athlete 
seeking to reach and maintain peak condition, efficiency and optimal utilization of 
protein and amino acids will be key to performing at their highest level. 
Nitrogen balance and metabolic tracers have been used to measure muscle 
metabolic processes, however, each of these methods has potentially confounding 
factors. While nitrogen balance can be measured over longer time periods, the lack of 
resolution does not allow optimal protein intakes to be determined. On the other hand, 
metabolic tracers provide more information about the behavior of muscle metabolic 
processes but require highly controlled, short-term measurement periods that may not 
reflect real-world conditions.  The recent application of deuterium oxide (2H2O) tracer 
methodology to measurement of protein synthesis has been shown to accurately measure 
muscle metabolic processes in detail over longer time periods (42-44, 58).  The 
deuterium method has now been used to measure protein synthesis in both rats (43, 44) 
and humans (42, 58, 114). 
Timing of protein intake has also been investigated in conjunction with exercise, 
though to a lesser extent than total protein intake.  Immediate post-exercise protein 
ingestion is accepted as an optimal strategy, however, substantial variation exists 
between these studies as well.  Some found no difference between timing strategies (25, 






post-exercise ingestion (2, 39, 47, 49).  To our knowledge, there has been no 
measurement of interaction effects between timing of protein intake in conjunction with 
exercise, and total daily protein needs for athletes and active individuals.  It is our 
central hypothesis that if timing of protein ingestion affects overall net anabolic 
processes then optimal total protein intake over 24 hours will also change. Upon 
completion of this study, it is our expectation that the relation between timing and total 
protein intake in trained individuals, in an intense, stable training program, will be better 
understood; such information will provide insight into improving performance in 
individuals engaged in rigorous sport training. 
Objectives, Specific Aims, and Hypotheses 
The overall objective of these studies is to determine whether, in well-trained 
individuals/athletes, total protein requirement is elevated above the RDA and whether 
immediate post exercise protein intake affects cumulative muscle protein synthesis using 
deuterium oxide, “heavy water”, tracer methodology developed in our laboratory.   We 
also seek to identify any interaction effects between timing of protein intake and total 
daily protein requirements. 
Objectives 
The objectives of this study are as follows: 
1. Determine whether steady-state trained individuals have elevated total protein 
requirements 
2. Determine whether immediate post exercise protein intake affects muscle protein 






3. Determine whether there is an interaction between timing of protein intake post-
exercise and total daily intake 
Specific Aims 
The specific aim of this study is to determine the effects of varying total daily 
protein intake and timing of protein ingestion on cumulative muscle protein synthesis 
responses to high intensity exercise using deuterium oxide (2H2O).  We hypothesize that 
if there is indeed a timing effect, then protein ingestion at a more optimal time will 
decrease overall protein need.  Alternatively, since muscle protein synthesis (MPS) 
peaks 12-24 hours after exercise, our study is designed to determine whether timing of 
protein intake matters over the course of 24 hours of recovery following high intensity 
exercise when total protein is held constant.  Total energy will also be held constant in 
these experiments, recognizing that adequate energy spares protein and sufficient energy 
is a prerequisite for full activation of protein synthesis signaling pathways.  Individuals 
who have limited energy intake may benefit from such an interaction between timing of 
protein intake and total protein ingestion.  Optimally timing protein intake with exercise 
could allow such individuals to meet protein needs on limited calories to allow for 
ingestion of other necessary macronutrients (i.e., carbohydrates for athletes) while 
consuming enough protein to maintain or grow fat-free mass. 
Additionally, our study will address common limitations in previous 
investigations involving optimal protein intake with exercise.  The use of both trained 
and untrained subjects may have contributed to the variation in recommendations for 






beginning an exercise program, however, there is evidence that rapid adaptations occur 
to meet this need through an increase in efficiency (18, 60, 102).  Thus, trained 
individuals may require less protein following regular training to maximally stimulate 
muscle protein synthesis (85), and elevation of MPS may follow a much different time 
course compared to untrained subjects (14). Shorter experimental periods may not 
capture adaptations to training or to manipulated levels of protein intake. To minimize 
effects of training status and reduce effects of adaptation periods, we will utilize trained 
subjects and longer adaptation periods so that steady-state dynamics can be achieved.  
Moreover, protein quality and energy intake between groups will be held constant to 
isolate the total protein and timing effects. 
The primary goal of this study is to measure muscle protein synthesis in trained 
individuals under stable training conditions.  It is the athletic community that is most 
likely to follow diet recommendations, especially in regards to protein intake.  While 
athletes typically ingest high levels of protein, we hypothesize that individuals 
undergoing consistent training have adapted to their workload and do not have elevated 
protein needs.  This effect may not have been evident in previous studies due to use of 
untrained subjects, fasted conditions necessitated by metabolic tracers, and/or 
uncertainty associated with the assumptions made when using previous methodologies.  
A study that measures muscle metabolic processes in free-living, steady-state trained 
subjects has not been done before, however, it has the potential to greatly impact the 










The following hypotheses are proposed: 
1. Increases in daily protein intake will not have additive effects on cumulative muscle 
protein synthesis in individuals undergoing consistent training. 
2. Cumulative muscle protein synthesis will not be significantly different between 
immediate and delayed post-exercise protein supplementation. 
3. There will be no interaction between total daily protein requirements and timing of 
protein supplementation post-exercise.
 
*Reprinted with permission from Cumulative Muscle Protein Synthesis and Protein 
Intake Requirements by Simmons E, JD Fluckey, and SE Riechman, 2016. Annual 





CHAPTER II  
LITERATURE REVIEW* 
 
Protein intake requirements to optimize skeletal muscle health have been studied 
extensively for decades, and although a specific dogma has emerged from this work, 
considerable controversy still exists. Many studies support the idea that active 
individuals and athletes have higher protein requirements than do sedentary populations; 
however, other studies propose that adaptation to intakes near the Recommended Daily 
Allowance (RDA; 0.8 g-1kg-1d-1 protein) occurs over time with training through increases 
in the efficiency and utilization of amino acids and reductions in protein catabolism. 
Tipton & Witard (110) argued that the question of optimal protein intake is interesting 
from a scientific point of view, but the applicability of these values to the athletic 
community is irrelevant due to the excessive intake levels typically seen in athletes. In 
fact, dietary assessments indicate that intake is beyond even the highest 
recommendations: 2 to 3 g-1kg-1d-1 protein in strength and power athletes, and 1.2 to 1.6 
g-1kg-1d-1 protein in endurance athletes (110). Although excessive protein intake for 
athletes may be considered the norm, if athletes are consuming an excess of protein on a 
limited-energy diet, carbohydrate intake may suffer as a result of elevated protein intake. 
Because carbohydrate is the key limiting source of energy to fuel muscle contraction 






 compromise glycogen stores and impair both training and performance. In additional, 
high protein intake may increase the work of the kidneys, negatively affecting hydration 
status and electrolyte balance, and may also interfere with absorption, contribute to 
metabolic imbalances, and alter brain neurotransmitter activity (61). Some evidence 
indicates that efficiency in protein and amino acid turnover varies according to intake 
levels (18, 102, 110, 121). Although high efficiency may be obtained at optimal levels of 
protein and amino acid intake, low efficiency and low uptake may be associated with 
ingestion of protein at higher-than-optimal levels. For athletes seeking to reach and 
maintain peak condition, efficiency and optimal utilization of protein and amino acids 
may be key to performing at their highest level. 
Many factors account for the controversy in recommendations, including 
methods of measuring protein utilization, training status of subjects, exercise type and 
intensity, energy and carbohydrate content of the diet, type and timing of protein intake, 
and duration of the study. Most studies determining total daily protein requirements in 
exercising subjects did not account for the timing of protein ingestion, yet other studies 
using tracer methodologies have shown a strong effect of protein timing on muscle 
protein synthesis (MPS) in response to acute exercise. How to translate acute effects of 
protein timing on MPS to chronic adaptations with exercise training, and how to 
determine the ways in which these effects interact with total daily protein requirements, 
remains largely unresolved. This gap in knowledge is illustrated by Mitchell et al. (77), 
who found that acute measures of MPS following the initial acute bout of resistance 






chronic resistance exercise training (RET). Millward (75) states, “Thus, the key test of 
adequacy of either protein or amino acid intake must be the long-term response in terms 
of the specific function of interest” (p. 203). These long-term responses have proven 
difficult to measure, and it is likely that new methodologies for measuring cumulative 
MPS (C-MPS), such as the deuterium oxide method (Figure 1), must be applied to this 
question in order to better understand the dynamic fluctuations in protein requirements. 
 
 
Figure 1 - Muscle protein balance. Overall muscle protein balance is net muscle 
protein synthesis (MPS) less the muscle protein breakdown (MPB) that is directly 
related to meals. In an experiment using deuterium oxide to label amino acids 
entering protein synthesis, the total accumulation of newly synthesized proteins in 
the time frame of the experiment represents the area under the curve (AUC) 






Factors Affecting Protein Synthesis 
Blanket recommendations regarding protein intakes should be interpreted with 
extreme caution because a number of factors can affect the protein requirements of 
individuals, especially athletes. Factors that should be taken into account include total 
energy intake and expenditure, exercise history, current training volume and intensity, 
and the timing of protein intake, all of which will affect muscle metabolic processes and 
thus alter specific recommendations for individuals (56, 102, 104). 
Energy and Carbohydrate Intake 
Perhaps the most critical determinant of muscle protein balance is total energy 
intake, as evidenced by findings that energy intake improves nitrogen balance, even 
when no protein is consumed (19, 21, 112). Regardless of protein level, insufficient 
energy results in increased use of protein for energy production, which leads to increased 
urea nitrogen excretion and negative nitrogen balance (18, 19, 27, 63, 70, 83a, 102). 
However, even in a hypoenergetic state, RET attenuates and may prevent lean mass 
losses (87, 89). More specifically, a sufficient supply of carbohydrates has been shown 
to reduce amino acid oxidation for energy, improve protein balance, and support protein 
retention through antiproteolytic effects (27, 38, 63, 97, 98). Carbohydrates given alone 
after RE improve nitrogen balance, whereas carbohydrates in conjunction with protein 
improve MPS (11, 12, 73, 95, 106, 108, 117). Although high-protein, low-carbohydrate 
hypoenergetic diets paired with exercise training consistently results in improvements in 
lean and fat masses (55, 59), such a diet may not be a good strategy for athletes because 






work output during muscle contraction (15, 16). Thus, diets that displace carbohydrates 
in favor of elevated protein intake may reduce performance and training intensity (65). 
Protein Timing 
Significant variation exists in the findings of studies examining the timing of 
nutrient intake and its effect on muscle metabolism. Whereas many studies suggest that 
timing is important to muscle accretion (3, 7, 39, 50, 62, 64, 109), other studies have 
found no significant difference between various ingestion times (95, 113). A reduction in 
training-induced effects was found to occur when protein ingestion was delayed 
compared with when protein was consumed immediately following exercise (2, 39, 47, 
49). Conversely, Tipton & Wolfe (111) propose that MPS is stimulated to a greater 
extent if amino acids are ingested immediately before exercise, whereas others show no 
difference in MPS with protein consumption before, one hour after, or three hours after 
exercise (25, 94, 110). In addition to the various timing intervals used, considerable 
variation exists in quantities of amino acids or protein consumed during timing studies. 
The current recommended intake is 20 to 25 g protein (or 8 to 10 g essential amino 
acids) of intact, high-quality protein (50a), which maximally stimulates MPS with only 
slight increases in amino acid oxidation (30, 79, 83, 86). The limitations of using tracers 
and the lack of integration with total daily protein ingestion highlight the need for 
methods that are able to analyze muscle protein use over the course of days (or longer) 
and cautions against the extrapolation of short-term analysis of muscle protein 
metabolism to total daily protein recommendations. As illustrated in Figure 2, classic 






may not capture individual differences in response over longer periods. In contrast, the 
deuterium method of measuring C-MPS (Figure 3) can incorporate many of the 
hormonal, genetic, activity, and other influences over a more extended period in a free-
living, fed state. 
 
 
Figure 2 - Classic tracer methodology examining exercise and nutrition effects on 
muscle protein synthesis (MPS). This methodology requires control of meal 
consumption because of the diluting effect of the meal on the tracer. Additionally, 
the tracer infusions are provided at exactly the same time between subjects without 
regard to interindividual variation in slope and peak MPS (i.e., it assumes the 
changes in MPS are the same between subjects). This method can be applied to 
many time points across the recovery from exercise; however, the interindividual 








Figure 3 - The deuterium oxide method measures muscle protein synthesis (MPS) 
and labels amino acids from all sources contributing to the amino acid pool; long 
periods of measurement can be obtained to determine the cumulative MPS. This 
method incorporates the effects of all interindividual variations in response times to 
interventions within the window of measurement. The deuterium oxide method also 
does not require fasting to prevent diluting the tracer because of the rapid 












Exercise itself may increase MPS and improve nitrogen retention; however, 
previous training likely plays a role in determining protein requirements (18, 62). 
Moreover, the changes that occur in MPS during recovery from acute exercise are likely 
different for trained versus untrained individuals (14). Tang et al. (110) showed that 
trained individuals exhibit the greatest change in fractional synthesis rate (FSR) around 
4 hours postexercise and return to baseline quickly, whereas untrained individuals peak 
around 16 hours postexercise and return to baseline more slowly (54). These and other 
data are extrapolated into a model of fluctuations in MPS during recovery from exercise 
in Figure 4. Likewise, Murton & Greenhaff (80) suggest that acute transcriptional 
responses are likely dampened over time with chronic exercise. Highlighting the 
difference in protein intake requirements between trained and untrained individuals, 
Lemon (61) estimated that experienced body builders (>3 years) may require 0.9 g/kg 
per day, whereas novices during the first month of training require approximately 1.5 
g/kg per day. Nonetheless, recommendations persist, even by the same author, that 
endurance and resistance-trained athletes consume 1.2 to 1.4 g/kg per day and 1.6 to 1.8 
g/kg per day, respectively, which is above the RDA of 0.8 g/kg per day (62). 
The volume and intensity of exercise training may also contribute to protein 
requirements. Training too frequently leads to decreased gains or increased losses of 
muscle mass and strength, suggesting that elevated protein intake may be necessary with 
very frequent training (60). In rats, studies have found that longer or more intense 






exercise bout (4, 35, 45, 51). Reconciling these findings, Tipton & Witard (110) suggest 
that the MPS stimulus may be a bell-curve continuum, so that very-low-intensity 
exercise does not stimulate MPS, increasing exercise intensity increases the MPS 
response, and very-high-intensity exercise reduces the MPS response. Again, a 
cautionary approach to generalized recommendations is necessary due to the complex 
interactions of all factors that affect protein requirements and the short periods of 
experimental measures that have tested these requirements. 
 
 
Figure 4 - Change in muscle protein synthesis (MPS) over time in response to 
exercise and nutrition between trained and untrained subjects (extrapolated from 
classic tracer methodologies). These studies suggest that trained individuals have a 
larger, earlier response, whereas the response of untrained subjects is more delayed 







Measuring Protein Synthesis 
A range of protein recommendations from 0.8 to 2.67 g/kg per day has emerged 
from many studies (13, 18, 21, 50a, 60--63, 83, 85, 86, 102). Despite the variations in 
study methods and conclusions, a general integration of the protein requirements has 
been done several times. Male endurance athletes were estimated to require 1.0 to 1.2 
g/kg per day, whereas male strength and power athletes were estimated to require 1.3 to 
1.6 g/kg per day (13). Assuming that overall energy needs are met, Lemon (61) 
estimated that 1.5 to 2.0 g/kg per day from a mixed diet of approximately 12% to 15% 
energy from protein should be sufficient for strength athletes, although more recently, 
1.33 g/kg per day was determined to be a safe intake (85). These estimates of total daily 
intake are combined with results from tracer studies that recommend 20 to 25 g of high-
quality protein immediately following high-intensity exercise, despite the fact that the 
timing of intake and total intake have never been studied simultaneously. 
The evolution of technologies and methods to measure protein accretion suggest 
that optimal protein intake may be different from current and long-standing accepted 
norms. Over time, protein requirement studies have used multiple approaches to estimate 
protein accretion, both indirectly, with nitrogen balance, urinary urea, or Nt-
methylhistidine excretion, and more directly, with isotopic tracers. Each approach has its 
own unique set of strengths and challenges---especially when utilized in exercise 
studies---which have contributed to the inability to consistently reproduce estimates of 






Additionally, measurements taken during the training adaptation period may 
indicate an increased protein need, whereas data collected in stable training may show 
no change or a decrease in need (18). Nonetheless, these small windows of measurement 
are extrapolated into long-term recommendations under the assumptions that muscle 
metabolic processes will remain the same and that nitrogen retention stably reflects 
muscle growth. 
The utilization of metabolic tracers faces fundamental issues such as assumptions 
about the precursor pool of the labeled substance, determination of correct priming 
dosages, and method of injection/ingestion. The major issues for exercise studies are that 
assumptions about tracer behavior may not hold when metabolic rates change during 
exercise (116), as well as uncertainty regarding the interaction between energy 
requirements of exercise and methodological requirements for fasted subjects. 
Nevertheless, metabolic tracers are currently the most direct measure of protein 
metabolism.  
Other approaches that show considerable promise have emerged based on the 
underlying assumptions related to tracer methodologies. One example is the use of 
deuterium oxide methodologies (Figure 5), which overcome numerous hurdles 
regarding the control of the precursor pool. This model takes advantage of cellular 
function to label the amino acids in the cell. Thus, whereas other tracer methodologies 
place paramount importance on controlling the introduction/availability of a fixed tracer 
with regard to the total amino acid pool, the deuterium approach maintains a reasonably 






its own pool. Thus, eating meals or supplementing with amino acids during the 
experimental protocol maintains the precursor pool ratio because amino acids entering 
the free amino acid pool of the cell will be labeled in proportion to the total deuterium 
availability.  
Furthermore, an incredible advantage of this approach is that even amino acids 
reentering the free pool of the cell from muscle protein degradation are labeled before 
potentially being recycled into new proteins. The fixed-label methodologies likely 
underestimate protein synthesis because amino acids entering the free pool from 
degradation or protein ingestion perturb and/or dilute the overall pool within the cell. 








Figure 5 - Incorporating deuterium into newly synthesized proteins. Deuterium 
equilibrates quickly in vascular, extracellular, and intercellular spaces. 
Transamination reactions label amino acids in the intracellular amino acid pool 
provided by the transport of amino acids across the sarcolemma or from turnover 
of muscle proteins during muscle protein breakdown. Mass spectroscopy quantifies 
the incorporation of deuterium-labeled alanine (2H-Ala) into newly synthesized 







Despite the numerous experimental intervention studies and reviews of previous 
literature that have called for further studies to measure MPS and muscle protein 
breakdown (MPB) at multiple time points over a long-term recovery period following 
chronic exercise training and in conjunction with nutritional supplementation (3, 5, 6, 
28, 33, 72, 77, 80), such studies have not been possible to accomplish with fixed-label 
methodologies. Deuterium methodologies will enable scientists to better capture 
measures of protein synthesis with dynamic alterations to the precursor pool (as occurs 
with supplements and/or nutritional intake). These methods also will allow for 
assessments to occur over longer periods of time and thus permit the direct measure of 
protein synthesis following interventions, with or without exercise. 
Total Protein Intake and Muscle Accretion 
Total daily protein intake has been proposed to affect lean body mass.  Protein 
synthesis, protein breakdown, and amino acid recycling efficiency together contribute to 
lean body mass accretion.  
Measured Rates of Protein Synthesis Versus Lean Body Mass Accretion 
During the process of determining optimal protein intake, it is often forgotten 
that MPS is an intermediate measure of lean body mass (LBM) accretion. Accretion 
occurs due to elevated protein synthesis rates relative to rates of breakdown, and it is 
highly dependent on the availability of amino acids (10, 11, 73, 95, 105). Studies 
showing increased rates of protein synthesis without a subsequent increase in LBM 
accretion may suggest that rates of protein degradation are also elevated. However, it 






might be confounded by methodological limitations, such as utilization of fasted subjects 
who are likely to have suppressed rates of protein synthesis due to insufficient 
availability of protein or energy. Therefore, the observed increases in protein synthesis 
in response to energy and/or protein intake may occur only relative to this suppressed 
state, and simply normalizing rates of synthesis may not be adequate to allow for the 
accretion of LBM. Furthermore, anabolic responses over time are highly variable and are 
based on nutrient intake, the energy state of the cell, and whether the muscle is active or 
quiescent. Figure 2 illustrates how the magnitude of protein synthesis is dependent upon 
the time point in which it is measured.  Furthermore, interindividual variance may be 
magnified if the measurement period includes sharp increases in MPS. Although the 
intervention may acutely affect rates of synthesis, the extrapolation of these highly acute 
synthesis and oxidation rates over time may not be indicative of C-MPS and LBM 
accretion. 
For example, Biolo et al. (10) showed that amino acid infusion resulted in protein 
synthesis levels of 150% and >200% in individuals at rest and after RE, respectively. 
Although the authors hypothesized that amino acid infusion maintains intracellular 
amino acid concentration so that protein breakdown is attenuated, the observation may 
only reflect a transition from the fasted to fed state. Because protein synthesis does 
change on a linear scale of amino acid availability, the 150% increase in MPS may only 
demonstrate a shift back to baseline values. Indeed, few studies show an actual increase 
in LBM, which should occur in conjunction with such elevated rates of MPS unless that 






Sharp (82) showed no effect of protein intake on LBM in conjunction with exercise 
training. Studies of older men and women performing RET showed no difference in 
strength, protein accretion, fat mass, or lean mass between low- and high-protein-intake 
groups (3, 34, 53), suggesting that acute measures of protein synthesis using some 
classic tracer methodological approaches may overstate the impact of nutrient intake on 
muscle growth. 
In addition, the extrapolation of nitrogen balance to LBM accretion may not be 
valid, as illustrated by the results of Tarnopolsky et al. (104), where the positive nitrogen 
balance observed would predict the bodybuilders in the study to have gained 300 to 500 
g of LBM per day, which did not occur. Indeed, this same study showed highly trained 
bodybuilders to have only 12% greater protein requirements than sedentary controls, 
highlighting the disparity between nitrogen balance and LBM accretion as well as the 
difference between the protein requirements of trained and untrained individuals. 
It is generally expected that chronic training results in LBM accumulation but 
that the rate of accumulation diminishes over time as one becomes more trained. With 
regard to nutritional impact, Wolfe (117) proposed that the plateau in net muscle 
anabolism observed as a result of RET may necessitate greater protein/amino acid 
intakes to elicit the same magnitude of anabolic effects observed after acute bouts of 
exercise in untrained individuals, supporting the idea of high protein intakes even in the 
trained state. However, higher levels of protein intake in strength-trained individuals 
caused a nutritional overload such that additional protein above moderate levels resulted 






Untrained individuals often see higher levels of LBM accretion with exercise and 
protein/amino acid interventions, whereas trained individuals do not, despite progressive 
overload [as discussed by Atherton et al. (6)]. In fact, a recent study showed no 
correlation between acute measures of MPS and changes in leg volume following 
chronic RET, highlighting the changes that occur in the acute MPS response as an 
individual progresses from untrained to trained (77). Atherton et al. (6) suggest that the 
deuterium method will allow for the determination of the time course of hypertrophy and 
its relationship with MPS, which would clarify the anabolic effect of protein ingestion 
when moving from the untrained to the trained state. 
Although RET significantly increases strength and LBM, the addition of protein 
supplementation immediately after RET in seniors showed that variability in protein 
intake is not associated with LBM accretion; groups that were high versus low in total 
daily protein intake showed similar increases in LBM with 12 weeks of RET (3). 
Meredith et al. (70) found that an additional energy supplement resulted in greater 
hypertrophy, suggesting that total energy may be an important predictor of muscle 
protein accretion. 
Protein Synthesis Versus Breakdown 
 Cumulative muscle protein synthesis is determined by the long-term balance 
between protein synthesis and protein breakdown.  Additionally, amino acid recycling 







Cumulative Muscle Protein Synthesis 
LBM accretion can result only from chronic positive net protein balance, and 
such C-MPS is the sum of the synthetic responses to each exercise bout. As highlighted 
by Murton & Greenhaff (80), the contributions of MPS and MPB to overall 
improvement in LBM and strength in conjunction with exercise training is still largely 
unknown owing to the lack of long-term studies. It is commonly accepted that exercise 
usually causes an increase in MPB, which must be later offset by a greater increase in 
MPS in order for LBM accretion to occur. In fact, participating in a single session of RE 
in a fasted and/or untrained state results in MPB that exceeds synthesis (88). RE also 
stimulates MPS between 40% and 150% above resting levels (9, 88, 89), but muscle 
protein balance remains negative in the fasted state postexercise due to the increase in 
MPB. However, MPB has been shown to change less than MPS does in response to 
nutrient intake and exercise, and thus MPB may have less overall effect on LBM 
accretion (57). MPS is increased following exercise, though this response may not be 
stimulated for some time (48). Surplus protein/amino acids during digestion have thus 
been proposed to aid protein synthesis and/or minimize protein breakdown, allowing a 
net positive protein balance and LBM accretion (61). Therefore, the cumulative synthetic 
response over the 24 hours following exercise and the long-term response to chronic 
training are the primary measures of interest, but few studies exist using these 
approaches. 
As noted previously, the extrapolation of acute protein synthetic rates may not be 






responses to the same nutrition and exercise intervention found no correlation between 
MPS following the first acute bout of exercise and muscle hypertrophy after the training 
period (68, 77). Therefore, although synthetic responses between acute and chronic 
exercise bouts may be qualitatively similar, training status determines the magnitude and 
time course of these responses. Consistent with that notion, studies have shown that 
MPS increases in most untrained individuals postexercise, whereas a dampened response 
is observed in trained individuals (9, 88, 100, 107). It is important to note that these 
measures assessed acute time points soon after the exercise period (as described in 
Figure 2), making it difficult to interpret whether anabolism no longer responds to an 
acute bout of exercise with training or whether an “optimal” window for anabolism has 
shifted to another period. Thus, the cumulative synthetic response may predict LBM 
accretion, but acute responses within the few hours following a single exercise bout may 
not accurately predict accretion. 
Measures of Muscle Protein Breakdown 
The measurement of overall muscle protein accretion is based on the relative 
contributions of protein synthesis and degradation. From a methodological standpoint, 
the assessment of MPB is fraught with assumptions, many of which are reliant on the 
assessment of protein synthesis and LBM to interpolate rates of degradation. Other 
studies have used specific markers that arise from degraded muscle proteins or assessed 
the appearance of amino acids in blood/extracellular compartments as an indication of 
the catabolic state of the muscle. For example, in early studies utilizing indirect 






MeHis), some studies indicated an increase (35, 96), no change (26, 90), or a decrease 
(81) in MPB with exercise. Given the presumed changes in amino acid recycling with 
exercise training, it is very difficult to determine if the altered mass with exercise 
training is actually due to an altered rate of degradation or synthesis, or whether the 
ability to capture the label in the cytosol (or blood) has been affected by the capacity for 
that label to be reincorporated into skeletal muscle protein through recycling. 
Some investigators have speculated that the increase in MPB is confined to the 
sarcoplasmic pool to provide amino acids for synthesis of myofibrillar proteins. This 
idea is based on the observation that the sarcoplasmic protein fraction turns over at a rate 
that is twofold greater than that of myofibrillar proteins in the fasted state (30, 78). 
Although that is true, it should also be noted that the capacity to actually measure 
changes in rates of protein degradation is enhanced in faster turnover pools (cytosolic) 
when compared to slower turnover pools, particularly when changes are acutely assessed 
over a relatively short window. Thus, it is difficult to determine if the altered rates of 
degradation are mostly limited to sarcoplasmic proteins with exercise training or whether 
changes in rates of degradation occurring in the myofibrillar fraction are not reliably 
measured over the brief period they are assessed. A reliable, direct measure of MPB 
currently does not exist. Likewise, no single measure of protein degradation can account 
for how many times an amino acid may reenter the anabolic apparatus, rendering the 
appearance of that label in the blood or urine as a predictor of protein breakdown less 
interpretable. For example, a study utilizing a nonradioactive technique involving 






muscle fiber types (46). Little difference was found between type 2a and type 1 muscle 
fibers; however, types 2b and 2x had significantly lower rates of MPS than did type 2a 
(46). Miller et al. (72) developed a mathematical model from published data and coupled 
it with an in vitro experiment to show that a four-week period was necessary to measure 
all protein synthesis in mixed tissue. They found that proteins that turn over more rapidly 
will increase the label incorporation in a sample, creating a bias toward these proteins 
and violating the homogeneous protein pool assumption of stable amino acid isotopes 
(72). This model also verified that the prolonged labeling period allowed by deuterium 
methods has a greater sensitivity to slower turnover proteins and proteins in lower 
abundance in skeletal muscle (72). Establishing reliable estimates of longer-term MPS, 
as made possible by deuterium methods, will allow more systematic and accurate 
determination of average synthetic rates in all proteins of skeletal muscle. Furthermore, 
as noted previously, use of this methodology allows for the measure of MPS under a 
variety of physiological stimuli, including alterations of recycling efficiency. Ultimately, 
deuterium methodologies positively impact the interpretive value of MPS measurements. 
Efficiency of recycling 
As discussed previously, many have proposed that chronic training results in adaptation 
to protein intakes near the RDA by increasing efficiency and utilization of amino acids. 
However, methods such as nitrogen balance and traditional metabolic tracers have been 
unable to capture such changes in recycling efficiency. Nitrogen balance fails to account 
for increased efficiency of nitrogen use at marginal protein intakes, and thus results 






capture changes of protein synthesis, particularly over extended periods, with alterations 
of recycling efficiency.  Using such tracers does not allow determination of how many 
times a labeled amino acid was involved in the formation of nascent proteins because 
they were captured and/or recycled from short-lived, recycled proteins (Figure 5). As 
noted previously, a distinct advantage of deuterium methodologies is that amino acids 
arising from degraded proteins are labeled by the cell once they enter the free pool. It is 
therefore impossible at this time to determine whether exercise training actually results 
in a lost anabolic response to the acute bout of exercise or if the improved recycling 
from degraded proteins diminishes our capacity to measure anabolic responses. Either of 
those outcomes could negate a need for elevated protein intake with exercise training 
(albeit for very different reasons). It should be noted that if muscle protein turnover 
increases without an increase in recycling efficiency, it is doubtful that one could sustain 
an elevated level of LBM with a diminished protein intake. 
Alternatively, some evidence suggests that intake levels are the basis of 
variations in protein and amino acid turnover efficiency (121). Whereas high efficiency 
can be obtained at optimal levels of protein and amino acid intake, low efficiency and 
moderate actual uptake may be associated with elevated protein intakes. Campbell et al. 
(23) compared low (0.8 g/kg per day) and high (1.62 g/kg per day) protein intakes over 
12 weeks of RET in untrained men and women. The low-protein group showed 
increased efficiency (measured as greater nitrogen retention) and rates of protein 
synthesis, whereas high protein intake was associated with increased leucine oxidation. 






high efficiency but compromised metabolic function, indicating nutrient insufficiency. 
Nitrogen balance methodologies can be misleading because such marginal protein 
intakes can yield net balance either through increased efficiency or downregulation of 
processes requiring protein/amino acid (120). Although radioactive amino acid tracers 
may be able to measure overall MPS to determine whether downregulation has occurred, 
direct measurement of the efficiency of amino acid is thus far not possible. 
Individuals in training, especially athletes, are concerned with maximizing efficiency 
and optimizing nutrient intake. However, such individuals commonly attempt to 
accommodate muscle metabolic processes by overfeeding protein and amino acids in an 
effort to avoid the downregulation of processes requiring amino acid. Such behavior 
assumes that these individuals expect to elicit a greater anabolic stimulus by engaging in 
regular training, though this may not be the case. It is unclear whether additional 
nutritional protein is required to maintain the accrued muscle mass, particularly given 
the elevation of metabolic rate. If the adaptations to exercise training include an 
increased efficiency of amino acid uptake and recycling, it is indeed possible that 
increased overall protein requirements in the diet to support this heightened metabolic 
turnover may not be as necessary as once believed. Campbell et al. (24) recognized such 
adaptation as a desirable response, defining it as “metabolic changes that occur in 
response to changes in protein intake and result in the establishment of a new steady 
state without a compromise or loss in physiological function” (p. M376). In comparison, 
the process of accommodation is defined as a survival response and “refers to further 






establish steady state, but only with a compromise or loss in physiological function” (24, 
p. M376). Without direct, accurate measures of efficiency and recycling, it is difficult to 
tell whether the “new steady state” anabolic outcome is because of an actual change in 
the requirement for maintained protein homeostasis or because of our inability to 
measure altered anabolic responses in the presence of exercise-induced improvements of 
amino acid recycling. The ability of deuterium to label amino acids coming from this 
recycling pathway (Figure 5) highlights an important strength of this method to measure 
MPS. 
Timing of Protein Intake and Muscle Protein Synthesis
Timing of protein supplementation in conjunction with exercise has been 
proposed to affect lean body mass.  Protein synthesis, protein breakdown, and amino 
acid recycling efficiency together contribute to lean body mass accretion.  Various 
supplementation timing strategies have been suggested to affect these measures. 
Measured Rates of Protein Synthesis Versus Lean Body Mass Accretion 
Many studies have attempted to determine a supplementation strategy to elicit an 
optimal anabolic response in conjunction with individual exercise bouts, and many have 
shown the timing of nutrient intake to be important to muscle accretion (7, 64, 111). 
Acute studies show that muscle is sensitive to ingestion of nutrients, especially amino 
acids, for up to three hours following RE (10). Such studies have consisted of short-term 
measurements of muscle metabolism and extrapolation of the cross-sectional measure of 
increased MPS (Figure 2) to the potential for increased overall accretion. However, as 






not in fact reflect the cumulative protein synthesis in response to exercise that results in 
LBM accretion. 
Although some controversy exists regarding whether preexercise 
supplementation is preferable to postexercise supplementation, it is generally agreed that 
postexercise protein supplementation yields the greatest increase in MPS. Tipton & 
Wolfe (111) propose that the increase in MPS is smaller when amino acids are ingested 
immediately after exercise, as opposed to immediately before, as a result of enhanced 
amino acid delivery to muscle due to exercise hyperemia. Campbell (22) states that the 
greatest anabolic state is achieved soon after an individual who has consumed protein 
performs RE. It is important to note that those studies, as well as other studies exploring 
preexercise protein supplementation effects, were largely conducted during a period of 
net negative nitrogen balance, when FSR may actually be suppressed. Because MPS is 
likely downregulated during exercise of moderate to high intensities and for some time 
afterward due to the dedication of adenosine triphosphate to work output, administration 
of amino acids either immediately prior to or shortly after exercise may take advantage 
of exercise-induced hyperemia to deliver both the nutrient and the tracer to the muscle, 
but it is questionable whether such a dampened MPS response will actually allow the 
nutrient and/or tracer to be incorporated into new tissue. Thus, the controversy behind 
the timing of protein should not overshadow the importance of the methodological 
conditions through which these measures of MPS were obtained. 
A review of past literature does not yield unequivocal evidence for any one 






with exercise, despite the common recommendation to consume protein immediately 
postexercise (5). Some studies presented no difference in MPS with protein consumption 
before, one hour after, or three hours after exercise (25, 94, 110); however, other studies 
showed that delaying protein ingestion by two hours in both young and older individuals 
caused a reduction in training-induced effects compared with immediate protein 
consumption (39, 47). Esmarck et al. (39) reported increases in LBM and muscle 
hypertrophy in older men taking a 10-g protein supplement immediately after exercise 
over a 12-week period, whereas no significant changes were shown in the group 
consuming the supplement two hours postexercise. Other longitudinal studies confirmed 
this finding, showing greater increases in strength and muscle mass with consumption of 
essential amino acids immediately postexercise (2, 49). It is important to note, however, 
that the fasted state causes an increase in MPB preexercise and the persistence of net 
negative amino acid balance into the postexercise period. Such a scenario could account 
for significant differences between subjects fed immediately postexercise and control or 
delayed-intake subjects who inherently have an increased period of MPB due to 
methodological requirements as opposed to intervention effects. One study showed that 
a group that consumed a protein and creatine supplement immediately before and after 
exercise had greater increases in LBM, strength, and type II fiber area than the group 
that ingested the same supplement at different times over the course of the day (29), 
although the specific cause of these positive effects cannot be elucidated because both 
protein and creatine were used. Another study found no effect of protein 






mass and strength after three months of RET in elderly men habitually consuming 
adequate dietary protein of approximately 0.9 g/kg per day (113). However, evidence 
suggests that elderly subjects may have a decreased anabolic response to protein 
consumption and thus may realize benefit only from an elevated protein intake (28). A 
crossover study by Tipton et al. (106) measured MPS in three male and three female 
subjects following acute RE and ingestion of either an amino acid or placebo solution 
and found that muscle protein balance is negative after exercise in the postabsorptive 
condition without amino acid ingestion, but positive (anabolic state) if amino acids were 
ingested during the 225 minutes immediately following exercise. As mentioned above, 
the tracer methodology used requires fasting exercise to be performed, which may 
explain such results. It is also possible that the timing of other nutrients affects protein 
needs (62). For example, ingestion of carbohydrates following exercise can enhance 
muscle glycogen resynthesis and, together with protein ingestion, stimulate MPS. One 
study found that 100 g of carbohydrates administered one hour after RE improved 
muscle protein balance so that it was not different from zero, but positive balance could 
not be achieved (12). Carbohydrates are protein sparing due to the antiproteolytic effect 
of insulin, and thus carbohydrate consumption may prevent MPB but cannot support 
LBM accretion, as reviewed by Aragon & Schoenfeld (5). 
In addition, the time course of elevated MPS may differ between trained and 
untrained subjects (14). Tang et al. (101) showed that trained individuals exhibit the 
greatest change in FSR around at approximately four hours postexercise, with FSR 






hours postexercise and returns to baseline more slowly (54). Damas et al. (32) compiled 
data from multiple studies (54, 67, 88, 100, 101, 118, 119) to characterize the acute 
response of trained and untrained individuals to a bout of RE (see Figure 6). Those 
collective data demonstrated a transient synthetic response in trained individuals, 
whereas the synthetic response to the exercise bout in untrained individuals is slower and 
remains elevated over an extended period. However, it is important to keep in mind the 
previously discussed methodological limitations of the studies whose data are used in 
this analysis. Although Figure 6 appears to show the time course of MPS, each data 
point actually represents an acute measurement (in contrast to C-MPS measures, as 
illustrated in Figures 3 and 4), making their area under the curve misleading. As such, 
the conclusions drawn from this figure should be regarded with caution. Based on this 
figure and other data, we hypothesize that free-living individuals respond to training and 
feeding as illustrated in Figure 4, with variable responses between trained and untrained 
subjects. Also, because turnover rates may be faster or slower depending on the specific 
proteins in the muscle, it may be hypothesized that in comparison with untrained 
subjects, trained athletes are more responsive to rapid turnover proteins. Evidence exists 
to support the theory that the acute response to exercise in untrained individuals becomes 
more specialized with training (36, 115). Thus, it has been generally concluded that MPS 
is greater in the untrained state than in the trained state, highlighting the increased 
capacity for LBM accretion in untrained individuals. Indeed, a comparison of untrained 
and trained subjects found the untrained group to have significantly greater hypertrophy 






work (1). Thus, the acute synthetic responses to exercise may differ significantly 
between trained and untrained individuals such that extrapolation of these measurements 
likely is not an accurate measure of these individuals’ potential for LBM accretion. 
Multiple studies have found little or no correlation between initial acute responses to 
exercise and subsequent hypertrophy following training (6, 77, 84). One study used 
principal components analysis to show that pretraining acute anabolic signals did not 
share variance with LBM gains, though a weak relationship was observed with 
postexercise anabolic signaling (84); this result suggests that phosphorylation may be 
involved in acute remodeling leading to hypertrophy but remains a weak predictor of 
LBM accretion in response to chronic exercise. Wilkinson et al. (115) showed that 
mixed MPS may decrease with chronic resistance training, but the change is due to a 
decrease in mitochondrial MPS without a decrease in myofibrillar MPS. Additionally, 
they propose that with training, a state of “signaling efficiency” is reached, wherein key 
anabolic signaling molecules are able to be activated and deactivated more rapidly than 
in the untrained state. Generally, studies with untrained subjects have found benefits to 
timing protein intake with exercise, suggesting that the acute responses associated with 
initial exposure to exercise may require special accommodations in terms of timing 








Figure 6 - Projected time course of muscle protein synthesis (MPS) in humans, 
compiled from several investigations. Figure used with permission from Reference 
32. Abbreviation: AUC, area under the curve. 
 
It has long been hypothesized that a single bout of high-intensity work can lead 
to a robust anabolic response for up to 48 hours, even without feeding. Indeed, a recent 
study found that both mitochondrial and myofibrillar rates of protein synthesis were 
elevated for up to 28 hours following an acute bout of high-intensity exercise, and both 
were significantly higher at 24 to 28 hours compared with 0.5 to 4.5 hours postexercise 
(33). This phenomenon has been referred to as the window of anabolic opportunity, and 
it is hypothesized that feeding during this period should stimulate a greater response than 
feeding at rest. As such, any meal containing an amino acid source consumed within 24 






processes over longer periods to accurately determine the effects of supplementation 
timing. Such quantification has not been possible using traditional methodologies for 
measuring MPS and MPB. Acute measures of MPS in response to exercise and nutrition 
interventions have led to the current dogma that protein should be ingested immediately, 
or at least within two hours, following exercise bouts. Hartman et al. (47) suggest that 
acute changes in protein turnover during postexercise recovery can be at least 
qualitatively predictive of chronic adaptations to different training or feeding 
interventions. However, because there has been no true quantification of C-MPS over 
extended time periods, this idea remains speculative. 
Protein Synthesis Versus Breakdown 
C-MPS is not dependent on individual fluctuations over the time course 
following exercise bouts but rather the end summation of synthetic responses (Figures 1 
and 3). Methodological approaches that allow for the continued assessment of protein 
synthesis over time must be robust enough to measure rates of synthesis even when they 
are impacted by protein breakdown or nutrient intake. Our understanding of protein 
turnover using previous methodological approaches is that an exercise bout results in a 
net loss of muscle protein due to decreased or unchanged protein synthesis and increased 
protein breakdown (20, 26, 96). As noted previously, evidence suggests that the 
mechanism for the greater exercise-induced effects observed when amino acids are 
supplemented immediately postexercise involves an attenuated MPB response (10, 106), 
which would normally increase following exercise. As Burd et al. (14) state, the 






measure of muscle protein breakdown, in skeletal muscle largely precludes its ability to 
be utilized in the fed state and therefore is leaving an incomplete understanding of 
muscle protein turnover following exercise” (p. 1698). Determining the long-term time 
course of muscle metabolic processes over 24 to 48 hours postexercise is critical to the 
understanding of MPB and MPS and how they contribute to overall C-MPS. 
Integration of Recommendations for Timing of and Total Protein Intake to 
Optimize Muscle Protein Synthesis and Accretion with Resistance Exercise 
Training  
While total daily protein intake and timing of protein supplementation with 
exercise have been proposed to affect lean body mass, no interaction effects between the 
total consumption and timing have been investigated.  Potential mechanisms for 
interaction exist and could be tested in future studies using the deuterium oxide labeling 
methodology. 
Potential Mechanisms for Interaction 
Much work has been done to establish recommendations for timing of and total 
protein intake for exercising individuals. The interaction of these two factors, however, 
has been largely ignored. If, in fact, timing of protein intake can be optimized, then the 
increased uptake during this period may allow an overall reduction in the total amount of 
protein consumed over the course of the day. In other words, if MPS is highest following 
exercise, then supplementing in conjunction with the exercise-induced anabolic window 
should provide an adequate supply of amino acids to the muscle precisely at the time 






only marginally increased above the normal recommended intake. Such reasoning 
assumes that the acute muscle protein synthetic response immediately following exercise 
is indeed the optimal time point for protein supplementation. Two alternatives exist to 
this hypothesis. First, if immediate postexercise protein is valuable, then it is possible 
that the total protein intake necessary to optimize muscle responses is higher than 
previously suggested, because studies of total protein intake never accounted for timing 
and therefore may have limited the potential of the response. Second, if timing doesn’t 
matter and optimal total protein over the entire recovery period is the key factor in 
muscle responses, then results of deuterium-measured C-MPS would show no difference 
when total protein is held constant and timing is varied. 
Although most studies suggest that a greater anabolic state requires a greater total 
protein intake, Andrews et al. (3) show, at least in elderly adults, no difference in LBM 
accumulation with RET across a range of total protein intakes when a supplement is 
provided immediately after exercise. They argue, “Consuming protein in the post-
exercise period may be a way to minimize overall protein intake and conserve fat-free 
mass during periods of either increased energy expenditure or marginal protein intake” 
(3, p. 369). Their argument highlights the need for methods that are able to analyze 
muscle protein metabolism over the course of days or weeks as well as cautions against 










The deuterium oxide methodology for measuring muscle protein synthesis could 
alleviate confounding factors associated with current methods of measuring muscle 
protein synthesis. 
Deuterium 
 Issues with metabolic tracers include the necessity for fasted and resting 
subjects, the need for adequate time to achieve a steady state of enrichment, and the 
uncertainty regarding the size of the precursor pool. Even when accurately assessed and 
controlled, the limited duration of these measures makes interpretations about anabolic 
responses problematic for anything other than proteins with short half-lives. It is 
important to note that ingestion of nutrients will dilute tracers and change precursor 
labeling assumptions. In recent years, interest has grown in a methodology that allows 
measurements of MPS over longer periods in free-living subjects. The advantage of 
using deuterium oxide is that it rapidly equilibrates with the total body water pool in 
approximately two hours, which allows for rapid access to hydrogen-containing 
substrates. As such, deuterium molecules are incorporated into multiple metabolic pools 
and tissues because they can be exchanged with existing hydrogens during metabolic 
processes (Figure 5), and this exchange occurs in proportion to the deuterium pool as it 
relates to the total body water pool. By taking advantage of this deuterium labeling 
process, this molecule has been successfully integrated into protein synthesis 
measurements in animals (8, 17, 31, 37, 43, 44, 52, 71, 122) and humans (42, 58, 66, 92, 






organism can be easily controlled, maximizing the stability of the precursor pool over 
the period of measurement. 
A study by Wilkinson et al. (114) utilized deuterium over eight days of RET to 
measure myofibrillar, sarcoplasmic, and collagen protein fractions in eight untrained, 
healthy young men. Subjects undertook one-legged RE in order to confirm work by 
others as to the capacity of deuterium oxide methodologies to measure MPS. No changes 
were detected in the nonexercised leg; however, myofibrillar protein synthesis was 
significantly greater in the exercised leg, with collagen protein synthesis tending to 
increase, whereas no change was observed in the sarcoplasmic fraction. Another study 
compared the FSR measured by both deuterium and phenylalanine flooding in rats 
following RE (44). Neither method detected an effect of RE on FSR in mixed 
gastrocnemius, plantaris, or soleus muscle, and the actual percentage of newly 
synthesized proteins was greater in the measurement taken at 24 hours than at 4 hours 
for both deuterium and phenylalanine. We can conclude from deuterium oxide studies 
that this method provides results that are qualitatively similar to prior approaches but 
may be quantitatively different. 
Future Directions  
Much work has been done to develop the current total protein recommendations 
and to determine the factors that affect overall protein needs, but the timing of protein 
intake is one factor that has been largely ignored. Although the timing of intake and its 
stimulation of MPS have been studied independently, no studies exist related to its effect 






been shown to affect MPS. However, studies have not yet examined total protein intake 
needs over an extended recovery period when timing is optimized in conjunction with 
repeated exercise bouts. If the timing of protein intake does indeed stimulate MPS to a 
greater degree, then optimal timing may decrease total daily protein needs. Thus, 
individuals who have limited energy intake could benefit from such an interaction 
between timing of protein intake and total protein ingestion. Optimally timing protein 
intake with exercise could allow such individuals to meet protein needs on limited 
calories to allow for ingestion of other necessary macronutrients (e.g., carbohydrates for 
athletes) while consuming enough protein to maintain or increase LBM. Alternatively, if 
total protein needs are not altered, the importance of nutrient timing may be overstated 
within the context of the entire recovery period, and only total protein consumption 
should be monitored. Given that MPS peaks 12 to 24 hours after exercise (or even after 
48 hours in untrained individuals), future studies should be designed to determine 
whether the timing of protein intake matters over the course of 24 hours of recovery 
following high-intensity exercise when total protein and energy are held constant. 
Deuterium methodology may be useful to investigate the relationship between timing 
and total protein intake in trained individuals undergoing an intense, stable training 
protocol, and ultimately to rectify two parallel lines of research on protein intake and 
exercise. 
Another goal of future studies should be measurement of MPS across training 
states to determine important transitions in anabolic state with exercise. Untrained 






time course of increased protein need and the effect on efficiency is unknown (18, 60, 
102). Evidence suggests that trained individuals require less protein following training to 
support the maximal protein synthetic response (85) and may exhibit a different time 
course of elevated MPS (14). Shorter experimental periods may not capture adaptations 
to training or to manipulated levels of protein intake. To minimize the effects of training 
status and reduce the effects of adaptation periods, future studies should use trained 
subjects---who are more likely to consume high-protein diets---and longer adaptation 
periods so that steady-state dynamics can be achieved. 
The development of new methodologies together with the lack of information on 
the interactions between total protein intake and timing of intake highlight the need for 
new studies. The limitations of previous methodologies have left gaps in our 
understanding of C-MPS in free-living individuals. Damas et al. (32) state that to 
determine the potential for protein accretion after a bout of RE, analyses of the time 
course and the overall response of MPS are critical. In addition, because multiple factors 
interact to affect synthesis and breakdown following exercise, a methodology is needed 
that can measure these processes in free-living individuals. C-MPS and LBM accretion 
in an individual represent an integrated response of the sum of these factors, which 
include RE bouts, nutrition, sleep, general activity, and genetic predispositions. Focusing 
on any one without regard for the others leaves an incomplete picture of muscle 
metabolism and limits the applicability of results to free-living subjects. 
Damas et al. (32) also pointed out the current lack of information on muscle 






is not only a summation of multiple factors, as listed above, but also a summation of the 
muscle metabolic processes over time. A complete characterization of muscle plasticity, 
growth, and remodeling in response to RET has yet to be realized. Measurements of 
muscle metabolic processes over longer time windows would allow a better 
understanding of the effects of RE and RET on C-MPS and subsequent LBM accretion. 
Indeed, Garlick et al. (41) suggest, “Studies with more sensitive methods over longer 
periods of dietary treatment may be necessary to detect slow rates of accumulation of 
protein of 1 gN/d, which is equivalent to only 0.05% of total body N per day” (p. S41). 
In other words, small changes in protein accumulation may not be seen when measured 
acutely but could be important to LBM accretion over time. Thus, the effects of the 
interaction of total protein intake and timing of intake may be seen only if muscle 
metabolism can be measured over longer time frames following exercise. 
Summary 
Although the field of sports nutrition currently accepts that a protein intake up to 
1.8 g/kg per day is recommended for highly active individuals (50a), and protein/amino 
acid supplementation is critical during the postexercise anabolic window (5), a great deal 
of uncertainty exists regarding these recommendations. Previously, nitrogen balance 
methods have been used to measure muscle metabolic processes over extended periods 
of time but with low resolution. Metabolic tracers have allowed these processes to be 
studied in greater detail but only for short periods of time and under fasted conditions. A 
method utilizing deuterium oxide (2H2O) has also been identified to enable the 






periods of time. This approach warrants further study to examine total protein intake in 
the context of timing of protein intake, which has not been methodologically possible to 
accomplish until now. 
As mentioned above, deuterium oxide methods have been developed to address 
the issues inherent in traditional methods, such as nitrogen balance and metabolic 
tracers. Although the use of nitrogen balance is adequate for establishing requirements to 
prevent deficiency, it is not likely to be adequate to determine optimal intake for 
maximizing muscle metabolic processes. Metabolic tracers are currently the most direct 
measure of protein metabolism; however, this method faces critical issues concerning 
the priming dosage, the method of injection/ingestion, assumptions about precursor 
pools, and assumptions about tracer behavior. A major issue with metabolic tracer use in 
exercise studies is that assumptions about tracer behavior may not hold when metabolic 
rate changes (60, 116). Utilization of deuterium methods will circumvent these 
limitations in order to more accurately measure MPS. Gasier et al. (44) concluded that 
metabolic tracer and deuterium methods provide qualitatively similar results but may be 
quantitatively different. Deuterium methods may prove to be better in establishing 
working recommendations because subjects are not required to be fasting or resting, as 
they must be for metabolic tracer studies. This allows subjects to be free living, which 
removes potentially altered metabolic processes that occur during a fasted state. Tracer 
flooding may also increase pool size and alter metabolic processes, interfering with a 
true measurement of the response to an intervention. Deuterium methods, in contrast, 






maintained by sustaining overall deuterium oxide levels in the organism (40, 44, 58). By 
utilizing this novel methodological application, future work will be able to more 
accurately measure MPS in free-living subjects to better replicate real-world scenarios. 
Although athletes typically ingest high levels of protein, we hypothesize that 
individuals undergoing consistent training have adapted to their workload and do not 
have elevated protein needs. This effect may not have been evident in previous studies 
due to the use of untrained subjects, fasted conditions necessitated by metabolic tracers, 
and/or uncertainty associated with the assumptions made when using previous methods. 
Because previous studies have shown that untrained subjects do require additional 
protein to support LBM accretion during the adaptation response to exercise, protein 
requirements for these subjects may not be easily extrapolated to individuals undergoing 
chronic training. Studies that measure muscle metabolic processes in free-living, steady 
state, trained subjects do not exist; however, this type of study has the potential to 
greatly impact the field of sports nutrition. 
In conclusion, the costs and benefits of high protein intakes need to be 
considered in light of the current standard of consuming large amounts of protein to 
reduce risk of deficiency rather than adhering to currently accepted optimal intakes. 
Lemon (61) cited some benefits of increased protein intakes, such as surplus amino acid 
intake during digestion of a high-protein diet aiding protein synthesis and/or minimizing 
protein breakdown, as well as greater nitrogen retention in novice bodybuilders 
consuming a high-protein diet (334% versus 124% of RDA). However, high protein 






performance. These drawbacks include increased work by the kidneys, dehydration, 
storage of excess protein as fat, a high fat content potentially coupled with the protein, 
and increased calcium loss, which could accelerate osteoporosis, particularly in women 
(60). Optimal dietary protein intake should not cause excessive urea production or 
oxidative losses of amino acids beyond what is necessary for peak functioning (86). 
Because the amino acid pool size cannot be expanded beyond a certain point and 
nitrogen cannot be stored, intake above the threshold will simply be oxidized and/or 
excreted; both of these processes require energy above efficient expenditure. As such, 
large intakes of amino acids can interfere with absorption, contribute to metabolic 
imbalances, and alter brain neurotransmitter activity (61). When protein intake is 
excessively high, degradative pathways may be upregulated to accommodate this state 
so that a subsequent period of lower protein intake may be insufficient to offset losses 
until the body is able to adapt to the new, lower intake (75, 93). Habitual consumption of 
a high-protein diet may cause the increased need for dietary protein due to the adaptation 
of pathways for oxidative amino acid catabolism (74, 76, 93). Such accommodative 
processes may prevent adaptation from occurring by keeping the efficiency of amino 
acid recycling and uptake low. The efficient and optimal utilization of protein and amino 
acids will be key for elite athletes seeking to reach and maintain peak condition and thus 










 Based on the review of the literature in the field of muscle protein synthesis, the 
following points have been identified as areas of future interest: 
1. Future studies should investigate the interaction effect between timing of and total protein 
intake to determine whether optimally timing intake in conjunction with the exercise-
induced anabolic window affects total daily protein needs. 
2. Future studies should determine the effect of training status on longer-term MPS response 
to exercise. 
3. Future studies should determine the relationship between acute and chronic MPS 
responses to exercise. 
4. Future studies should measure C-MPS and subsequent LBM accretion over longer periods 
in order to better understand the overall intervention effect. 
Summary Points 
 The following points summarize the findings from a review of the literature in 
the area of muscle protein synthesis, total daily protein requirements, and timing of 
protein supplementation in conjunction with exercise: 
1. Current protein intake recommendations for endurance athletes and resistance-training 
athletes are 1.2 to 1.4 g/kg per day and 1.6 to 1.8 g/kg per day, respectively. 
2. Inconsistent results in timing and total protein effects on muscle metabolism and LBM 
accretion may be the result of differences in subject training status, fasted status of 






3. Individuals in a stable training program have likely adapted to their workload and may not 
have elevated protein needs. 
4. Although the effect of timing of protein intake in conjunction with exercise may be an 
artifact of the methodologies previously used to measure muscle protein synthesis acutely, 
if there is indeed an optimal window for nutrient ingestion, it is reasonable to hypothesize 
that supplementation at that time would result in a decreased total daily protein 
requirement. 
5. It is unclear whether acute MPS responses can be extrapolated to LBM accretion following 
chronic RET. 
6. Although radioactive metabolic tracer methodologies are currently the gold standard in 
measuring MPS, assumptions about precursor pool labeling and tracer behavior may not 
hold with exercise. 
7. Because deuterium methods are not subject to the same assumptions and limitations as 
other metabolic tracers, deuterium may allow recommendations to be made that have 
better application to real-world scenarios. 
8. Active individuals and athletes often follow an energy-restricted diet; therefore, optimal 
nutrient intake and efficiency of nutrient utilization are critically important to their ability 







CHAPTER III  
DESIGN AND METHODS 
 
Subjects 
Subjects (n=67) were recruited for this study from a pool of trained, healthy 
males between 18 and 29 years old.  Subjects were recruited from Texas A&M 
University, and all subjects were screened prior to participation to ensure that they met 
study requirements for health and “trained” status.  Subjects were required to have at 
least one year of involvement in resistance and aerobic training, which was evaluated by 
a validated physical activity questionnaire to assess their overall training status 
(Appendix A6). Subjects with cardiac abnormalities, history of blood thinning 
medication, chronic illnesses, and other pertinent health conditions were excluded 
(Appendix A3).  First semester students, subjects less than 18 years old, females, and 
individuals with less than one year of resistance or aerobic training were excluded as 
well. Risks and benefits were explained to subjects (Appendix A5), who provided 
written consent (Appendix A1 and A2) to participate in this study in accordance with 
the Texas A&M Institutional Review Board (IRB2016-0376; IBC: 2016-018, 2014-054).  
Of the 67 volunteers, 46 (21.8±3.1 yr, 182.2±6.2 cm, 83.5±13.6 kg) completed the full 
requirements of the study. Subjects were allowed a maximum of two absences from the 
training protocol, and missed sessions were made up within the same week. 









A randomized double blind experimental design was employed.  Participants 
were randomly assigned to low (LO) or high (HI) protein intake groups (1 g-1×kg-1×day-1 
and 2 g-1×kg-1×day-1, respectively).  These groups were further randomized to either 
supplementation immediately post-exercise (IPE), or supplementation three hours 
delayed post-exercise (DPE) (Table 1).  Thus, there were four intervention groups: (1) 
Low Protein Delayed Supplementation (LO/DPE, n=9), (2) Low Protein Immediate 
Supplementation (LO/IPE, n=9), (3) High Protein Delayed Supplementation (HI/DPE, 
n=9), and (4) High Protein Immediate Supplementation (HI/IPE, n=9).  Additionally, a 
non-intervention control group (CON) ingested protein according to their normal diet 





PROTEIN INTAKE DPE IPE 
1 g-1×kg-1×day-1 LO/DPE (n=9) 
LO/IPE 
(n=9) 
2 g-1×kg-1×day-1 HI/DPE (n=9) 
HI/IPE 
(n=9) 
Table 1 - Experimental Design. High and low protein intake groups were 
supplemented either immediately post-exercise or three hours post-exercise.  
 
This study lasted a total of four weeks (31 days).  After recruitment and consent, 
subjects in the intervention groups began a two-week familiarization period to adjust to 






before beginning the two-week intervention period.  While subjects were exempt from 
any external physical training, they logged any and all physical activity on training days 
utilizing a 24-hour recall method (Appendix A11).  Subjects also logged acute sleep 
patterns on training days as well as chronic sleep patterns at baseline and follow-up 
testing using validated Stanford (48a) and Pittsburgh (19a) questionnaires, respectively 
(Appendix A12 and A13).  Muscle biopsies (MB) and deuterium (D2O) administration 
occurred during the final experimental days to measure muscle protein synthesis over the 
entire 24-hour post-exercise recovery period following the final exercise training 
session.  Follow-up measurements were taken 48 hours after the final exercise bout 
(Figures 7 and 8).    
 
 
Figure 7 - Timeline Overview of Study Protocols. Subjects completed two weeks of 
familiarization with the exercise protocol before beginning two weeks of the 
intervention period.  The experimental days began before the final exercise bout. 









Figure 8 - Timeline of Experimental Days. Subjects received a muscle biopsy prior 
to the final bout of exercise, after which deuterium was consumed at intervals 
throughout the day. A second muscle biopsy was taken 24 hours post-exercise. 




Subjects completed an exercise protocol similar to that of Parr et al. (2014), 
which is a concurrent training model designed to simulate the key characteristics of sport 
training by including both resistance training and sprint interval training.  Since the 
majority of sport training consists of intervals of intense interval activity combined with 
a strength-training regimen, this exercise protocol was designed to more closely reflect 
the activities of elite athletes in a typical training environment compared to aerobic or 
resistance exercise training protocols alone.  Additionally, muscle protein synthesis has 
been shown to increase with sprint intervals performed on a cycle ergometer (83aa).  
Sprint intervals and resistance training combine to create a strength and power exercise 






require the highest intake of dietary protein. This protocol was thus designed to simulate 
elite athlete training, maximize muscle protein synthesis, and provide the greatest 
potential to detect effects of total daily and timing of protein intake in a strength and 
power athlete. 
On training days, subjects were asked to jog to the laboratory as part of their 
warm-up.  They then conducted a series of dynamic stretches and plyometrics for three 
minutes.  The sprint intervals were conducted on a cycle ergometer (Schwinn Airdyne, 
Nautilus, Inc., Vancouver, WA) and consisted of a two-minute warm-up followed by 10 
sets of 30-second sprint intervals with 30 seconds of active recovery between each sprint 
bout.  Sprint bouts were performed at 100% effort, measured as a rating of perceived 
exertion (RPE) of 10 using the OMNIResistance Exercise Scale (Appendix A14; 98a).  
The warm-up as well as active recovery were completed at 50% effort, or 5 RPEs.  A 
two-minute cool-down at 50% effort was completed following the final sprint bout, and 
an additional 5 minutes of rest were given before beginning the resistance exercise 
component of the training session.  The resistance-training component consisted of 
bench press, leg press, leg extension, and lat pulls (Keiser, Fresno, CA).  Subjects 
performed a warm-up of five repetitions at 50% of the subject’s one-repetition maximum 
(1RM), and five repetitions at 60% of the 1RM on each machine.  Once warm-up was 
completed, subjects then completed three sets to failure at 80% of their 1RM with three 
minutes of recovery between each set.  If at any point subjects performed less than 4 or 






1RM up or down, respectively, in order to maintain the prescribed intensity. This 
protocol was completed four times per week for two weeks (8 total sessions).   
There was a two-week familiarization period to allow subjects to be introduced 
to the exercise protocol and equipment.  The first four sessions of the familiarization 
period scaled the exercise protocol to approximately 60% of their maximal RPE, while 
the final four sessions were scaled to 70% maximal RPE.  Baseline testing to determine 
1RM was performed after the final familiarization session.  The experimental diet was 
followed during this familiarization period to allow any adaptive processes to occur 
before the start of the intervention.  
Nutrition 
Food intake was controlled and monitored for these subjects by study personnel.  
Prior to the familiarization period, an online nutritional brief was viewed by subjects in 
order to educate their meal choices and provide instruction for logging meals.  
Researchers monitored food log entries on training days to verify appropriate serving 
sizes and macronutrient content. Supplementation for the intervention groups was 
provided in the form of whey protein (Vanilla Cor-Performance Whey, CelluCor, Bryan, 
TX) in the amount of 0.4 g protein per 1 kg of lean mass per dose.  One intervention 
group received their supplement immediately post-exercise (IPE), while the other group 
received their supplement three hours delayed post-exercise (DPE).  The group not 
receiving a protein supplement at a given time (immediate or delayed) did not receive 
any other supplementation and did not ingest any other foods during the three-and-one-






normally over the course of the day without intervention.  All groups maintained 
individualized isocaloric diets so that total energy intake was controlled.  All meals were 
photographed and recorded on each training day, including training during the 
familiarization period, and all food logs (n=16 per person) were analyzed with Nutribase 
Professional 11 (Cybersoft, Phoenix, AZ) to ensure that diets were in accordance with 
study procedures.   
On the experimental day (IPE + 24 hours), subjects were required to follow a 
prescribed diet with administered protein to precisely match their protein level and 
caloric intake.  The non-intervention control group also followed a 2 g/kg/d diet on the 
experimental day to ensure maximal rates of muscle protein synthesis.  Intake during the 
experimental day was verified by written food logs and photographed meals.  
Performance Measures 
Baseline measurements of body composition, strength, 1RM, and power were 
obtained following the familiarization period and prior to the start of the intervention 
period.  Body composition, including whole body percent fat, fat mass, and lean body 
mass, were assessed using dual-energy X-ray absorptiometry (DEXA).  Total thigh and 
thigh cross section composition were also determined from DEXA data as described by 
Hansen et al. (2007).  Assessment of isometric and isokinetic strength for quadriceps and 
hamstring was conducted by measuring force production using an isokinetic 
dynamometer (Biodex Medical Systems, Shirley, NY) as validated by Drouin et al. 
(2004) and summarized by Harbo et al. (2012).  Subjects obtained their 1RM on bench 






machines (leg press, lat pull, knee extension) as an additional measure of strength.  For 
exercises where a 3RM was obtained, the 1RM was calculated using the Epley Equation 
(38a).  Maximum power and relative power were also measured using a power bike 
(Power Cycle SS, Austin, TX) as described by Martin et al. (1997).  Isometric and 
isokinetic strength and power measurements were all normalized to thigh lean mass (in 
kg) for analysis.  All of these measurements were taken again one day after the 24-hour 
post-exercise muscle biopsy (48 hours after the final training session).  
Control Group 
A control group was established to provide a metabolic baseline for the 
intervention groups.  Control subjects did not report to the lab for organized training but 
continued to exercise on their own as normal.  Controls were active in the study for 15 
days, beginning with baseline testing and ending with experimental days and follow-up 
testing.  For each day the intervention group trained, controls logged activity to verify 
they were exercising as normal and completed food logs (8 days total).  Controls 
received the muscle biopsies at the same time points as subjects in the intervention 
groups but did not perform exercise during this time.   The control group followed the 
same protocols on the experimental days for blood draws, biopsies, deuterium 
administration, and standardized protein intake.  Thus, the control group acted as a 
reference point for activity levels, diet, and normal rates of protein synthesis without 









Blood samples were taken in conjunction with deuterium administration and 
muscle biopsies.  Blood samples were drawn without stasis from an antecubital vein 
with the subject seated at quiet rest into Vacutainer tubes containing 10.5 mg Na-EDTA 
for plasma collection.  Plasma samples were immediately isolated by centrifugation at 
2500 x g for 25 minutes at 4°C and stored at -80°C for later analysis.  The first blood 
sample was taken prior to the first muscle biopsy and the start of the final bout of 
exercise to establish each subject’s resting baseline.  Plasma levels of deuterium were 
measured via blood draw immediately after each bolus of deuterium oxide to verify 
maintenance of appropriate levels.  The final blood draw (BD) was taken 24 hours post-
exercise immediately before the second muscle biopsy. 
Muscle Biopsy 
Muscle biopsies were obtained twice: once immediately before the final bout of 
exercise, and again 24 hours after the final bout of exercise.  Biopsies were taken from 
the vastus lateralis under local anesthesia (1% Xylocaine HCl) using a 5-mm needle.  All 
muscle samples were cleaned of visible fat, connective tissue, and blood.  Muscle 
samples were immediately frozen in liquid nitrogen (−190ºC), and then stored at −80ºC 
until analyzed.  Muscle biopsies were necessary to determine cumulative muscle protein 
synthesis based on the measurement of deuterium tracer incorporated into tissue.  
Subjects were given a list of medications to avoid that may increase bleeding risk in 







Muscle Protein Synthesis Using Deuterium 
Deuterium, or “heavy water”, can be used as a means of measuring muscle 
protein synthesis in free-living humans over longer time periods (58).  D2O acts as a 
tracer by equilibrating within the body water pool in approximately 2 hours (44, 114).  
As hydrogen molecules are exchanged, deuterium is incorporated into multiple 
metabolic pools and tissues, including muscle.  The slow rate of decay allows adequate 
concentrations to be maintained within body water over the course of at least one week, 
so that the deuterium can continue to be taken up by muscle to allow for accurate 
measurement of muscle protein synthesis.  Myofibrillar fractional synthetic rate was 
determined from the incorporation of deuterium-labeled alanine into protein, which was 
measured using body water enrichment over the 24-hour recovery period following the 
final bout of exercise. Thus, cumulative protein synthesis was measured over the entire 




The following methods for administering and measuring deuterium have been 
previously published (42, 58).  Subjects received a blood draw and their first of 4 
boluses of 70% 2H2O (3 ml·kg bodyweight total) (Cambridge Isotopes, Andover, MA) to 
achieve approximately 0.4% to 0.8% 2H-labeling of body water immediately following 






following exercise.  Subjects returned to the laboratory 24h following cessation of 
exercise for another blood draw and vastus lateralis muscle biopsy.   
Analysis of Myofibrillar FSR 
 Analysis of 2H-labeling of body water was obtained from the blood draw, and 
protein-bound alanine was determined from the biopsy as previously described (42, 44, 
44a, 58).  In summary, 2.0 µL of 10N NaOH and 4.0 µL of a 5% solution of acetone in 
acetonitrile was added to 20 µL of plasma. After 24 hours, 600 µL of hexane was added 
to separate water from the sample and 200 µL were extracted for measurement. Muscle 
tissue was prepared by pulverizing the entire sample and measuring approximately 50 
mg for subsequent homogenization.  Samples were homogenized in 0.4 mL of 1x Norris 
Buffer with NaF and Na3VO4 and 1% Triton and allowed to settle on ice for one hour.  
Homogenates were then centrifuged at 14,000 rpm for 30 minutes at 4ºC. The 
supernatant containing the cytosolic portion was decanted and stored at -80ºC for future 
Western Blot analysis.  The remaining muscle pellet was vortexed with 300 µL of TCA 
and homogenized once more.  A second “soft” spin at 3800 rpm for 15 minutes at 4ºC 
was performed and the supernatant was decanted.  The addition of TCA and subsequent 
soft spin were performed two additional times for a total of three rounds.  After the final 
soft spin, 6N HCl was added in proportion to sample weight (6 µL per mg) and placed 
on a 100ºC heating block for 24 hours. After heating, 50 µL of the sample was dried 
down in the heating block for one hour before 50 µL of a 3-2-1 methyl-
8/methanol/acetonitrile solution was added. The samples were incubated for one hour 






equipped with an Agilent 6890 GC system and a DB17-MS capillary column (30m x 
0.25 mm x 0.25 µm).  
Statistical Analysis 
The statistical analysis of data collected from the study was broken down into 
preliminary and primary analyses.   
Preliminary Analysis 
Preliminary statistics were conducted to determine power and adequate sample 
size, identify statistical outliers, verify difference from controls, and validate the 
nutritional intervention. 
Power 
The number of subjects per group (n=9) was determined to meet the minimum 
sample size needed to detect differences in 24-hour fractional synthetic rates (%/day) 
between groups with a 1-β of 0.8, based on an estimated effect size of 0.68 standard 
deviation units (based on previous studies measuring FSR with deuterium) and a two-
tailed alpha level of 0.05.   
Outliers 
 Outlier tests were conducted in SPSS for all data sets overall and group by group. 
One control subject was identified as both an overall and group outlier for multiple data 
sets and was thus removed from all further analyses, bringing the control group count to 








A preliminary analysis used four independent samples t-tests to compare the 
primary outcome (FSR) of the non-intervention control group to each of the four 
intervention groups, as well as an independent samples t-test to compare the combined 
training groups together to the control group.  This analysis determined whether there 
was an overall exercise effect as well as effects of each intervention on FSR.  
Additionally, demographic data, MAQ, and sleep variables were analyzed with SPSS 
(IBM Corp. 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY) using 
a one-way ANOVA to ensure the study was well-controlled and groups were not 
significantly different in these areas prior to beginning the study. 
Intervention Validation 
Nutribase food logs were analyzed with SPSS (IBM Corp. 2013. IBM SPSS 
Statistics for Windows, Version 22.0. Armonk, NY) using a one-way ANOVA to 
compare protein intake among groups and thus ensure that subjects followed their 
respective intervention diets.  Other macro- and micro- nutrients were compared, as well 
as total calories, as these have the potential to affect muscle metabolic processes in 
response to exercise.  
Primary Analysis 
Primary analyses focused on the primary outcome of myofibrillar fractional 
synthetic rate as a measure of muscle protein synthesis, and the secondary outcomes of 








Fractional synthetic rates (specifically, myoFSR) for intervention groups were 
normalized a priori to non-exercising (over 24-hour period) controls to measure the 
relative increase in FSR above baseline.  Normalized FSR was then analyzed using a 2 
(total protein intake) x 2 (timing of post-exercise supplementation) independent samples 
ANOVA using SPSS (IBM Corp. 2013. IBM SPSS Statistics for Windows, Version 
22.0. Armonk, NY).  When appropriate, a corrected Tukey’s HSD post-hoc analysis was 
employed to identify differences between factors. 
Secondary Outcomes 
Performance and descriptive data, including 1RM, strength, power, and body 
composition, were analyzed using a one-way ANOVA, with application of a corrected 










 Baseline characteristics of subjects in each group are shown in Table 2; no 
significant differences among groups were found (Appendix B1).  Analysis of the 
Modified Activity Questionnaire (MAQ) showed that subjects were active 10.4±5.6 
hours per week in the past year and had an average lifetime activity level of 18.8±13.8 
hrs/wk (Table 3).  Of that activity, strength training made up 4.2±3.0 hrs/wk in the past 
year and 3.7±4.4 hrs/wk overall (Table 4).  Statistical analysis of the MAQ found no 
significant differences among groups in overall activity or strength training history 
(Appendix B2 and B3, respectively).  There were also no significant differences 
between acute sleepiness among training groups or between baseline and follow-up 
measures of chronic sleep patterns (Appendix B4).  The average Stanford Sleepiness 
Scale (SSS) was a 2.4±0.8, and the Pittsburgh Sleep Quality Index (PSQI) was 5.0±2.1 
and 4.3±2.0 at baseline and follow-up, respectively (Table 5).  All subjects were 










Table 2 – Demographic Characteristics of Five Groups.  Means of age (years), height (cm), and weight (kg) are given 
for each intervention group (LO/DPE, LO/IPE, HI/DPE, and HI/IPE) and the control group (CON).  Overall means for 
the entire study population (Total) are also shown.  There were no significant differences among groups for any 






Group Mean SD Mean SD Mean SD
1 (LO/DPE) 22.0 3.3 185.1 6.5 92.4 16.9
2 (LO/IPE) 22.1 3.4 182.3 7.9 81.5 11.9
3 (HI/DPE) 20.5 3.3 181.5 6.5 75.5 9.0
4 (HI/IPE) 22.9 3.6 180.9 5.8 81.1 7.3
5 (CON) 21.5 2.3 181.3 4.6 85.1 17.6








Table 3 – Overall Modified Activity Questionnaire.  Results of the MAQ for the last year, ages 12-18, ages 19-34, and 
lifetime are given in hours per week (hr/wk) and Met-hours (Met-hr) for each intervention group (LO/DPE, LO/IPE, 
HI/DPE, and HI/IPE) and the control group (CON).  Overall means for the entire study population (Total) are also 







Group Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 8.6 3.9 45.2 18.2 13.5 12.2 80.5 70.6 3.4 3.4 18.0 18.1 14.6 15.1 85.5 86.7
2 (LO/IPE) 7.9 5.2 38.3 24.2 14.0 7.5 91.2 39.7 12.2 9.7 71.7 60.1 24.9 16.6 154.9 93.2
3 (HI/DPE) 10.9 6.4 85.9 115.8 13.5 8.1 91.4 60.8 7.1 8.1 51.1 77.2 19.7 12.7 136.1 121.1
4 (HI/IPE) 11.6 3.9 53.6 15.8 8.5 5.7 48.1 40.8 7.2 7.4 32.6 30.6 15.7 10.4 80.8 51.6
5 (CON) 13.3 7.2 71.4 51.9 9.7 7.3 73.9 93.6 12.0 8.5 62.7 43.5 18.7 13.7 120.9 111.5
Total 10.4 5.6 58.7 58.5 11.9 8.3 77.4 62.6 8.4 8.0 47.1 51.5 18.8 13.8 115.9 95.4
hr/wk Met-hr hr/wk Met-hr
Age 19-34 LifetimePast Year Age 12-18







Table 4 – Strength Training Modified Activity Questionnaire.  Results of the MAQ for strength training for the last 
year, ages 12-18, ages 19-34, and lifetime are given in hours per week (hr/wk) and Met-hours (Met-hr) for each 
intervention group (LO/DPE, LO/IPE, HI/DPE, and HI/IPE) and the control group (CON).  Overall means for the 
entire study population (Total) are also shown.  There were no significant differences among groups for any measure at 




Group Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 2.5 2.2 11.3 10.0 0.8 1.7 3.7 7.6 0.5 1.0 2.3 4.5 1.1 2.4 4.9 10.6
2 (LO/IPE) 3.5 2.1 15.5 9.7 1.1 1.0 4.9 4.3 2.4 1.7 10.9 7.4 3.4 2.1 15.3 9.3
3 (HI/DPE) 4.7 3.7 21.0 16.7 2.7 3.2 12.2 14.5 2.0 3.2 8.9 14.4 4.7 5.7 21.1 25.8
4 (HI/IPE) 5.3 2.4 23.8 10.6 0.9 1.0 4.1 4.4 2.7 2.5 11.9 11.2 3.6 2.8 16.1 12.6
5 (CON) 5.1 3.7 23.0 16.6 2.3 2.2 10.2 10.0 3.9 4.5 17.7 20.3 6.2 6.5 27.8 29.2
Total 4.2 3.0 18.9 13.3 1.6 2.1 7.1 9.2 2.3 2.9 10.4 13.0 3.7 4.4 16.7 19.6
Age 19-34 Lifetime
hr/wk Met-hr hr/wk Met-hr
Past Year Age 12-18







Table 5 – Acute and Chronic Sleep Pattern Measures.  Mean acute sleepiness, represented by the Stanford Sleepiness 
Scale, and mean chronic sleep quality, represented by the Pittsburgh Sleep Quality Index, are given in scale units for 
each intervention group (LO/DPE, LO/IPE, HI/DPE, and HI/IPE) and the control group (CON).  Overall means for the 
entire study population (Total) are also shown.  There were no significant differences among groups for any measure at 
any time point (Appendix B4).
Group Mean SD Mean SD Mean SD
1 (LO/DPE) 2.7 1.4 4.2 2.2 3.4 2.2
2 (LO/IPE) 2.5 0.7 5.4 2.8 4.8 2.3
3 (HI/DPE) 2.5 0.3 5.8 1.6 4.9 2.1
4 (HI/IPE) 2.1 0.6 5.0 1.3 4.4 1.4
5 (CON) - - 4.8 2.5 4.2 2.0
Total 2.4 0.8 5.0 2.1 4.3 2.0









 Food logs for subjects engaged in training were analyzed separately for the 
familiarization period (FAM) and the intervention period (INT) (Table 6). There were 
no significant differences between the familiarization and intervention diet within the 
low and high protein groups (Appendix B5 and B6, respectively). The low and high 
protein intake intervention groups were compared to controls, as seen in Table 7.  
Low protein groups consumed a significantly lower average calorie intake of 
2031±593 versus 2655±489 calories in the high protein group (p=0.013, Appendix B7 
and B8).  Low protein groups consumed a diet of 24±5, 43±9, 33±7% of calories from 
protein/carbohydrate/fat compared to 27±5, 42±5, 31±5% in high protein groups, and 
22±4, 43±8, 33±6% in controls.   
Protein consumption relative to total body weight was an average of 1.3±0.3 
g/kg/day in the low protein groups compared to 2.2±0.3 g/kg/day in the high protein 
groups (p<0.001, 95% CI [-1.2, -0.5]), while control group protein intake fell between 
the two intervention groups at 1.6 g/kg/day, which was significantly lower than the high 
protein group (p=0.002, 95% CI [-1, -0.2]).   
Protein consumption relative to lean mass was significantly lower for the low 
protein groups at 1.9±0.5 g/kg/day compared to the high protein group that ingested 
2.7±0.5 g/kg/day (p=0.002, 95% CI [-1.2, -0.3].  Again, the control group fell between 
the high and low protein groups and consumed 2.1±0.9 grams of protein per kg lean 






A Tukey HSD post-hoc test revealed that the low protein group ingested 
significantly less Omega-6 (p=0.046), ash (p=0.006), choline (p=0.01), Vitamin D3 
(p=0.014), gamma tocopherol (p=0.012), magnesium (p=0.021), potassium (p=0.031), 
and selenium (p=0.001) compared to controls (Appendix B8).  Low protein groups 
ingested significantly less cholesterol than high protein groups (p=0.043) and control 
group (p=0.001).  Retinol, Vitamin D, Vitamin D2+D3, delta tocopherol, Vitamin K1D, 
and phosphate were all lower in intervention groups than controls but were not 
significantly different from each other (Appendix B8). Little amino acid data was 
available for analysis in Nutribase, but differences in logged amino acids can be found in 
Appendix B6a.  Furthermore, comprehensive nutritional analyses of all assessed 








Table 6 – Summary of Nutrition for Low and High Protein Groups During Familiarization and Intervention Periods. 
Calorie and macronutrient intake during familiarization and intervention periods compared for combined low and 
combined high protein groups.  There were no significant differences among groups for any measure at any time point 
(Appendix B5 and B6). 
 
Group Period Mean SD Mean SD Mean SD Mean SD Mean SD
FAM 2233 656 9342 2744 122 30 1.4 0.4 1.9 0.5
INT 2031 593 8490 2486 112 21 1.3 0.3 1.8 0.3
FAM 2557 635 10696 2655 162 37 2.1 0.4 2.7 0.5
INT 2655 489 11106 2047 170 31 2.2 0.3 2.8 0.5
Group Period Mean SD Mean SD Mean SD Mean SD Mean SD
FAM 266 89 79 31 23 6 44 9 32 7
INT 239 84 74 27 24 5 43 9 33 7
FAM 273 81 93 29 26 4 40 7 33 4















Table 7 – Summary of Nutrition for Three Groups.  Macronutrients and significant micronutrients compared for three 
groups: Low Protein, High Protein, and Control.  Overall means for the entire study population (Total) are also shown. 
Significant differences among groups were found for total calories, energy, total calories from protein, %calories from 
protein, total grams of protein, grams per kg total body mass per day protein, grams per kg lean mass per day protein, 
and all displayed micronutrients (* = ANOVA p<0.05; ᵃᵇ = Tukey p<0.05).  See Appendix B6a for full table, and 
Appendix B7 and B8 for analyses.
Group n Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 2031ᵃ 593 8490ᵃ 2486 459ᵃ 90 24ᵃᵇ 5 882 326 43 9 684 259 33 7
High Protein 18 2655ᵇ 489 11106ᵇ 2047 696ᵇ 127 27ᵃ 5 1122 274 42 5 826 208 31 5
Control 9 2429ᵃᵇ 908 10165ᵃᵇ 3798 534ᵃ 210 22ᵇ 4 1017 318 44 9 878 482 35 8
Total 45 2360 677 9871 2838 569 171 25 5 1005 317 43 8 780 302 33 6
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 112ᵃ 21 1.3ᵃ 0.3 1.9ᵃ 0.5 239 84 74 27
High Protein 18 170ᵇ 31 2.2ᵇ 0.3 2.7ᵇ 0.5 299 73 89 22
Control 9 130ᵃ 51 1.6ᵃ 0.7 2.1ᵃᵇ 0.9 268 83 95 53
Total 45 139 42 1.7 0.6 2.2 0.7 268 83 84 33
Group n Mean SD Mean SD Mean SD Mean SD
Low Protein 18 195 68 2.7 2.2 2 5 30 25
High Protein 18 384 180 4.9 3.7 3 9 122 130
Control 9 564 437 8.2 7.1 25 48 278 406
Total 45 345* 262 4.7* 4.5 7* 23 116* 213
Group n Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 53ᵃ 64 35ᵃ 61 0.1ᵃ 0.3 0.2ᵃ 0.5 0.6ᵃ 0.8 0ᵃ 0 1ᵃ 2.9
High Protein 18 61ᵇ 81 66ᵃ 65 0.7ᵃᵇ 1.2 0.8ᵃ 1.2 1.4ᵃᵇ 1.9 0.1ᵃ 0.3 1.1ᵃ 2.0
Control 9 190ᵇ 202 163ᵇ 169 2.3ᵇ 3.8 2.9ᵇ 3.8 2.4ᵇ 1.9 0.4ᵇ 0.5 4.1ᵇ 4.7
Total 45 84 120 73 103 0.8 2.0 1.0 2.1 1.3 1.7 0.1 0.3 1.6 3.2
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 66ᵃ 59 226ᵃ 154 711ᵃ 492 2901 1014 12ᵃ 10
High Protein 18 118ᵃᵇ 85 456ᵃ 314 1067ᵃᵇ 653 3874 1243 43ᵃᵇ 40
Control 9 165ᵇ 133 876ᵇ 754 1475ᵇ 1113 4013 1822 74ᵇ 69
Total 45 107 94 448 456 1006 752 3512* 1362 37 45
GammaTocopherol(mg) DeltaTocopherol(mg) Vit-K1D(mcg)
Minerals Magnesium(mg) Phosphate(mg) Potassium(mg) Sodium(mg) Selenium(mcg)





Macronutrients Protein(g) Protein(g/kg TOTAL)
Calorie Information Calories Energy(kj) Calories/Protein %Calories/Protein Calories/Carbohydrate








 Analysis of thigh cross section from DEXA data was conducted by two 
researchers with an intertester correlation of 99%.  Total body percent fat and lean mass 
were not significantly different at baseline or follow-up among groups, nor was there a 
significant change between the two time points for either measure (Table 8, Appendix 
B12).  However, change in thigh percent fat (p=0.002) and percent change in total thigh 
fat mass (p=0.034) were significantly greater in the LO/DPE group compared to controls 
(Tables 9-10, Appendix B13-15).   
ANOVA found significant differences among groups in change in cross section 
percent fat (p=0.002) and percent change in thigh cross section fat mass (p=0.033) but 
Tukey HSD did not detect group differences.  Baseline thigh fat mass was higher in the 
LO/DPE group compared to HI/DPE (2820.6±1325.6 vs. 1615.5±629.1 grams, p=0.05) 
and HI/IPE (2820.6±1325.6 vs. 1587.5±454.5 grams, p=0.047), and baseline cross 
section fat mass was higher in the LO/DPE group compared to HI/DPE (74.1±38.7 vs. 
38.2±16.5 grams, p=0.045; Appendix B15).  Total thigh lean mass and thigh cross 
section lean mass were not significantly different among groups. 
Normalized isokinetic knee extension strength was significantly greater at 
baseline in the LO/IPE and HI/DPE groups compared to controls (p=0.044 and p=0.024, 
respectively; Table 11, Appendix B16 and B18).  A paired samples test found that 
normalized power increased from baseline to follow-up for all groups (p<0.001), but 
there were no significant differences among groups at baseline or follow-up for 






Analysis of 1RM (in total pounds) found absolute knee extension at follow-up 
was significantly greater in the LO/DPE group compared to controls (250.4±25.4 vs. 
192.2±31.4, p=0.006), and the percent change in knee extension 1RM was greater in the 
HI/DPE group compared to controls (p=0.006) (Appendix B17-18).   
An independent samples test found significantly greater percent increase in leg 
press 1RM and knee extension 1RM in the combined intervention groups vs. controls 
(p=0.027 and p=0.006, respectively), but no other significant differences were found 








Table 8 – Total Body Composition for Five Groups.  Values at baseline and follow-up and change between the two time points 
are given for total body percent fat and lean mass for each intervention group (LO/DPE, LO/IPE, HI/DPE, and HI/IPE) and 
the control group (CON). Overall means for the entire study population (Total) are also shown.  There were no significant 






Group Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 24.2 5.9 23.6 5.7 -0.6 0.6 66.5 8.7 67.3 8.7 0.7 0.9
2 (LO/IPE) 20.0 5.8 19.8 6.0 -0.2 1.1 62.6 9.7 62.4 9.1 -0.2 1.0
3 (HI/DPE) 18.8 6.3 18.9 5.9 0.1 0.8 58.6 7.2 59.1 7.4 0.5 0.6
4 (HI/IPE) 18.7 3.4 18.6 3.1 -0.1 0.7 63.2 4.9 63.1 4.3 -0.1 1.3
5 (CON) 18.7 3.4 21.6 7.1 0.2 1.1 63.0 10.6 63.1 10.4 0.1 1.6
Total 21.4 6.7 20.5 5.8 -0.1 0.9 62.8 8.5 63.0 8.3 0.2 1.1
Total Body Composition
% Fat Lean Mass (kg)







Table 9 – Total Thigh Composition for Five Groups.  Values at baseline and follow-up and percent change between the two 
time points are given for total thigh percent fat, total thigh fat mass, and total thigh lean mass for each intervention group 
(LO/DPE, LO/IPE, HI/DPE, and HI/IPE) and the control group (CON).  Overall means for the entire study population (Total) 
are also shown.  Significant differences among groups were found for change in thigh percent fat, baseline thigh fat mass, and 







Group Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 23.2 6.6 22.1 6.6 -1.1ᵃ 1.2 2820.6ᵃ 1325.6 2690.5 1285.5 -4.5ᵃ 5.7 8796.0 1328.6 8919.1 1291.9 1.6 3.6
2 (LO/IPE) 18.3 4.9 18.0 5.4 -0.3ᵃᵇ 1.2 1786.8ᵃᵇ 549.8 1783.8 615.9 -1.0ᵃᵇ 8.6 7971.4 1331.1 8089.7 1386.1 1.5 1.7
3 (HI/DPE) 17.4 5.7 17.3 5.5 -0.1ᵃᵇ 0.9 1615.5ᵇ 629.1 1606.6 614.7 0.0ᵃᵇ 5.8 7539.8 1148.1 7565.8 1167.7 0.4 3.7
4 (HI/IPE) 16.3 3.5 15.8 3.2 -0.4ᵃᵇ 0.9 1587.5ᵇ 454.5 1563.3 449.0 -1.5ᵃᵇ 4.1 8040.8 960.0 8156.3 932.6 1.5 3.0
5 (CON) 19.9 7.0 20.8 7.3 0.9ᵇ 0.6 2194.3ᵃᵇ 1201.6 2298.7 1283.3 4.6ᵃᵇ 3.6 8180.4 1575.7 8113.8 1617.0 -0.9 1.9













Table 10 – Thigh Cross Section Composition for Five Groups.  Values at baseline and follow-up and change between the two 
time points are given for thigh cross section percent fat, thigh cross section fat mass, and thigh cross section lean mass for each 
intervention group (LO/DPE, LO/IPE, HI/DPE, and HI/IPE) and the control group (CON).  Overall means for the entire 
study population (Total) are also shown.  Significant differences among groups were found for change in thigh cross section 
percent fat, baseline cross section fat mass, and percent change in cross section fat mass (* = ANOVA p<0.05; ᵃᵇ = Tukey 
p<0.05, Appendix B14 and B15). 
 
 
Group Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 18.3 6.5 17.6 6.3 -0.6 1.6 74.1ᵃ 38.7 71.1 37.8 -3.8 9.8 311.1 43.9 311.9 40.0 0.5 3.8
2 (LO/IPE) 14.3 4.6 13.3 4.6 -1.0 2.0 47.1ᵃᵇ 18.6 44.7 19.2 -5.0 15.7 280.7 41.6 288.1 43.4 2.7 2.8
3 (HI/DPE) 12.2 4.5 13.1 5.1 0.9 1.1 38.2ᵇ 16.5 41.8 18.6 9.4 8.1 270.3 35.8 271.1 32.9 0.5 4.1
4 (HI/IPE) 11.9 2.6 11.4 3.4 -0.5 1.5 40.4ᵃᵇ 12.1 39.3 14.3 -4.2 13.4 294.3 34.3 298.3 31.0 1.5 2.6
5 (CON) 15.5 6.4 16.3 6.7 0.9 1.3 59.5ᵃᵇ 34.3 63.7 37.0 7.5 11.2 302.2 52.3 303.3 49.7 0.5 3.0
Total 14.4 5.4 14.4 5.6 -0.1* 1.7 51.9 28.4 52.1 29.0 0.8* 13.1 291.7 42.8 294.5 40.7 1.1 3.3
Baseline%ChangeFollow-UpBaselineChangeBaseline Follow-Up
Thigh Cross Section Composition








Table 11 – Normalized Strength and Power for Five Groups.  Values at baseline and follow-up and percent change between 
the two time points are given for normalized isokinetic flexion and extension strength (ft-lbs/kg thigh lean mass), isometric 
strength (ft-lbs/kg thigh lean mass), and right leg power (Watts/kg thigh lean mass) for each intervention group (LO/DPE, 
LO/IPE, HI/DPE, and HI/IPE) and the control group (CON).  Overall means for the entire study population (Total) are also 
shown.  Significant differences among groups were found for baseline normalize isokinetic knee extension (ᵃᵇ = Tukey p<0.05, 
Appendix B16 and B18). 
 
Group Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 10.0 2.0 10.1 1.6 2.5 12.5 19.9ᵃᵇ 3.0 20.0 3.3 0.7 10.0
2 (LO/IPE) 10.6 1.3 10.7 1.9 1.8 14.2 20.4ᵃ 2.2 21.0 3.4 2.7 8.8
3 (HI/DPE) 10.5 1.6 10.4 2.1 -0.5 17.9 21.0ᵃ 2.0 18.8 3.6 -10.3 17.4
4 (HI/IPE) 9.4 1.9 10.5 2.2 12.1 6.9 19.7ᵃᵇ 3.2 20.2 3.3 2.8 5.9
5 (CON) 8.2 1.5 8.9 2.1 7.4 13.3 16.3ᵇ 2.7 16.9 2.9 4.1 13.9
Total 9.8 1.8 10.2 2.0 4.5 13.4 19.6 2.9 19.6 3.4 0.1 11.9
Group Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 23.3 3.4 22.7 5.3 -3.2 16.5 130.3 19.7 141.7 16.1 9.5 9.0
2 (LO/IPE) 22.4 3.4 21.4 2.9 -3.2 17.7 146.8 14.2 153.4 12.6 5.2 11.9
3 (HI/DPE) 21.2 3.1 20.4 4.9 -4.1 16.4 132.0 16.9 144.5 14.7 10.1 9.2
4 (HI/IPE) 23.1 3.9 22.1 4.5 -4.5 5.0 137.2 11.9 146.9 15.4 7.4 10.9
5 (CON) 20.2 3.6 19.2 3.9 -4.9 7.0 125.4 12.5 132.8 23.2 6.1 17.6

















Table 12 – One Repetition Maximum Testing Results for Five Groups.  Values at baseline and follow-up and percent change 
between the two time points are given for bench press, leg press, lat pull down, and knee extension 1RM (lbs) for each 
intervention group (LO/DPE, LO/IPE, HI/DPE, and HI/IPE) and the control group (CON).  Overall means for the entire 
study population (Total) are also shown.  Significant differences among groups were found for knee extension 1RM at follow-
up (ᵃᵇ = Tukey p<0.05, Appendix B17 and B18). 
Group Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 223.3 39.2 238.3 38.6 7.1 4.7 1145.6 256.1 1338.3 415.5 15.1 10.2
2 (LO/IPE) 215.6 56.4 231.7 56.6 7.8 3.2 1087.5 306.8 1282.6 503.4 16.1 14.4
3 (HI/DPE) 199.4 45.9 212.8 52.4 6.5 4.0 976.5 131.9 1049.2 131.2 7.6 4.4
4 (HI/IPE) 222.2 54.7 238.9 50.6 8.4 4.9 981.9 117.6 1135.0 167.4 15.6 10.1
5 (CON) 199.4 51.9 210.0 57.7 5.0 2.8 1022.8 310.4 1054.5 276.0 4.3 12.3
Total 212.0 48.9 226.3 50.8 7.0 4.0 1042.9 237.8 1171.9 337.5 11.7 11.4
Group Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 211.7 42.4 231.1 45.8 9.4 4.0 217.8 14.5 250.4ᵃ 25.4 15.0 9.0
2 (LO/IPE) 218.4 55.1 244.1 62.1 11.9 5.1 196.8 36.9 229.9ᵃᵇ 39.9 17.2 6.0
3 (HI/DPE) 202.3 43.6 229.6 57.0 13.0 8.0 187.0 33.8 220.3ᵃᵇ 40.4 18.7 15.6
4 (HI/IPE) 214.9 28.3 237.1 27.5 10.7 7.1 202.4 26.2 231.7ᵃᵇ 29.3 14.7 6.7
5 (CON) 193.2 44.3 213.1 39.8 12.9 24.5 180.3 26.1 192.2ᵇ 31.4 6.4 5.7
Total 208.1 42.6 231.0 47.0 11.6 11.8 196.8 30.2 224.9 37.6 14.4 9.9
%Change%Change
Bench Press 1RM Leg Press 1 RM
Lat Pull Down 1RM Knee Extension 1RM
Baseline Follow-Up Baseline Follow-Up








 Myofibrillar fractional synthetic rates over the 24-hour measurement period are shown 
for the combined intervention groups and the control group in Table 13. Levene’s Test of Equal 
Variances was rejected, therefore equal variances were not assumed for the independent samples 
t-test and FSR was significantly greater in the combined training groups compared to controls 
(p=0.009, 95% CI [3.4, 21.5], Appendix B19).  Individual intervention groups were also 
compared to the control group (Table 14), but only the LO/DPE group exhibited a significantly 
greater FSR compared to the control group that did not exercise during the 24-hour protein 
synthesis measurement period (p=0.043, 95% CI [0.9, 43.6], Appendix B20).   
 
 
Table 13 – FSR for Combined Intervention Groups vs. Control. Mean myofibrillar 
fractional synthetic rates (%/day) are given for the combined intervention groups (n=36) 
compared to control group (n=9). The combined intervention group FSR was significantly 





Group N Mean SD SEM
INT 36 28.6ᵃ 19.7 3.3
CON 9 16.1ᵇ 8.9 3.0







Table 14 – FSR for Individual Intervention and Control Groups.  Mean myofibrillar 
fractional synthetic rates (%/day) are given for each intervention group (LO/DPE, LO/IPE, 
HI/DPE, and HI/IPE) and the control group (CON). The LO/DPE group FSR was 
significantly greater than control group FSR (* = Independent Samples t-test p<0.05, 
Appendix B20). 
 
 Fractional Synthetic Rates of intervention groups normalized to controls are summarized 
in Table 15 as well as in Figure 9.  There were no significant main or interaction effects of total 
protein intake and timing of supplementation on FSR (Appendix B21-22).  Pairwise 
comparisons of High and Low total protein intake as well as Immediate and Delayed 
supplementation did not yield significant results (Appendix B23-24), nor did univariate tests of 




Group No. Group Name N Mean SD SEM
1 LO/DPE 9 38.4ᵃ 27.2 9.1
2 LO/IPE 9 26.6 16.1 5.4
3 HI/DPE 9 26.7 17.1 5.7
4 HI/IPE 9 22.6 15.9 5.3
5 CON 9 16.1ᵇ 8.9 3.0







Table 15 – FSR for Intervention Groups Normalized to Control. Means of myofibrillar 
fractional synthetic rates for total protein (low vs. high) and timing of supplementation 
(delayed vs. immediate) normalized to control group means. Means shown represent fold 
























Protein Level Supplementation Time Mean SD N
DPE 1.7 1.1 9
IPE 1.4 1.0 9
Total 1.5 1.0 18
DPE 2.4 1.7 9
IPE 1.6 1.0 9
Total 2.0 1.4 18
DPE 2.0 1.4 18
IPE 1.5 1.0 18
Total 1.8 1.2 36































Figure 9 – Mean FSR for Intervention Groups Normalized to Control.  Means 
of myofibrillar fractional synthetic rates for total protein (low vs. high) and 
timing of supplementation (delayed vs. immediate) normalized to control group 
means. There were no significant differences among groups.  Means shown 
represent fold difference from control group. Delayed supplementation is shown 
in blue while immediate supplementation is shown in red. Error bars represent 










The novel finding of this study was that no significant differences in muscle protein 
synthesis were detected between high and low daily protein intake or timing of protein 
supplement ingestion following exercise in a study of 36 young well-trained males who engaged 
in 4 weeks of concurrent, simulated elite athlete training (control group n=9).  This conclusion is 
contrary to the currently accepted dogma that greater protein intake is necessary for strength and 
power athletes, and that supplementation immediately post-exercise results in an elevated 
anabolic condition.  
This study was well-controlled using an age- and activity-matched control group which 
served as a baseline to indicate the initial metabolic state of all other groups prior to dietary and 
supplementation interventions imposed by the study.  This status of uniformity among groups at 
baseline was ensured by screening processes and verified by multiple measurements, including 
demographic data, activity levels, sleep patterns, body composition data, and strength and power 
measurements.  No significant differences were found in demographic data including height, 
weight, and age.  Likewise, acute and chronic sleep patterns were similar among groups.  
Analysis of the MAQ indicated no significant differences among groups for total activity levels 
or strength training history in the past year or over their lifetime, and all groups were highly 
active across a variety of sports and training modes.  Total body percent fat and lean mass were 
not significantly different among groups, although baseline thigh fat mass was higher in the 






LO/DPE group compared to HI/DPE.  Elevated fat mass in the thigh region prior to the start of 
the intervention period should not have affected primary outcomes of the study.  Most 
importantly, lean mass in the thigh region was similar among groups.  Normalized isokinetic 
knee extension strength was significantly greater at baseline in the LO/IPE and HI/DPE groups 
compared to controls, but all other measures of isokinetic or isometric strength, 1RM, and power 
were similar among groups at baseline.  While the control group did not perform exercise on the 
experimental day, they were highly active and engaged in regular training on their own over the 
course of the two-week period between baseline and follow-up testing.  Specifically, individuals 
in the control group were engaged in either military ROTC training (n=5), or university-affiliated 
club sports including weight lifting, rowing, and wrestling (n=4).  
This study did not investigate training effects but focused on dietary and supplemental 
intervention.  Subjects recruited to the study were already engaged in both cardiovascular and 
resistance training with a minimum training history of one year.  The purpose of the training 
protocol was to create a uniform, high-intensity stimulus among all intervention groups prior to 
measurement of muscle protein synthesis.  Standardized training allowed individuals to adapt to 
the exercise protocol during the two-week familiarization period and maintain a high level of 
exercise intensity throughout the two-week intervention period of the study.  Previous research 
has indicated that adaptation to exercise occurs over 14-16 days (18); however, our study lasted 
for 31 days and included 16 training days, thus ensuring adequate time for both learning and 
adapting to the established training protocol.  Concurrent training of sprint intervals followed by 
resistance exercise mimicked the format of workouts followed by elite athletes and developed 






of the study ensured a steady-state, high-intensity training environment for fit, young males with 
verified training history. 
The combined intervention groups were compared to the control group a priori with an 
independent samples t-test to establish that there was indeed an effect of exercise on mean FSR 
over the 24-hour measurement period.  The combined intervention groups did in fact exhibit an 
FSR significantly higher than the non-exercising control group.  However, when intervention 
groups were compared to the control group individually, only LO/DPE was significantly 
different from controls.  While all exercised groups exhibited greater mean FSR compared to the 
unexercised control group, the mean difference was significantly greater for the LO/DPE 
intervention group vs. controls.  
Intervention groups were normalized to control group mean FSR to provide a measure of 
the relative increase in FSR above the baseline represented by the age- and activity- matched 
control group that refrained from exercise on the experimental day.  As seen in Figure 9, mean 
normalized FSR was higher for the LO/DPE group, although this difference did not achieve 
significance.  Therefore, in conclusion, no differences in myofibrillar FSR were identified among 
groups that either consumed high or low protein or consumed the protein either immediately 
after exercise or delayed 3 hours.  
Secondary Outcomes 
Differences between low and high protein groups were verified at 1.3 and 2.2 g/kg/day 
(1.9 and 2.7 g/kg lean mass/day), respectively, with the control group protein intake falling at a 
moderate intake of 1.6 g/kg/day (2.1 g/kg lean mass/day).  Food logs during the familiarization 
period were not used for comparative analysis due to greater variation as subjects became 






logs for two weeks only, thus comparisons between intervention groups and the control group 
necessitated utilization of food logs completed during the two weeks between baseline and 
follow-up testing.  Regardless, analysis of food logs during the familiarization period and the 
intervention period for subjects engaged in training showed no significant differences between 
these two time periods.   
The decreased caloric intake in the low protein group reflected the difficulty in 
convincing subjects to replace protein sources with greater carbohydrate intake.  While there 
were no significant differences in carbohydrate or fat consumed between high and low protein 
groups, the reduction of calories from protein resulted in lower overall caloric intake for the low 
protein groups.  Despite the fact that the low protein diet was also lower in calories, there were 
no detrimental effects on performance measures, body composition, or rates of muscle protein 
synthesis.  
Interestingly, there were no differences in any measure of lean mass or lean mass change 
in total body, total thigh, or thigh cross section among groups.  This result suggests that multiple 
strategies for maintaining and/or accreting muscle mass may be utilized depending on the level 
of dietary protein intake.  The conclusion that ingesting a 1.3±0.3 g/kg/day protein diet, 
considered “low” compared to recommended protein intakes and actual amounts of protein eaten 
by athletes, coupled with three-hour delayed nutrient ingestion post-exercise did not negatively 
affect muscle mass is at odds with the high protein, post-exercise supplementation dogma that 
would predict an increase in protein degradation and decrease in muscle anabolism in this 
condition based upon studies individually examining protein timing and total protein 






While the LO/DPE group had a higher thigh fat mass at baseline, their average fat mass 
at follow-up was similar which resulted in a greater decrease in fat mass from baseline to follow-
up.  It is possible that the lower caloric intake of the LO/DPE group caused greater utilization of 
fat stores for energy while preserving lean mass.  On the other hand, groups with higher protein 
intakes may have converted excess amino acids to energy substrate, preventing the need to tap 
into fat stores.  Previous studies have proposed the “muscle full” hypothesis that once a 
maximum amount of amino acids is delivered to the muscle, any additional amino acids will be 
oxidized for energy (6, 10a, 76a). This strategy may not be advantageous, however, and potential 
drawbacks of excess nitrogen in the diet will be discussed further. 
While normalized isokinetic knee extension strength was significantly greater at baseline 
in the LO/IPE and HI/DPE groups compared to controls, there were no other significant 
differences at follow-up or in percent change for any strength and power measures that were 
normalized to thigh lean mass.  Our tests of 1RM did show greater absolute strength in knee 
extension at follow up in LO/DPE compared to controls, and a greater percent change in knee 
extension 1RM in HI/DPE compared to controls.  It is possible that there was some sort of 
learning effect associated with the knee extension machine, since multiple groups showed a 
significant increase over controls who did not use the machine regularly.  While both legs were 
exercised simultaneously on the knee extension machine, the unilateral design allowed each leg 
to move independently and therefore isolated each individual quadricep muscle.  At the time of 
baseline testing, subjects in the intervention groups would have used the machine for two weeks 
during the familiarization period, potentially giving them an advantage over the control group.  
This exercise is likely the most applicable exercise due to the isolation of the muscle that was 






suggesting yet again that total and timing of protein intake did not differentially affect 
performance measures.  
Discussion 
As previously discussed in the Introduction, many factors could have influenced results 
of previous studies that found increased rates of protein synthesis with high levels of protein 
ingestion and protein supplementation immediately post-exercise.  The use of untrained subjects 
and/or subjects not yet adapted to the prescribed exercise stimulus could have caused an 
exaggerated response to exercise and protein ingestion.  Untrained subjects have been shown to 
exhibit elevated protein requirements during the adaptation period (60, 61, 102). However, this 
condition does not describe the athletic population to which resulting recommendations have 
been applied.  This study not only utilized subjects with a uniform, habitual training background, 
but also allowed ample time for subjects to reach a steady-state within the training protocol.  
Use of fixed label isotopic tracers that require fasting prior to and resting during infusion 
may alter the metabolic state post-exercise and thus affect rates of protein synthesis.  Even with 
fasting, assumptions regarding the precursor pool of the label used are likely incorrect (40).  
Additionally, the assumptions of tracer behavior may not hold with exercise (40, 116), which is a 
key component to the question at hand.  Due to both fasting and resting requirements, the 
window of measurement with fixed label isotopic tracers has remained small, typically 1-3 hours 
(40).  However, individual responses to feeding and exercise vary, necessitating a larger 
measurement period to observe the cumulative effect of these stimuli.  Previous studies that have 
shown an increase in rates of protein synthesis without subsequent increases in lean mass may 
thus be confounded by the fixed label methodology used to measure MPS (3, 34, 53, 82).  






previous studies’ conclusions regarding timing of protein supplementation.  If subjects were 
already fasted prior to the exercise and nutrition intervention as a requirement for fixed label 
isotopic tracer methods, then subjects receiving their supplement at a later time point post-
exercise would experience a longer period of net negative amino acid balance.  This extended 
period of MPB caused by methodological limitations could create the appearance of a 
detrimental of effect of delayed supplementation compared to immediate supplementation.   
Conversely, measurement of FSR with the deuterium oxide label does not require fasting, 
resting, or assumptions regarding a precursor pool.  Therefore, the subject’s metabolism, 
specifically amino acid metabolism, is not impacted and the deuterium molecule will continue to 
label nutrients ingested throughout the day at the same proportion to the deuterium pool as it 
relates to the total body water pool.  Additionally, utilization of the deuterium tracer allows 
labeling of amino acids to occur as proteins are degraded and the resulting free amino acids are 
recycled for new protein synthesis.  When degraded proteins enter the free amino acid pool, they 
can be labeled by deuterium before reincorporation into muscle tissue.  Therefore, the results of 
our study may differ from previous results due the ability of the deuterium method to account for 
variation in recycling efficiency.  
 There are two main interpretations of our results: (1) that the low protein and delayed 
supplementation groups have an increase in efficiency and amino acid recycling, and/or (2) that 
the high protein and immediate supplementation groups have a decrease in efficiency and amino 
acid recycling.  If muscle becomes more efficient at recycling amino acids in the lower protein 
(here, 1.3 g/kg/day) and delayed supplementation condition, cells may become more 
metabolically active and could exhibit higher protein synthesis rates while maintaining or 






condition.  In a recent study of 43 untrained college-aged males engaged in 12 weeks of 
resistance training, supplementation with a maltodextrin placebo resulted in greater amino acid 
transporter activity (LAT1: L-amino acid transporter-1) than groups supplementing with leucine 
and whey but observed no difference among groups in muscle fiber cross sectional area (98aa).  
It is therefore possible that a lower protein diet or delayed supplementation metabolically 
sensitizes muscle cells to respond to protein intake and exercise to a greater extent and with 
greater efficiency.  It is also possible that maximal protein synthesis rates are reached 2-4 hours 
post-exercise and timing supplementation during this window results in more optimal nutrient 
uptake.  As previously discussed, the dedication of ATP to work output during and for some time 
after exercise likely results in a dampened MPS response.  Therefore, timing protein 
supplementation three hours post-exercise when protein synthesis rates are increased may have 
resulted in greater incorporation of ingested protein and tracer into muscle over the 24-hour 
measurement period.  As the primary energy source during exercise, carbohydrate replenishment 
post-exercise may be a more optimal supplementation strategy.  The delayed protein groups may 
have performed better had carbohydrates been ingested during the three-hour window post-
exercise instead of fasting until protein consumption.   
Alternatively, the decreased efficiency in groups ingesting high levels of protein and 
supplementing immediately post-exercise could be responsible for the similarities in MPS among 
groups in our study.  A previous study utilizing a crossover design fed 12 young males either 
moderate (1.08-1.18 g/kg/day) or high (1.74-2.00 g/kg/day) protein intake and found greater 
nitrogen excretion in urine and feces and decreased biologic value and net protein utilization 
when protein intake was high (50aa).  This evidence together with the observed decrease in 






(98aa) and the “muscle full” hypothesis (6, 10a, 76a) both previously discussed suggest that the 
high protein/supplemented condition does not result in optimal skeletal muscle protein 
metabolism.  The results of our study additionally indicate that no advantage is gained in 
strength, power, or lean mass by higher protein intakes or immediate supplementation post-
exercise in trained young males. 
Applications 
Based on this study, there does not appear to be a need for athletes or active individuals 
engaged in regular training to eat a high protein diet above 1.3 g/kg total mass/day (1.9 g/kg lean 
mass/day).  There was no difference between rates of protein synthesis or lean mass accretion in 
training groups who ingested 1.3 g/kg protein per day vs. group who ingested 2.2 g/kg/day (2.7 
g/kg lean mass/day), nor were there functional performance differences in strength or power.  
Previous studies have proposed that high protein intakes may not only increase overall calorie 
intake but also limit the intake of carbohydrates needed to fuel muscle contraction.  
Carbohydrate intake in this study was not significantly different between high and low groups in 
this study, however, indicating that individuals who decreased their protein intake to match study 
requirements did not replace these calories with added carbohydrate or fat.  It is important to 
note that although study participants were persistently reminded and encouraged to replace 
protein with carbohydrate in the diet by study staff as food logs were evaluated daily, this did not 
occur to the extent desired perhaps due to previously established dogmas.  Thus, the results of 
this study suggest a reevaluation of nutritional guidance given to athletes and active individuals 
to emphasize a balanced diet that more closely follows nutritional guidelines and places less 
emphasis on protein sources.  Interestingly, despite the decrease in overall energy, low protein 






body as a whole or in the targeted thigh regions, indicating that individuals were able to adapt to 
this nutritional strategy. 
 Protein sources are costly both financially and metabolically due to nitrogen production 
and urea excretion, potential kidney stress, and dehydration.  While effects on kidney function 
has been suggested as a drawback for high protein diets, there is currently no evidence for 
adverse effects on the kidneys at this time.  A study by Poortmans & Dellalieux (91) showed that 
individuals eating up to 2.8 g/kg/d protein had higher plasma concentrations of uric acid and 
calcium but normal renal clearances of creatinine, urea, and albumin.  However, very high 
protein diets have not been studied over long periods of time.  Some high protein diets advocate 
intakes up to 5 g/kg/day (8a), and studies of actual protein consumption in athletes indicates 
protein intake of 2-3 g/kg/day on average (110).  Protein intake on the order of 5 g/kg/day and 
greater than 35% of calories can lead to hyperaminoacidemia, hyperammonemia, 
hyperinsulinemia, nausea, and diarrhea (8a).   A primary goal for athletes is consuming the 
optimal diet for performance and obtaining higher efficiency of nutrient utilization.  A low or 
moderate protein diet would not only be more nutritionally efficient, but more affordable as well.  
Many athletes seeking to reach the elite levels of their sport are likely be financially challenged, 
often due to the time constraints placed upon them by their training.  Maintaining a high protein 
diet appears to conflict with both financial and metabolic costs without providing additional 
performance benefits. 
Limitations and Delimitations
 Limitations and delimitations of this research are important to recognize as they 









 The results of this study are subject to certain limitations.  Self-reporting 
measures were used for sleep, activity, food, and training history.  While real-time 
monitoring of these measures would increase confidence in the data, non-compliance 
with study requirements would not have been expected partly because there was no 
incentive to mislead investigators.  A more thorough study could be conducted in a 
metabolic unit to verify these measures.   
Self-reporting training history could have resulted in individuals overstating the 
time they had previously trained so that they could participate in the study.  However, 
due to the intensity of the prescribed exercise, a truly untrained individual would not 
have been able to complete the exercise protocol (and indeed, some did withdraw from 
the study due to inability to perform the protocol).  With two weeks of familiarization 
prior to the intervention period, all subjects should have reached a uniform training level.   
 Although the objective of the study was to determine the optimal protein intake 
for athletes, only moderate and relatively high levels of protein ingestion were tested in 
this study.  Therefore, it is possible that an even lower protein intake could be optimal. 
 The timing of supplementation focused specifically on protein ingestion, 
therefore no other nutrients were ingested post-exercise.  Thus, the delayed protein 
group underwent a period of complete fasting post-exercise that was not experienced by 
the immediately supplemented group.  This increased period of muscle protein 






 Finally, the application of these results is limited to healthy, young adult males 
who are currently in the trained state.  While qualitatively similar results would be 
predicted for healthy, young females, quantitative statements regarding their daily 
protein requirements and timing of supplementation cannot be made with certainty.  
Additionally, these results may not be applicable to adolescents or older athletes/active 
individuals.  It is possible that an older population could have higher protein 
requirements due to an age-related reduction in their ability to adapt to the exercise 
stimulus by increasing efficiency of amino acid transport, recycling, and utilization.  
Likewise, this study does not have application to the general population (whose needs 
are characterized by the RDA), obese individuals, or individuals with chronic illnesses.  
Delimitations 
 The specific aim of this study was to determine the effects of low and high 
protein intake, immediate and delayed supplementation, and any interaction between 
these two variables in athletes.  Since athletes are a young, healthy population, 
individuals with chronic illnesses and metabolic dysfunction were excluded, as were 
individuals greater than 29 years old.  To maintain a more uniform population, females 
and first semester freshmen were excluded due to the variability they would contribute.   
 While the study required individuals to have a history of aerobic training, no 
measures of cardiovascular fitness were taken.  Since the goal of the study was to 
determine whether protein intake was indeed elevated in athletes, the strength and power 
population for which current daily protein recommendations are highest was targeted.  






intended to maximize the exercise stress applied to the muscle, therefore, differences in 
protein requirements should be greatest and most easily detected in the strength and 
power trained state.  Because the study focus was on muscle anabolism, we chose to 
measure strength and power performance outcomes instead of cardiovascular and 
endurance outcomes. 
 Finally, a control group served as a baseline for the intervention group subjects.  
Subjects were not their own control in this study for a variety of reasons.  Additional 
pre-study muscle biopsies would have incurred greater up-front cost to investigators and 
risk to study participants.  Most importantly, however, pre-study measures of muscle 
protein synthesis would have caused deuterium enrichment to persist throughout the 
familiarization and intervention periods, thus affecting enrichment during post-study 
measurements of cumulative muscle protein synthesis.  Therefore, utilizing a control 
group with verified similarity to the intervention group was the ideal choice both 
practically and methodologically.  
Summary 
The objectives of this study were to determine (1) whether steady-state trained 
individuals have elevated total protein requirements, (2) whether immediate post 
exercise protein intake affects cumulative muscle protein synthesis and total lean mass, 
and (3) whether there is an interaction between timing of protein intake post-exercise 
and total daily intake on anabolic muscle responses.  In a double blind, randomized 
controlled trial with 45 healthy, previously-trained young men, we determined that total 






mass/day, nor did timing of protein intake affect the primary outcome of muscle protein 
synthesis or secondary outcomes of body composition, strength, and power.  In fact, only 
the group consuming low daily protein and supplementing three hours delayed post-
exercise showed a significantly higher FSR compared to controls.  Thus, our hypothesis 
that individuals undergoing consistent training have adapted to their workload and 
increases in daily protein intake would not have additive effects on cumulative muscle 
protein synthesis was not rejected.  Similarly, we were unable to reject the hypothesis 
that cumulative muscle protein synthesis would not be significantly different between 
immediate and delayed post-exercise protein supplementation.  Finally, the hypothesis 
that there would be no interaction between total daily protein requirements and timing of 
protein supplementation post-exercise was also not rejected.  This study only compared a 
modest (1.3 g/kg/day) and a relatively high (2.2 g/kg/day) protein intake.  Future studies 
are necessary to determine whether the lower threshold for protein intake is different 
from the RDA of 0.8 g/kg/day, or if previously trained individuals in a steady-state 
training condition are able to adapt to such a protein intake.  Furthermore, we call for 
future recommendations to be given relative to lean mass to reduce the overconsumption 
of protein in athletes with higher body fat.  Additional studies incorporating 
carbohydrate supplementation post-exercise would be beneficial for comparison to post-
exercise protein supplementation.  In our study, the lower protein, three-hour delayed 
group was able to optimize their efficiency to maintain high performance measures and 
rates of muscle protein synthesis, but it is unclear if they could have performed better 






fasting.  Future studies should also investigate cell signaling by analyzing the cytosolic 
portion of muscle samples with Western Blots to determine the metabolic activity of 
cells under varying total protein intakes and supplementation schemes.  Such studies 
would provide insight into the cellular mechanisms that led to the results presented here.  
Finally, future studies should also further investigate additional effects of long-term high 
protein intake, including but not limited to hydration status, glycogen storage and 
utilization, excess nitrogen and nitric oxide production, and amino acid transport and 
utilization within the muscle.  Such studies would allow a more accurate characterization 
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1. Consent Form 
 
Project Title: Revisiting total protein intake and timing of ingestion in conjunction 
with exercise utilizing deuterium 
You are invited to take part in a research study being conducted by Steven Riechman 
(Principle Investigator), Erin Simmons (Co-principle Investigator), and James 
Fluckey (Co-principle Investigator), researchers from Texas A&M University and 
funded by the Huffines Institute.  The information in this form is provided to help 
you decide whether or not to take part. If you decide to take part in the study, you 
will be asked to sign this consent form. If you decide you do not want to participate, 
there will be no penalty to you, and you will not lose any benefits you normally would 
have. 
 
Why Is This Study Being Done? 
The purpose of this study is to clarify the total protein ingestion requirements for active 
individuals and athletes who are involved in stable exercise training, and to determine 
whether there is an optimal time to ingest protein following exercise events. 
 
Why Am I Being Asked To Be In This Study?  
You are being asked to be in this study because you are a healthy male, aged 19-29 
years old, who has been involved in both strength training and cardiovascular 
exercise for over one (1) year. As a Corps of Cadets member, you are being asked to 
participate in the study to lessen the potential for variability between study 
participants (in terms of food, sleep, schedule, training history, etc.).  You have also 
been selected because you have informed researchers that you: 
1. Do not have any metabolic disorders including known electrolyte 
abnormalities, heart disease, arrhythmias, diabetes, thyroid disease, or 
hypogonadism; 
2. Do not have a history of hypertension, hepatorenal, musculoskeletal, 
autoimmune, or neurologic disease; 
3. Do not have any bleeding disorders and are not taking any anti-coagulants; 
4. Are not taking thyroid, hypoglycemic, anti-hypertensive, or androgenic 
medications;  
5. Have not taken ergogenic levels of nutritional supplements that may affect 
muscle mass (e.g. HMB, creatine), insulin-like substances, or 
anabolic/catabolic hormone levels (DHEA, etc.) within six months prior to 
the start of the study. 
 
How Many People Will Be Asked To Be In This Study? 







What Are the Alternatives to Being in This Study? 
The alternative to being in the study is not to participate.  
 
What Will I Be Asked To Do In This Study? 
If you agree to participate in this study, you will report to the laboratory four (4) days 
per week for two (2) weeks to familiarize you with the exercise protocol. You will then 
undergo baseline testing, starting with a dual energy x-ray absorptiometry (DEXA) scan 
to measure body composition after the familiarization period and before the start of the 
study.  You will also be asked to utilize an isokinetic dynamometer to obtain a measure 
of your maximal voluntary contraction. You will be asked to pedal on a power bike to 
obtain measures of maximal rate of force development, peak power, and relative power.  
 
You will be asked to attend one nutrition education session and to follow a well-
balanced diet that meets certain daily protein requirements, and document all your food 
intakes using a program (Nutribase) that will be installed on your PC. Additionally, you 
will be asked to log activity each day.  
 
If you are selected for an intervention group, you will be asked to perform cycling sprint 
intervals and resisted leg extensions as part of the exercise routine for four days each 
week. Trained personnel will supervise your training sessions.  Each exercise session 
will take approximately 90 minutes.  You will consume a protein supplement either 
immediately following each exercise session or three (3) hours post-exercise.    
 
Before and after your final exercise session, blood samples will be collected from your 
arm (6 blood draws total).  You will also be asked to consume four (4) boluses of 
deuterium oxide tracer following the final exercise session.   
 
You will also be asked to provide a muscle sample from your leg muscle for us to 
determine muscle protein synthesis rates. Muscle biopsies will be conducted 
immediately before the final exercise session, and again 24 hours after the final exercise 
session. Samples will be obtained using the Bergstrom technique, which involves a 1 cm 
incision on the skin and the use of a 5mm biopsy needle using sterile procedures.  Local 
anesthetic will be used prior to incision and biopsy.  Percutaneous muscle biopsies (50-
70 mg) will be obtained from the middle portion of the vastus lateralis muscle (thigh 
muscle covering the outermost portion of the front of the leg) of one leg at the midpoint 
between the knee and hip joint at a depth between 2 and 4 cm. For the final biopsy, the 
procedure will be repeated about 2 cm closer to the hip joint.   
 
Your participation in this study will last up to fifty-five (55) hours over the course of 
twenty-nine (29) days (approximately 4 weeks) and includes twenty-two (22) visits.  
 






1. Excessive use of alcohol 
2. Performance of exercise outside of this study 
3. Use of medication that increases bleeding risks 
4. Injury that results in the inability to perform study tasks 
 
Are There Any Risks To Me? 
This study will involve minor increases above minimal risk that are greater than 
those you would come across in everyday life.  
1. Sprint interval and resistance exercise may lead to discomfort, pain, and muscle 
injury. These risks are reduced by inclusion of appropriate warm-ups and 
stretches, proper performance of exercises, and discontinuation of exercise if 
necessary.  The exercise sessions will be closely supervised by trained personnel 
to ensure appropriate compliance. 
2. The biopsy procedure carries the risk of complications including soreness 
(100%), infection (<1%), and permanent numbness («1%). Additional risks 
include discomfort, bleeding and possible scarring at biopsy site. 
3. Risks associated with blood sampling include minor discomfort at puncture site 
and possible bruising.  There is a slight risk of infection, however, only trained 
phlebotomist will be performing blood sampling using previously approved 
sterilization procedures. 
4. DEXA scan for body composition measurement uses low amounts of radiation 
(less than a 2 hour plane ride). 
5. Ingestion of deuterium oxide can cause lightheadedness, dizziness, and nausea if 
consumed quickly, however, consumption will be monitored to reduce the risks 
of these effects. No other side effects for deuterium have been observed. 
6. There is potential economic risk for medical referral if needed.   
 
Are There Any Benefits To Me?  
The direct benefits to you by being in this study include: 
1. Receipt of body composition and bone density data from DEXA analysis as well 
as information from strength and power tests. 
2. Provision of protein supplements. 
3. Provision of training with professional trainers. 
4. Participants will be able to access nutritional software and will be provided with a 
copy of their dietary analysis.  
NOTE: If you are randomly selected to be part of the control group, you will not 
receive supplements or training, and time commitments will be significantly 
decreased.  
 
Will There Be Any Costs To Me?  
Aside from your time, there are no costs for taking part in the study. 
 






If you are hurt in this study, it will be your responsibility to notify the study investigators, 
to seek treatment, and to pay for such treatment. You will be recommended to Beutel 
Health Center on the Texas A&M Campus, or you may elect to be treated by your 
preferred physician.  
 
If you suffer any injury as a result of taking part in this research study, please understand 
that nothing has been arranged to provide free treatment of the injury or any other type of 
payment. However, all needed facilities, emergency treatment and professional services 
will be available to you, just as they are to the community in general. You should report 
any injury to Dr. Steven Riechman at (979) 862-3213. You will not give up any of your 
legal rights by signing this consent form. 
 
Side effects (injury) can happen in any research study. These effects may not be 
your fault or the fault of the researcher involved. Known side effects have been 
described in the “Are there any risks to me?” section of this consent form. However, side 
effects that are not currently known may happen and require care. You do not give up 
any of your legal rights by signing this form. 
 
Will I Be Paid To Be In This Study? 
You will receive $100 for completing the study. Disbursement will occur following the 
final muscle biopsy. Partial payment of $50 may occur if only one biopsy is performed. 
No compensation will be provided before the completion of the first biopsy. 
 
Will Information From This Study Be Kept Private? 
The records of this study will be kept private.  No identifiers linking you to this study will 
be included in any sort of report that might be published.  Research records will be stored 
securely and only principle and co-principle investigators Steven Riechman, Erin 
Simmons, and James Fluckey will have access to the records. You will be given an 
identifying code during this study, and the key to decode data will be stored separately. 
 
Information about you will be stored in a locked file cabinet in a locked laboratory, and 
computer files will be protected with a password and stored on a secure server. This 
consent form will be filed securely in an official area. 
 
People who have access to your information include the Principal Investigator and 
research study personnel.  Representatives of regulatory agencies such as the Office of 
Human Research Protections (OHRP) and entities such as the Texas A&M University 
Human Subjects Protection Program may access your records to make sure the study is 
being run correctly and that information is collected properly.  
  
Information about you and related to this study will be kept confidential to the extent 
permitted or required by law.  If there are any reports about this study, your name will not 







Who may I Contact for More Information? 
You may contact the Principal Investigator, Steven Riechman, Ph.D., to tell him about a 
concern or complaint about this research at 979-862-3213 or sriechman@hlkn.tamu.edu. 
You may also contact the Co-Principle Investigator, Erin Simmons, M.S., at 940-300-
6029 or ees06f@tamu.edu.  
 
For questions about your rights as a research participant, to provide input regarding 
research, or if you have questions, complaints, or concerns about the research, you may 
call the Texas A&M University Human Subjects Protection Program office by phone at 
1-979-458-4067, toll free at 1-855-795-8636, or by email at irb@tamu.edu.  
 
What if I Change My Mind About Participating? 
This research is voluntary and you have the choice whether or not to be in this research study.  
You may decide to not begin or to stop participating at any time.   If you choose not to be in 
this study or stop being in the study, there will be no effect on your student status, medical 
care, employment, evaluation, relationship with Texas A&M University, etc. Any new 
information discovered about the research will be provided to you. This information could 
affect your willingness to continue your participation. 
 
STATEMENT OF CONSENT 
I agree to be in this study and know that I am not giving up any legal rights by 
signing this form.  The procedures, risks, and benefits have been explained to me, 
and my questions have been answered.  I know that new information about this 
research study will be provided to me as it becomes available and that the 
researcher will tell me if I must be removed from the study.   I can ask more 
















Either I have or my agent has carefully explained to the participant the nature of the 













































2. Consent to Provide PHI 
Project Title:  Revisiting total protein intake and timing of ingestion in conjunction with 
exercise utilizing deuterium 
 
The federal and state governments have issued a privacy rule to protect the privacy 
rights of individuals enrolled in research.  The privacy rule is designed to protect the 
confidentiality of an individual’s health information.  This describes your rights and 
explains how your health information will be used and disclosed for this study. 
PURPOSE  
You are being invited to participate voluntarily in the above-titled research project. The 
purpose of collecting Protected Health Information (PHI) for this study is help researchers 
answer the questions that are being asked in this research study. 
 
WHAT INFORMATION MAY BE USED AND GIVEN TO OTHERS? 




• Medical history 
• Training history 
• Body composition 
• Maximal voluntary contraction 
• Peak power output 
• Maximal rate of force development 
• Relative power 
• Food records 
• Muscle protein synthesis rates 
 
WHO MAY USE AND RECEIVE INFORMATION ABOUT ME? 
Information about you may be given out by the Principal Investigator and study personnel 
to: 
• Representatives of regulatory agencies (including Texas A&M University Human 
Subjects Protection Program) to ensure quality of data and study conduct. 
 
WHY WILL THIS INFORMATION BE USED AND/OR GIVEN TO OTHERS? 
This information will be used to more accurately characterize the role of protein ingestion 
in stimulating muscle protein synthesis in exercising individuals and athletes. Your 
information may be given to regulatory agencies to ensure compliance with all human 







The results of this research may be published in scientific journals or presented at 
professional meetings, but your identity will not be revealed. 
 
HOW LONG WILL THIS INFORMATION BE USED AND/OR GIVEN TO 
OTHERS? 
Your PHI will be linked to your identifying information for two years.  After this time, all 
links will be destroyed and your identity will not be able to be determined. 
 
This authorization will expire on the date the research study ends. 
 
MAY I REVIEW OR COPY THE INFORMATION OBTAINED FROM ME OR 
CREATED ABOUT ME? 
You have the right to access your PHI that may be created during this study as it relates to 
your treatment or payment. Your access to this information will become available only 
after the study analyses are complete.  
 
MAY I WITHDRAW OR REVOKE (CANCEL) MY PERMISSION? 
You may withdraw this authorization at any time by notifying the Principal Investigator 
in writing. If you choose to withdraw your authorization, any information previously 
disclosed cannot be withdrawn and may continue to be used. The address for the Principal 
Investigator is 213E Heldenfels Hall, Texas A&M University, College Station, Texas, 
77840. 
 
WHAT IF I DECIDE NOT TO GIVE PERMISSION TO USE AND GIVE OUT MY 
HEALTH INFORMATION? 
You may refuse to sign this authorization form.  If you choose not to sign this form, you 
cannot participate in the research study. Refusing to sign will not affect your present or 
future medical care and will not cause any loss of benefits to which you are otherwise 
entitled. 
 
IS MY HEALTH INFORMATION PROTECTED AFTER IT HAS BEEN GIVEN 
TO OTHERS? 
Once information about you is disclosed in accordance with this authorization, the 
individual or organization that receives this may redisclose it and your information may 
no longer be protected by Federal Privacy Regulations. 
 
CONTACTS  
You can obtain further information from the Principal Investigator, Steven Riechman, 
Ph.D., at (979) 862-3213 or sriechman@hlkn.tamu.edu.  You may also contact the Co-
Principle Investigator, Erin Simmons, M.S., Ph.D. candidate, at 940-300-6029 or 
ees06f@tamu.edu. If you have questions concerning your rights as a research subject, you 









I hereby authorize the use and disclosure of my individually identifiable health 
information. I will be given a copy of this signed authorization form. 
 
________________________________________________ _____________ 
Subject’s Signature        Date 
 
________________________________________________  
Printed Name of Subject 
 
________________________________________________ _____________ 
Signature of Subject’s Legal Representative (if necessary)   Date 
 
________________________________________________ 
Printed Name of Subject’s Legal Representative 
 
_______________________________ 























3. Medical History Questionnaire 
Questionnaire 
 
Project Title: Revisiting total protein intake and timing of ingestion in conjunction 
with exercise utilizing deuterium 
 
Name: _______________________________________________________ 
Age:    ____________ 
Sex (circle one):  Male / Female 
 
How long have you been engaged in resistance exercise/strength training? 
_____________________________________________________________ 
 
Do you have any metabolic disorders including known electrolyte abnormalities, heart 
disease, arrhythmias, diabetes, thyroid disease, or hypogonadism?  (circle one)   Yes / 
No 
 
Do you have a history of hypertension, hepatorenal, musculoskeletal, autoimmune, or 
neurologic disease?  (circle one)   Yes / No 
 
Do you have any bleeding disorders?  (circle one)   Yes / No   
 
Are you taking thyroid, hypoglycemic, anti-hypertensive, or androgenic medications?  
(circle one)   Yes / No 
 
Have you taken ergogenic levels of nutritional supplements that may affect muscle 
mass (e.g. HMB, creatine), insulin-like substances, or anabolic/catabolic hormone 
levels (DHEA, etc.) within six months prior to the start of the study?  (circle one)   Yes 
/ No 
 
If you answered yes to the above question, please list any supplements you have taken 






























5. Information for Subjects 
 
Information for Prospective Participants: 
 
We are currently recruiting research participants for a study to be conducted within the 
Department of Health & Kinesiology at Texas A&M University.  
The duration of the study will be approximately 4 weeks, which includes 2 weeks of 
familiarization with the exercise procedures followed by 2 weeks of the experimental 
period.  You will receive $100 at the completion of all the study procedures. 
 
The purpose of the study is to investigate the effects of protein supplementation on 
muscle metabolism. 
 
What is required? 
1. You will be required to perform 16 sessions of supervised high intensity 
sprint interval and resistance exercises (~80 minutes per session).   
2. You will be required to consume a protein supplement following exercise 
during the study period.  
3. You will be required to keep track of what you eat/drink and may be asked to 
make changes during the study period so that your dietary protein intake 
matches study requirements. 
4. Six blood samples and two muscle biopsy samples will be taken. 
5. The exercise sessions/sample collections/tests are most likely to be conducted 
between 7-9 am. 
 
  Who is eligible? 
1. Healthy males between the ages of 19-29 years. 
2. Member of the Texas A&M Corps of Cadets. 
3. Persons involved in both strength training and cardiovascular exercise for at 
least one (1) year. 
4. You cannot participate in the study if you have any of the following: 
a. A blood pressure > 160/100 
b. Cardiac Arrhythmias 
c. Cancer 
d. Hernia 
e. Aortic Aneurysm 
f. Kidney Disease 
g. Lung Disease 
h. Smoker 
i. Cannot be currently taking cholesterol lowering medications 









Please feel free to email or call if you have any further questions or if you fit the 
criteria and are interested in signing up.  If you are interested, the next step 
would be to have you come in and go over the details of the study, have you sign 
an informed consent document, provide information about your medical 
history/exercise readiness prior to the start of this investigation. Contact Erin 















































































































My name is Erin Simmons. I am a graduate student working in the Nutrition and 
Food Science and the Health & Kinesiology departments for the Human 
Countermeasures and Muscle Biology labs. Currently we are conducting a research 
study regarding the effect of protein supplementation on muscle metabolism. 
 
The nature of the study will include nutrition education sessions, DEXA scan, 
blood draws, and four weeks of sprint interval and resistance exercise training. Two 
muscle biopsies will also be performed at the end of the study, and several other non-
invasive measurements will be taken throughout the study. You may be asked to 
consume a protein supplement after your workouts.  
 
The study will last approximately 29 days. Participation is completely voluntary. 
This study is not associated with any current classes or your membership in the Corps of 
Cadets in any manner. You may decide not to participate or to withdraw at any time 
without your current or future relations with the Corps of Cadets or Texas A&M 
University being affected. There will be a $100 compensation for completing the study.  
Disbursement will occur after you finish the last biopsy at the end of the study.  This 
study is strictly confidential, and any personal information will not be released at any 
point.  
 
If you are interested in participating in the study or would like to find out more 

















10. In-Person Recruitment Script 
In-Person Recruitment 
 
Hi, my name is Erin Simmons. I am a graduate student working in the Health & 
Kinesiology department for the Human Countermeasures and Muscle Biology labs. 
Currently we are conducting a research study regarding the effect of protein 
supplementation on muscle metabolism. 
 
The nature of the study will include nutrition education sessions, DEXA scan, 
blood draws, and four weeks of sprint interval and resistance exercise training. Two 
muscle biopsies will also be performed at the end of the study, and several other non-
invasive measurements will be taken throughout the study. You may be asked to 
consume a protein supplement after your workouts.  
 
The study will last approximately 29 days. Participation is completely voluntary. 
This study is not associated with any current classes or your membership in the Corps of 
Cadets in any manner. You may decide not to participate or to withdraw at any time 
without your current or future relations with the Corps of Cadets or Texas A&M 
University being affected. There will be a $100 compensation for completing the study.  
Disbursement will occur after you finish the last biopsy at the end of the study.  This 
study is strictly confidential, and any personal information will not be released at any 
point.  
 
If you are interested in participating in the study or would like to find out more 
























11. 24 Hour Physical Activity Recall Form 
24 Hour Activity Recall 
 
Project Title: Revisiting total protein intake and timing of ingestion in conjunction 




1. In the past 24 hours, did you engage in any strenuous physical activity?   (circle one)    
Yes     No 






3. Please list ALL activity (including walking to class, marching, drilling, etc.) that you 
have engaged in over the past 24 hours and how much time you spent on each: 
 
Activity Description Time 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   



































































1. ANOVA Results for Group Demographics  
 
 
Appendix B1 – ANOVA Results for Demographic Characteristics of Five Groups.  Means 
of age (years), height (cm), and weight (kg) were analyzed with a one-way ANOVA for each 
intervention group (LO/DPE, LO/IPE, HI/DPE, and HI/IPE) and the control group (CON). 



















Sum of Squares df Mean Square F Sig.
Between Groups 29.281 4 7.32 0.712 0.589
Within Groups 411.451 40 10.286
Total 440.732 44
Between Groups 103.89 4 25.972 0.645 0.634
Within Groups 1611.296 40 40.282
Total 1715.186 44
Between Groups 1394.274 4 348.569 1.969 0.117
Within Groups 7256.877 41 176.997
Total 8651.151 45









2. ANOVA Results for Overall Modified Activity Questionnaire 
 
Appendix B2 – ANOVA Results for Overall Modified Activity Questionnaire.  Mean results 
of the MAQ in hours per week (hr/wk) and Met-hours (Met-hr) were analyzed with a one-
way ANOVA for the past year, ages 12-18, ages 19-34, and lifetime for each intervention 
group (LO/DPE, LO/IPE, HI/DPE, and HI/IPE) and the control group (CON).  There were 











Sum of Squares df Mean Square F Sig.
Between Groups 160.846 4 40.212 1.319 0.282
Within Groups 1067.016 35 30.486
Total 1227.862 39
Between Groups 12427.178 4 3106.795 0.898 0.475
Within Groups 121025.508 35 3457.872
Total 133452.686 39
Between Groups 212.836 4 53.209 0.752 0.563
Within Groups 2546.62 36 70.739
Total 2759.456 40
Between Groups 10297.308 4 2574.327 0.633 0.642
Within Groups 146294.819 36 4063.745
Total 156592.127 40
Between Groups 396.5 4 99.125 1.648 0.187
Within Groups 1864.434 31 60.143
Total 2260.934 35
Between Groups 14013.347 4 3503.337 1.375 0.265
Within Groups 78988.296 31 2548.01
Total 93001.643 35
Between Groups 569.802 4 142.451 0.729 0.578
Within Groups 7226.864 37 195.321
Total 7796.667 41
Between Groups 35350.01 4 8837.503 0.967 0.437
















3. ANOVA Results for Strength Training Modified Activity Questionnaire 
 
Appendix B3 – ANOVA Results for Strength Training Modified Activity Questionnaire.  
Mean results of the strength training portion of the MAQ in hours per week (hr/wk) and 
Met-hours (Met-hr) were analyzed with a one-way ANOVA for the past year, ages 12-18, 
ages 19-34, and lifetime for each intervention group (LO/DPE, LO/IPE, HI/DPE, and 
HI/IPE) and the control group (CON).  There were no significant differences among groups 









Sum of Squares df Mean Square F Sig.
Between Groups 44.874 4 11.218 1.317 0.283
Within Groups 298.091 35 8.517
Total 342.964 39
Between Groups 909.08 4 227.27 1.318 0.282
Within Groups 6035.184 35 172.434
Total 6944.263 39
Between Groups 23.328 4 5.832 1.446 0.24
Within Groups 137.088 34 4.032
Total 160.416 38
Between Groups 472.773 4 118.193 1.447 0.24
Within Groups 2777.398 34 81.688
Total 3250.171 38
Between Groups 49.023 4 12.256 1.543 0.211
Within Groups 285.982 36 7.944
Total 335.005 40
Between Groups 992.153 4 248.038 1.542 0.211
Within Groups 5790.973 36 160.86
Total 6783.126 40
Between Groups 119.802 4 29.95 1.686 0.174
Within Groups 657.08 37 17.759
Total 776.882 41
Between Groups 2425.619 4 606.405 1.685 0.174
Within Groups 13312.097 37 359.786
Total 15737.716 41














4. ANOVA Results for Acute and Chronic Sleep Measures 
 
Appendix B4 – ANOVA Results for Acute and Chronic Sleep Pattern Measures.  Mean 
acute sleepiness, represented by the Stanford Sleepiness Scale, and mean chronic sleep 
quality, represented by the Pittsburgh Sleep Quality Index, were analyzed with a one-way 
ANOVA for each intervention group (LO/DPE, LO/IPE, HI/DPE, and HI/IPE) and the 
control group (CON).  There were no significant differences among groups for any 





















Sum of Squares df Mean Square F Sig.
Between Groups 1.878 3 0.626 0.883 0.46
Within Groups 22.695 32 0.709
Total 24.573 35
Between Groups 13.022 4 3.256 0.697 0.599
Within Groups 186.889 40 4.672
Total 199.911 44
Between Groups 11.497 4 2.874 0.69 0.603













5. ANOVA Results for Low Protein Groups During Familiarization vs. Intervention 
 
 
Appendix B5 – ANOVA Results for Low Protein Group Nutrition During Familiarization 
and Intervention Periods.  Calorie and macronutrient intake during familiarization and 
intervention periods were analyzed with a one-way ANOVA for the combined low protein 
groups (LO/DPE and LO/IPE).  There were no significant differences between the 










Sum of Squares df Mean Square F Sig.
Between Groups 364816 1 364816 0.933 0.341
Within Groups 13289604 34 390870.706
Total 13654420 35
Between Groups 6539101.361 1 6539101.36 0.954 0.336
Within Groups 233132255.4 34 6856831.04
Total 239671356.8 35
Between Groups 821.778 1 821.778 1.243 0.273
Within Groups 22484.111 34 661.297
Total 23305.889 35
Between Groups 0.124 1 0.124 0.946 0.337
Within Groups 4.443 34 0.131
Total 4.567 35
Between Groups 0.219 1 0.219 1.203 0.28
Within Groups 6.192 34 0.182
Total 6.412 35
Between Groups 14.694 1 14.694 0.438 0.513
Within Groups 1141.611 34 33.577
Total 1156.306 35
Between Groups 6480.25 1 6480.25 0.858 0.361
Within Groups 256758.5 34 7551.721
Total 263238.75 35
Between Groups 11.111 1 11.111 0.13 0.721
Within Groups 2915.111 34 85.739
Total 2926.222 35
Between Groups 225 1 225 0.259 0.614
Within Groups 29532.556 34 868.605
Total 29757.556 35






















Appendix B6 – ANOVA Results for High Protein Group Nutrition During Familiarization 
and Intervention Periods.  Calorie and macronutrient intake during familiarization and 
intervention periods were analyzed with a one-way ANOVA for the combined low protein 
Sum of Squares df Mean Square F Sig.
Between Groups 86534.028 1 86534.028 0.269 0.607
Within Groups 10921618.28 34 321224.067
Total 11008152.31 35
Between Groups 1507984 1 1507984 0.268 0.608
Within Groups 191067007.6 34 5619617.87
Total 192574991.6 35
Between Groups 584.028 1 584.028 0.494 0.487
Within Groups 40194.722 34 1182.198
Total 40778.75 35
Between Groups 0.2 1 0.2 0.844 0.365
Within Groups 8.074 34 0.237
Total 8.275 35
Between Groups 0.106 1 0.106 0.834 0.367
Within Groups 4.332 34 0.127
Total 4.438 35
Between Groups 2.778 1 2.778 0.139 0.711
Within Groups 678.222 34 19.948
Total 681 35
Between Groups 5852.25 1 5852.25 0.981 0.329
Within Groups 202740.5 34 5962.956
Total 208592.75 35
Between Groups 40.111 1 40.111 1.133 0.295
Within Groups 1203.889 34 35.408
Total 1244 35
Between Groups 182.25 1 182.25 0.269 0.607
Within Groups 23048.056 34 677.884
Total 23230.306 35
Between Groups 53.778 1 53.778 2.645 0.113


















groups (HI/DPE and HI/IPE).  There were no significant differences between the 











Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 2031 593 8490 2486 459 90 24 5 882 326
High Protein 18 2655 489 11106 2047 696 127 27 5 1122 274
Control 9 2429 908 10165 3798 534 210 22 4 1017 318
Total 45 2360* 677 9871* 2838 569* 171 25* 5 1005 317
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 43 9 684 259 33 7 5 19 0.2 0.7
High Protein 18 42 5 826 208 31 5 8 25 0.3 1.0
Control 9 44 9 878 482 35 8 0 0 0 0
Total 45 43 8 780 302 33 6 5 20 0.2 0.8
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 112 21 1.3 0.3 1.9 0.5 0.2 0.4 0.6 0.6
High Protein 18 170 31 2.2 0.3 2.7 0.5 1.1 1.0 2.1 1.7
Control 9 130 51 1.6 0.7 2.1 0.9 1.9 2.4 3.4 4.2
Total 45 139* 42 1.7* 0.6 2.2* 0.7 0.9* 1.4 1.8* 2.4
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 0.4 0.6 0.1 0.2 0.3 0.5 0.3 0.8 0 0
High Protein 18 1.9 1.6 0.7 0.7 1.1 1.0 1.0 0.9 0.2 0.4
Control 9 3.1 3.9 0.9 1.3 1.8 2.1 1.8 2.1 0.4 0.7
Total 45 1.6* 2.2 0.5* 0.8 0.9* 1.3 0.9* 1.3 0.2* 0.4
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 0.4 0.5 0.3 0.5 0.5 0.6 0.7 0.6 0 0
High Protein 18 1.4 1.1 1.3 1.1 1.6 1.3 2.3 1.7 0.3 0.5
Control 9 2.2 2.6 2.3 2.6 2.6 3.0 3.9 5.1 0.7 1.0
Total 45 1.2* 1.5 1.1* 1.5 1.4* 1.7 2.0* 2.7 0.2* 0.6
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 1.6 1.3 0.2 0.4 0 0 0.4 0.5 0.4 0.5
High Protein 18 4.3 3.3 1.2 1.0 0 0 1.4 1.2 1.1 0.9
Control 9 7.9 8.4 1.7 1.8 0.1 0.3 2.3 2.7 2.0 2.7
Total 45 3.9* 4.8 0.9* 1.2 0.02 0.1 1.2* 1.6 1.0* 1.5
Group n Mean SD Mean SD
Low Protein 18 0.1 0.3 0.1 0.2
High Protein 18 0.8 0.8 0.8 0.8
Control 9 1.4 1.8 1.1 1.5









Alanine(g) Arginine(g) Aspartic Acid(g) Cystine(g)
Glutamic Acid(g) Glycine(g)
Calories/Carbohydrate























Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 239 84 8 7 58 40 3.6 6.9 3.4 5.0
High Protein 18 299 73 16 22 77 38 3.5 3.4 4.1 4.3
Control 9 268 83 25 31 78 34 6.6 4.9 6.4 6.3
Total 45 268 83 14 20 70 39 4.2 5.4 4.3 5.0
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 0 0 2.7 3.3 0.1 0.2 0.2 0.4 25 12
High Protein 18 0 0 3.4 2.9 0.7 2.4 0.7 1.0 27 11
Control 9 0 0 4.2 2.4 0.7 1.7 0.4 0.7 20 6
Total 45 0 0 3.3 2.9 0.4 1.7 0.4 0.8 25 11
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 74 27 20 8 0.5 0.7 0 0 0 0
High Protein 18 89 22 25 8 0.5 0.6 0 0 0 0
Control 9 95 53 28 16 0.7 1.0 0.1 0.3 0 0
Total 45 84 33 24 10 0.5 0.7 0.02 0.1 0 0
Group n Mean SD Mean SD Mean SD Mean SD
Low Protein 18 8.9 6.8 4.2 2.3 0 0 0.8 1.2
High Protein 18 9.9 5.8 5.7 3.9 0.2 0.7 1.3 1.1
Control 9 16.6 21.3 8.3 9.6 0.2 0.4 3.2 5.0
Total 45 10.8 11.0 5.6 5.2 0.1 0.5 1.5 2.5
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 195 68 5 8 0.2 0.4 0.5 0.9 8.4 15.9
High Protein 18 384 180 10 12 0.2 0.5 0.4 0.9 5.9 12.7
Control 9 564 437 12 15 0.3 0.5 0.2 0.4 1.1 1.7
Total 45 345* 262 9 11 0.2 0.5 0.4 0.8 6.0 13.0
Monounsaturated Fat(g)
Fiber(g)
Polyunsaturated Fat(g) Omega3(g) Omega6(g)
Sterols Cholesterol(mg) Phytosterol(mg) Stigmasterol(mg) Campesterol(mg) Beta-sitosterol(mg)
Fats Fat(g) Saturated Fat(g) TransFat(g) Trans-Monounsat Fat(g) Trans-Polyunsat Fat(g)
Carbohydrates Carbohydrate(g) Starch(g) Sugars(g) Glucose(g) Fructose(g)
Carbohydrates
Fats
Galactose(g) Sucrose(g) Lactose(g) Maltose(g)
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 410 301 2.3 9.9 66 59 226 154 711 492
High Protein 18 568 274 0 0 119 85 456 314 1067 653
Control 9 680 364 0 0 165 133 876 754 1475 1113
Total 45 527 315 0.9 6.3 107* 94 448* 456 1006* 752
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 2901 1014 0.4 1.9 0.1 0.5 114 259 0.7 2.8
High Protein 18 3874 1243 0.2 0.7 0.4 0.6 36 123 0.3 1.4
Control 9 4013 1822 0.3 1.0 0.6 0.7 30 33 0.8 2.0
Total 45 3512* 1362 0.3 1.3 0.3 0.6 66 183 0.6 2.1
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 8.6 4.4 0.6 0.8 0.3 1.2 12 10 3.6 6.0
High Protein 18 10.6 5.7 1.1 1.3 0.2 0.7 43 40 4.5 3.6
Control 9 10.0 5.5 1.4 1.3 0.3 1.0 74 69 6.4 6.0
Total 45 9.7 5.1 1.0 1.1 0.2 1.0 37* 45 4.5 5.2
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 0.7 2.6 2.7 2.2 20 47 2 5 30 25
High Protein 18 1.2 3.6 4.9 3.7 16 54 3 9 122 130
Control 9 0.0 0.0 8.2 7.1 9 11 25 48 278 406
Total 45 0.8 2.8 4.7* 4.5 16 45 7* 23 116* 213
Group n Mean SD
Low Protein 18 2 3
High Protein 18 31 67
Control 9 8 9




Other Alcohol(g) Ash(g) Caffeine(mg) Theobromine(mg) Choline(mg)















Appendix B6a – Nutritional Analysis for Three Groups.  Macronutrients and 
micronutrients are given for three groups: Low Protein, High Protein, and Control.  
Significant differences among groups were found for total calories, energy, total calories 
from protein, %calories from protein, total grams of protein, grams protein per kg total 
body mass per day, grams protein per kg lean mass per day, and micronutrients as 
indicated (* = p<0.05).   
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 152 170 53 64 1061 1717 177 404 24 41
High Protein 18 238 238 61 81 1757 2201 283 575 15 27
Control 9 298 259 190 202 1169 1684 147 403 30 65
Total 45 216 221 84* 120 1368 1910 213 473 21 42
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 300 647 622 1624 3431 3418 0.4 0.5 0.8 2.3
High Protein 18 912 2621 627 1016 4892 3752 0.7 0.7 0.7 0.6
Control 9 394 594 745 876 4435 4030 0.8 0.8 1.3 0.7
Total 45 564 1722 648 1249 4216 3655 0.6 0.6 0.9 1.5
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 11 17 2.0 5.3 0.9 2.1 118 97 56 77
High Protein 18 13 9 1.9 1.4 0.8 0.8 174 104 86 69
Control 9 14 9 3.1 3.0 1.2 1.0 188 139 113 107
Total 45 12 13 2.2 3.7 1.0 1.4 154 110 79 82
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 29 48 96 96 2.2 6.0 1.1 3.3 1.1 4.7
High Protein 18 35 55 136 127 2.2 3.9 0.9 3.5 0.4 1.9
Control 9 51 46 197 164 3.3 2.8 0 0 0.9 2.7
Total 45 36 50 132 127 2.4 4.6 0.8 3.0 0.8 3.4
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 71 106 35 61 0 0 0.1 0.3 0.2 0.5
High Protein 18 49 41 66 65 0 0 0.7 1.2 0.8 1.2
Control 9 51 32 163 169 0 0 2.3 3.8 2.9 3.8
Total 45 58 73 73* 103 0 0 0.8* 2.0 1.0* 2.1
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 1.6 2.4 0 0 0.6 0.8 0 0 0 0
High Protein 18 1.7 1.3 0.1 0.2 1.4 1.9 0.1 0.3 0.1 0.2
Control 9 3.0 2.4 0.1 0.3 2.4 1.9 0.4 0.5 0.1 0.3
Total 45 1.9 2.1 0.04 0.2 1.3* 1.7 0.1* 0.3 0.04 0.2
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
Low Protein 18 0 0 0 0 0 0 3.7 5.8 0 0
High Protein 18 0.1 0.5 0.1 0.3 0 0 4.7 4.5 0.1 0.2
Control 9 0 0 0.1 0.3 0 0 5.2 4.2 0 0
Total 45 0.04 0.3 0.1 0.3 0 0 4.4 4.9 0.02 0.1
Group n Mean SD Mean SD Mean SD
Low Protein 18 51 141 1.0 2.9 0.3 0.6
High Protein 18 30 44 1.1 2.0 0.7 2.6
Control 9 31 33 4.1 4.7 1.3 1.9










Vit-C(mg) Vit-D(IU) Vit-D2(mcg) Vit-D3(mcg)
Vit-B6(mg) Folate(mcg) FoodFolate(mcg)
FolicAcid(mcg) Dietary Folate Equivalents(mcgDFE)Vit-B12(mcg)
Vit-K1D(mcg) Vit-K2(mcg)
BetaTocopherol(mg) GammaTocopherol(mg) DeltaTocopherol(mg) Vit-E(IU) Vit-E, added(mg)
Vit-K1(mcg)
Vit-D2+D3(mcg)
AlphaTocopherol(mg) BetaTocopherol(mg) GammaTocopherol(mg) DeltaTocopherol(mg) AlphaTocopherol(mg)
Vit-B12, added(mcg) Vit-H(mcg)
Lutein+Zeaxanthin(mcg) Vit-A IU Vit-B1(mg) Vit-B2(mg)
Vit-B3(mg) Vit-B5(mg)






7. ANOVA Results for Nutrition Logs of Three Groups 
 
Sum of Squares df Mean Square F Sig.
Between Groups 3556004.522 2 1778002.261 4.488 0.017*
Within Groups 16637758.72 42 396137.112
Total 20193763.24 44
Between Groups 62548225.94 2 31274112.97 4.503 0.017*
Within Groups 291720120.1 42 6945717.144
Total 354268346 44
Between Groups 30951.589 2 15475.794 14.416 <0.001*
Within Groups 45087.389 42 1073.509
Total 76038.978 44
Between Groups 6.764 2 3.382 20.381 <0.001*
Within Groups 6.97 42 0.166
Total 13.734 44
Between Groups 5.133 2 2.566 7.32 0.002*
Within Groups 14.726 42 0.351
Total 19.859 44
Between Groups 517839.367 2 258919.683 14.189 <0.001*
Within Groups 766431.611 42 18248.372
Total 1284270.978 44
Between Groups 163.333 2 81.667 3.347 0.045*
Within Groups 1024.667 42 24.397
Total 1188 44
Between Groups 32221.856 2 16110.928 2.528 0.092
Within Groups 267663.389 42 6372.938
Total 299885.244 44
Between Groups 1873.2 2 936.6 2.381 0.105
Within Groups 16520 42 393.333
Total 18393.2 44
Between Groups 4053.5 2 2026.75 1.379 0.263
Within Groups 61744.944 42 1470.118
Total 65798.444 44
Between Groups 64.911 2 32.456 1.137 0.33
Within Groups 1199 42 28.548
Total 1263.911 44
Between Groups 55.633 2 27.817 1.109 0.339
Within Groups 1053.611 42 25.086
Total 1109.244 44
Between Groups 0 2 0 . .
Within Groups 0 42 0
Total 0 44
Between Groups 13.8 2 6.9 0.793 0.459
Within Groups 365.444 42 8.701
Total 379.244 44
Between Groups 4.556 2 2.278 0.781 0.465
Within Groups 122.556 42 2.918
Total 127.111 44
Between Groups 1.778 2 0.889 1.6 0.214
Within Groups 23.333 42 0.556
Total 25.111 44
Between Groups 295.2 2 147.6 1.322 0.278
Within Groups 4689.778 42 111.661
Total 4984.978 44
Between Groups 36752.8 2 18376.4 3.141 0.054
Within Groups 245737.111 42 5850.884
Total 282489.911 44
Between Groups 520862.667 2 260431.333 2.804 0.072
Within Groups 3900755.111 42 92875.122
Total 4421617.778 44
Between Groups 15.633 2 7.817 0.128 0.88
Within Groups 2566.944 42 61.118
Total 2582.578 44
Between Groups 3506.3 2 1753.15 1.693 0.196
Within Groups 43485.611 42 1035.372
Total 46991.911 44
Between Groups 423.244 2 211.622 2.284 0.114































Sum of Squares df Mean Square F Sig.
Between Groups 0.089 2 0.044 2.1 0.135
Within Groups 0.889 42 0.021
Total 0.978 44
Between Groups 0 2 0 . .
Within Groups 0 42 0
Total 0 44
Between Groups 378.8 2 189.4 1.596 0.215
Within Groups 4983.778 42 118.661
Total 5362.578 44
Between Groups 104.3 2 52.15 2.046 0.142
Within Groups 1070.5 42 25.488
Total 1174.8 44
Between Groups 0.389 2 0.194 0.812 0.451
Within Groups 10.056 42 0.239
Total 10.444 44
Between Groups 36.922 2 18.461 3.123 0.054
Within Groups 248.278 42 5.911
Total 285.2 44
Between Groups 289486.7 2 144743.35 1.628 0.208
Within Groups 3734501.611 42 88916.705
Total 4023988.311 44
Between Groups 89.444 2 44.722 1.167 0.321
Within Groups 1609.667 42 38.325
Total 1699.111 44
Between Groups 862468.8 2 431234.4 8.4 0.001*
Within Groups 2156124.444 42 51336.296
Total 3018593.244 44
Between Groups 8.2 2 4.1 0.512 0.603
Within Groups 336.111 42 8.003
Total 344.311 44
Between Groups 384.133 2 192.067 0.491 0.616
Within Groups 16436.444 42 391.344
Total 16820.578 44
Between Groups 0.667 2 0.333 0.516 0.6
Within Groups 27.111 42 0.646
Total 27.778 44
Between Groups 182.7 2 91.35 5.337 0.009*
Within Groups 718.944 42 17.118
Total 901.644 44
Between Groups 662.033 2 331.017 0.159 0.854
Within Groups 87501.611 42 2083.372
Total 88163.644 44
Between Groups 3445.644 2 1722.822 3.575 0.037*
Within Groups 20239.556 42 481.894
Total 23685.2 44
Between Groups 348.2 2 174.1 1.346 0.271
Within Groups 5431 42 129.31
Total 5779.2 44
Between Groups 0.167 2 0.083 0.364 0.697
Within Groups 9.611 42 0.229
Total 9.778 44
Between Groups 0.467 2 0.233 0.323 0.726
Within Groups 30.333 42 0.722
Total 30.8 44
Between Groups 322.7 2 161.35 0.959 0.392
Within Groups 7066.278 42 168.245
Total 7388.978 44
Between Groups 142537.356 2 71268.678 1.499 0.235
Within Groups 1996781.889 42 47542.426
Total 2139319.244 44
Between Groups 128480.2 2 64240.1 5.335 0.009*
Within Groups 505751 42 12041.69
Total 634231.2 44
Between Groups 4693578.181 2 2346789.09 0.632 0.537

































Sum of Squares df Mean Square F Sig.
Between Groups 150452.967 2 75226.483 0.326 0.724
Within Groups 9698331.833 42 230912.663
Total 9848784.8 44
Between Groups 1506.089 2 753.044 0.42 0.66
Within Groups 75247.111 42 1791.598
Total 76753.2 44
Between Groups 3698809.533 2 1849404.767 0.613 0.547
Within Groups 126746578.8 42 3017775.685
Total 130445388.3 44
Between Groups 104994.689 2 52497.344 0.032 0.968
Within Groups 68506814.56 42 1631114.632
Total 68611809.24 44
Between Groups 19731737.2 2 9865868.6 0.73 0.488
Within Groups 567927706.4 42 13522088.25
Total 587659443.6 44
Between Groups 0.967 2 0.483 1.153 0.326
Within Groups 17.611 42 0.419
Total 18.578 44
Between Groups 2.333 2 1.167 0.48 0.622
Within Groups 102.111 42 2.431
Total 104.444 44
Between Groups 60.644 2 30.322 0.178 0.838
Within Groups 7158.556 42 170.442
Total 7219.2 44
Between Groups 9.911 2 4.956 0.358 0.701
Within Groups 580.667 42 13.825
Total 590.578 44
Between Groups 0.911 2 0.456 0.21 0.811
Within Groups 91 42 2.167
Total 91.911 44
Between Groups 368570.033 2 184285.017 4.78 0.013*
Within Groups 1619147.167 42 38551.123
Total 1987717.2 44
Between Groups 40200.133 2 20100.067 1.699 0.195
Within Groups 496953.111 42 11832.217
Total 537153.244 44
Between Groups 20560.3 2 10280.15 1.571 0.22
Within Groups 274826.278 42 6543.483
Total 295386.578 44
Between Groups 2926.533 2 1463.267 0.568 0.571
Within Groups 108234.667 42 2577.016
Total 111161.2 44
Between Groups 61645.533 2 30822.767 2.011 0.147
Within Groups 643734.111 42 15327.003
Total 705379.644 44
Between Groups 8.889 2 4.444 0.202 0.818
Within Groups 926.222 42 22.053
Total 935.111 44
Between Groups 7.311 2 3.656 0.39 0.68
Within Groups 393.889 42 9.378
Total 401.2 44
Between Groups 4.089 2 2.044 0.173 0.841
Within Groups 495.111 42 11.788
Total 499.2 44
Between Groups 4777.144 2 2388.572 0.441 0.646
Within Groups 227272.5 42 5411.25
Total 232049.644 44
Between Groups 99097.189 2 49548.594 5.727 0.006*
Within Groups 363354.722 42 8651.303
Total 462451.911 44
Between Groups 0 2 0 . .
Within Groups 0 42 0
Total 0 44
Between Groups 29.811 2 14.906 4.366 0.019*
Within Groups 143.389 42 3.414
Total 173.2 44






























Sum of Squares df Mean Square F Sig.
Between Groups 43.867 2 21.933 6.437 0.004*
Within Groups 143.111 42 3.407
Total 186.978 44
Between Groups 13.589 2 6.794 1.659 0.203
Within Groups 172.056 42 4.097
Total 185.644 44
Between Groups 0.078 2 0.039 0.891 0.418
Within Groups 1.833 42 0.044
Total 1.911 44
Between Groups 21.856 2 10.928 4.639 0.015*
Within Groups 98.944 42 2.356
Total 120.8 44
Between Groups 1.2 2 0.6 6.3 0.004*
Within Groups 4 42 0.095
Total 5.2 44
Between Groups 0.078 2 0.039 0.891 0.418
Within Groups 1.833 42 0.044
Total 1.911 44
Between Groups 0.133 2 0.067 0.741 0.483
Within Groups 3.778 42 0.09
Total 3.911 44
Between Groups 0.133 2 0.067 1.05 0.359
Within Groups 2.667 42 0.063
Total 2.8 44
Between Groups 0 2 0 . .
Within Groups 0 42 0
Total 0 44
Between Groups 15.633 2 7.817 0.311 0.734
Within Groups 1055.167 42 25.123
Total 1070.8 44
Between Groups 0.033 2 0.017 0.741 0.483
Within Groups 0.944 42 0.022
Total 0.978 44
Between Groups 4825.411 2 2412.706 0.268 0.766
Within Groups 378625.833 42 9014.901
Total 383451.244 44
Between Groups 68.478 2 34.239 3.67 0.034*
Within Groups 391.833 42 9.329
Total 460.311 44
Between Groups 6.778 2 3.389 0.941 0.398
Within Groups 151.222 42 3.601
Total 158 44
Between Groups 8137.889 2 4068.944 2.193 0.124
Within Groups 77910.556 42 1855.013
Total 86048.444 44
Between Groups 489298.522 2 244649.261 2.653 0.082
Within Groups 3872413.389 42 92200.319
Total 4361711.911 44
Between Groups 58.8 2 29.4 0.741 0.483
Within Groups 1666 42 39.667
Total 1724.8 44
Between Groups 64096.2 2 32048.1 4.155 0.023*
Within Groups 323957 42 7713.262
Total 388053.2 44
Between Groups 2537589.422 2 1268794.711 8.046 0.001*
Within Groups 6623061.556 42 157691.942
Total 9160650.978 44
Between Groups 3614030.867 2 1807015.433 3.57 0.037*
Within Groups 21256249.44 42 506101.177
Total 24870280.31 44
Between Groups 11334115.91 2 5667057.956 3.387 0.043*
Within Groups 70282678.89 42 1673397.116
Total 81616794.8 44
Between Groups 0.7 2 0.35 0.191 0.827
Within Groups 76.944 42 1.832
Total 77.644 44





























Sum of Squares df Mean Square F Sig.
Between Groups 1.556 2 0.778 2.262 0.117
Within Groups 14.444 42 0.344
Total 16 44
Between Groups 68967.5 2 34483.75 1.034 0.364
Within Groups 1400640.278 42 33348.578
Total 1469607.778 44
Between Groups 1.556 2 0.778 0.162 0.851
Within Groups 201.556 42 4.799
Total 203.111 44
Between Groups 35.278 2 17.639 0.655 0.525
Within Groups 1130.722 42 26.922
Total 1166 44
Between Groups 4.467 2 2.233 1.823 0.174
Within Groups 51.444 42 1.225
Total 55.911 44
Between Groups 0.2 2 0.1 0.105 0.901
Within Groups 40.111 42 0.955
Total 40.311 44
Between Groups 23994.8 2 11997.4 7.585 0.002*
Within Groups 66434 42 1581.762
Total 90428.8 44
Between Groups 50.078 2 25.039 0.931 0.402
Within Groups 1129.167 42 26.885
Total 1179.244 44
Between Groups 8.644 2 4.322 5.985 0.005*
Within Groups 30.333 42 0.722
Total 38.978 44
Between Groups 17.5 2 8.75 5.49 0.008*
Within Groups 66.944 42 1.594
Total 84.444 44
Between Groups 51.5 2 25.75 5.625 0.007*
Within Groups 192.278 42 4.578
Total 243.778 44
Between Groups 49 2 24.5 5.979 0.005*
Within Groups 172.111 42 4.098
Total 221.111 44
Between Groups 5.367 2 2.683 5.162 0.01*
Within Groups 21.833 42 0.52
Total 27.2 44
Between Groups 14.333 2 7.167 5.364 0.008*
Within Groups 56.111 42 1.336
Total 70.444 44
Between Groups 12.889 2 6.444 4.545 0.016*
Within Groups 59.556 42 1.418
Total 72.444 44
Between Groups 1.244 2 0.622 3.564 0.037*
Within Groups 7.333 42 0.175
Total 8.578 44
Between Groups 21.8 2 10.9 5.715 0.006*
Within Groups 80.111 42 1.907
Total 101.911 44
Between Groups 25.2 2 12.6 6.615 0.003*
Within Groups 80 42 1.905
Total 105.2 44
Between Groups 27.311 2 13.656 5.36 0.008*
Within Groups 107 42 2.548
Total 134.311 44
Between Groups 65.411 2 32.706 5.193 0.01*
Within Groups 264.5 42 6.298
Total 329.911 44
Between Groups 2.7 2 1.35 4.883 0.012*
Within Groups 11.611 42 0.276
Total 14.311 44
Between Groups 245.467 2 122.733 6.531 0.003*
Within Groups 789.333 42 18.794
Total 1034.8 44






























Appendix B7 – ANOVA Results for Nutrition Logs of Three Groups.  Macronutrients and 
micronutrients were analyzed with a one-way ANOVA for three groups: Low Protein, 
High Protein, and Control.  Significant differences among groups were found for total 
calories, energy, total calories from protein, %calories from protein, total grams of protein, 
grams protein per kg total body mass per day, grams protein per kg lean mass per day, and 























Sum of Squares df Mean Square F Sig.
Between Groups 15.422 2 7.711 7.007 0.002*
Within Groups 46.222 42 1.101
Total 61.644 44
Between Groups 0.089 2 0.044 2.1 0.135
Within Groups 0.889 42 0.021
Total 0.978 44
Between Groups 22.478 2 11.239 5.32 0.009*
Within Groups 88.722 42 2.112
Total 111.2 44
Between Groups 15.944 2 7.972 4.29 0.02*
Within Groups 78.056 42 1.858
Total 94 44
Between Groups 11.5 2 5.75 6.273 0.004*
Within Groups 38.5 42 0.917
Total 50 44
Tyrosine(g)










8. Tukey Post-Hoc Test for Nutrition Logs of Three Groups
 
Dependent Variable (I) GROUP (J) GROUP Mean Difference (I-J) SD Sig.
Calories LO HI -623.83333 209.79808 0.013
Energy(kj) LO HI -2615.72222 878.49095 0.013
LO HI -57.83333 10.92148 <0.001
HI CON 39.77778 13.37603 0.013
LO HI -0.85224 0.13579 <0.001
HI CON 0.60382 0.1663 0.002
Protein (g/kg LEAN) LO HI -0.73592 0.19738 0.002
LO HI -236.72222 45.02884 <0.001
HI CON 161.66667 55.14885 0.015
%Calories/Protein HI CON 5 2.01647 0.045
Estimated Net Carb(g) LO HI -63.55556 25.49702 0.043
Omega6(g) LO CON -2.44444 0.99259 0.046
HI -188.22222 75.52505 0.043
CON -368.88889 92.49892 0.001
Ash(g) LO CON -5.5 1.68907 0.006
LO CON -137.61111 44.79898 0.01
HI CON -128.83333 44.79898 0.017
Choline(mg) LO CON -247.5 80.15727 0.01
LO CON -127.55556 37.97215 0.005
HI CON -96.72222 37.97215 0.038
Vit-D3(mcg) LO CON -2.22222 0.75432 0.014
LO CON -2.66667 0.75359 0.003
HI CON -2.11111 0.75359 0.021
GammaTocopherol(mg) LO CON -1.88889 0.62661 0.012
LO CON -0.44444 0.12599 0.003
HI CON -0.33333 0.12599 0.03
LO CON -3.11111 1.24695 0.043
HI CON -3.05556 1.24695 0.048
Magnesium(mg) LO CON -99.83333 35.85448 0.021
LO CON -650.11111 162.11721 0.001
HI CON -420.77778 162.11721 0.034
Potassium(mg) LO CON -764.05556 290.43105 0.031
Selenium(mcg) LO CON -61.66667 16.23659 0.001
HI -0.77778 0.28328 0.024
CON -1.05556 0.34694 0.011
HI LO 0.77778 0.28328 0.024
Isoleucine(g) LO CON -1.66667 0.51541 0.007
Leucine(g) LO CON -2.83333 0.8735 0.006
Lysine(g) LO CON -2.72222 0.82643 0.006
HI -0.61111 0.24033 0.038
CON -0.83333 0.29435 0.019
Phenylalanine(g) LO CON -1.5 0.47187 0.008
Threonine(g) LO CON -1.44444 0.48614 0.013
Tryptophan(g) LO CON -0.44444 0.17059 0.033
Valine(g) LO CON -1.83333 0.56383 0.006
Alanine(g) LO CON -2 0.56344 0.003
Arginine(g) LO CON -2.05556 0.65162 0.008
Aspartic Acid(g) LO CON -3.22222 1.0245 0.008
Cystine(g) LO CON -0.66667 0.21465 0.009
Glutamic Acid(g) LO CON -6.33333 1.76982 0.003
HI -1 0.34969 0.018
CON -1.44444 0.42828 0.004
Proline(g) LO CON -1.88889 0.59336 0.008
Serine(g) LO CON -1.61111 0.55655 0.016




















Appendix B8 – Tukey Post-Hoc Test for Nutrition Logs of Three Groups.  Macronutrients 
and micronutrients were analyzed with a one-way ANOVA and Tukey HSD for three 












Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 1750 483 7322 2021 457 80 27 6 681 251
2 (LO/IPE) 70 2313 579 9658 2446 462 104 21 2 1084 268
3 (HI/DPE) 71 2592 628 10840 2626 685 175 27 6 1101 286
4 (HI/IPE) 70 2718 325 11372 1358 707 59 26 3 1144 278
5 (CON) 71 2429 908 10165 3798 534 210 22 4 1017 318
Total 353 2360* 677 9871* 2838 569* 171 25* 5 1005* 317
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 38 10 602 246 34 8 10.9 26.3 0.4 1.0
2 (LO/IPE) 70 47 6 767 258 33 5 0.0 0.0 0.0 0.0
3 (HI/DPE) 71 42 4 806 261 31 4 0.0 0.0 0.0 0.0
4 (HI/IPE) 70 42 6 846 150 31 5 16.0 33.9 0.7 1.4
5 (CON) 71 44 9 878 482 35 8 0.0 0.0 0.0 0.0
Total 353 43 8 780 302 33 6 5.4 19.6 0.2 0.8
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 112 19 1.2 0.3 1.9 0.5 0.3 0.5 0.8 0.7
2 (LO/IPE) 70 113 24 1.4 0.3 2.0 0.5 0.1 0.3 0.4 0.5
3 (HI/DPE) 71 169 42 2.2 0.4 2.6 0.6 1.0 1.1 1.8 1.9
4 (HI/IPE) 70 171 16 2.1 0.3 2.7 0.4 1.1 0.9 2.4 1.5
5 (CON) 71 130 51 1.6 0.7 2.1 0.9 1.9 2.4 3.4 4.2
Total 353 139* 42 1.7* 0.6 2.2* 0.7 0.9* 1.4 1.8* 2.4
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 0.7 0.7 0.1 0.3 0.3 0.5 0.7 1.0 0 0
2 (LO/IPE) 70 0.1 0.3 0 0 0.2 0.4 0 0 0 0
3 (HI/DPE) 71 1.7 1.9 0.6 0.7 0.9 0.9 0.9 0.9 0.2 0.4
4 (HI/IPE) 70 2.2 1.4 0.8 0.7 1.2 1.1 1.1 0.9 0.2 0.4
5 (CON) 71 3.1 3.9 0.9 1.3 1.8 2.1 1.8 2.1 0.4 0.7
Total 353 1.6* 2.2 0.5* 0.8 0.9* 1.3 0.9* 1.3 0.2 0.4
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 0.6 0.5 0.4 0.5 0.8 0.7 0.8 0.7 0 0
2 (LO/IPE) 70 0.2 0.4 0.2 0.4 0.2 0.4 0.6 0.5 0 0
3 (HI/DPE) 71 1.2 1.2 1.2 1.2 1.4 1.5 1.9 2.0 0.3 0.5
4 (HI/IPE) 70 1.6 1.0 1.4 1.0 1.8 1.1 2.7 1.3 0.2 0.4
5 (CON) 71 2.2 2.6 2.3 2.6 2.6 3.0 3.9 5.1 0.7 1.0
Total 353 1.2* 1.5 1.1* 1.5 1.4* 1.7 2.0* 2.7 0.2 0.6
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 1.7 1.4 0.3 0.5 0 0 0.6 0.5 0.6 0.5
2 (LO/IPE) 70 1.4 1.3 0.1 0.3 0 0 0.3 0.5 0.2 0.4
3 (HI/DPE) 71 3.8 3.9 1.1 1.3 0 0 1.1 1.3 0.9 0.9
4 (HI/IPE) 70 4.9 2.8 1.3 0.7 0 0 1.7 1.1 1.3 0.9
5 (CON) 71 7.9 8.4 1.7 1.8 0.1 0.3 2.3 2.7 2.0 2.7
Total 353 3.9* 4.8 0.9* 1.2 0.02 0.1 1.2* 1.6 1.0 1.5
Group n Mean SD Mean SD
1 (LO/DPE) 71 0.2 0.4 0.1 0.3
2 (LO/IPE) 70 0 0 0 0
3 (HI/DPE) 71 0.7 0.9 0.7 0.9
4 (HI/IPE) 70 1.0 0.7 1.0 0.7
5 (CON) 71 1.4 1.8 1.1 1.5































Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 188 63 5 4 44 37 1.9 3.1 1.8 2.8
2 (LO/IPE) 70 290 73 11 8 73 40 5.3 9.3 5.1 6.3
3 (HI/DPE) 71 293 80 14 18 64 26 2.1 2.1 2.2 2.4
4 (HI/IPE) 70 304 71 18 25 91 44 4.9 3.9 5.9 5.0
5 (CON) 71 268 83 25 31 78 34 6.6 4.9 6.4 6.3
Total 353 268* 83 14 20 70 39 4.2 5.4 4.3 5.0
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 0 0 1.1 1.9 0.1 0.3 0.1 0.3 23 10
2 (LO/IPE) 70 0 0 4.3 3.6 0 0 0.3 0.5 27 14
3 (HI/DPE) 71 0 0 2.1 1.5 0 0 0.7 0.9 24 13
4 (HI/IPE) 70 0 0 4.7 3.4 1.4 3.4 0.7 1.1 30 9
5 (CON) 71 0 0 4.2 2.4 0.7 1.7 0.4 0.7 20.2 5.8
Total 353 0 0 3.3* 2.9 0.4 1.7 0.4 0.8 25.0 10.6
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 65 26 20 9 0.8 0.8 0 0 0 0
2 (LO/IPE) 70 82 27 21 7 0.2 0.4 0 0 0 0
3 (HI/DPE) 71 87 28 24 8 0.3 0.5 0 0 0 0
4 (HI/IPE) 70 90 17 26 8 0.7 0.7 0 0 0 0
5 (CON) 71 95 53 28 16 0.7 1.0 0.1 0.3 0 0
Total 353 84 33 24 10 0.5 0.7 0 0.1 0 0
Group n Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 7 4 4 3 0 0 0.7 1.1
2 (LO/IPE) 70 10 9 4 2 0 0 0.9 1.4
3 (HI/DPE) 71 8 5 5 4 0.3 1.0 1.2 1.3
4 (HI/IPE) 70 12 6 7 3 0 0 1.3 1.0
5 (CON) 71 17 21 8 10 0.2 0.4 3.2 5.0
Total 353 11 11 6 5 0.1 0.5 1.5 2.5
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 219 72 4.0 5.5 0.2 0.4 0.3 0.7 6.7 14.3
2 (LO/IPE) 70 172 58 6.3 9.9 0.2 0.4 0.7 1.1 10.2 18.0
3 (HI/DPE) 71 368 110 5.2 6.5 0 0 0.2 0.7 3.6 10.7
4 (HI/IPE) 70 399 237 15.6 14.7 0.3 0.7 0.6 1.1 8.3 14.7
5 (CON) 71 564 437 11.6 15.1 0.3 0.5 0.2 0.4 1.1 1.7
Total 353 345* 262 8.5 11.5 0.2 0.5 0.4 0.8 6.0 13.0
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 1.4 3.6 1.9 1.5 4 13 2 6 35 27
2 (LO/IPE) 70 0 0 3.6 2.5 35 63 2 3 25 23
3 (HI/DPE) 71 0 0 4.1 3.3 4 11 0 1 70 62
4 (HI/IPE) 70 2.3 4.9 5.7 4.1 28 75 6 12 174 161
5 (CON) 71 0 0 8.2 7.1 9 11 25 48 278 406
Total 353 0.8 2.8 4.7* 4.5 16 45 7 23 116* 213
Group n Mean SD
1 (LO/DPE) 71 2 3
2 (LO/IPE) 70 3 3
3 (HI/DPE) 71 46 92
4 (HI/IPE) 70 17 27
5 (CON) 71 8 9



























Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 104 152 23 25 926 1559 191 511 11 15
2 (LO/IPE) 70 200 182 82 79 1180 1932 163 291 37 54
3 (HI/DPE) 71 179 196 26 40 1651 2054 365 743 16 32
4 (HI/IPE) 70 297 273 97 96 1864 2460 200 369 14 24
5 (CON) 71 298 259 190 202 1169 1684 147 403 30 65
Total 353 216 221 84* 120 1368 1910 213 473 21 42
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 160 290 344 516 2851 2918 0.3 0.5 0.2 0.4
2 (LO/IPE) 70 440 872 899 2273 4012 3944 0.6 0.5 1.4 3.2
3 (HI/DPE) 71 1073 3219 638 1327 4701 3206 0.4 0.5 0.4 0.5
4 (HI/IPE) 70 752 2045 616 657 5083 4422 1.0 0.7 1.0 0.5
5 (CON) 71 394 594 745 876 4435 4030 0.8 0.8 1.3 0.7
Total 353 564 1722 648 1249 4216 3655 0.6 0.6 0.9 1.5
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 6.2 4.7 0.7 0.7 0.1 0.3 93 69 50 54
2 (LO/IPE) 70 15.9 23.5 3.3 7.4 1.8 2.7 143 117 63 98
3 (HI/DPE) 71 12.6 11.0 1.3 0.9 0.7 0.9 147 100 69 74
4 (HI/IPE) 70 14.0 7.8 2.4 1.6 1.0 0.7 201 106 102 64
5 (CON) 71 13.7 9.2 3.1 3.0 1.2 1.0 188 139 113 107
Total 353 12.5 12.8 2.2 3.7 1.0 1.4 154 110 79 82
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 7 9 46 36 0.4 0.5 0 0 0 0
2 (LO/IPE) 70 50 61 147 111 4.0 8.3 2.1 4.5 2.2 6.7
3 (HI/DPE) 71 35 58 114 109 0.9 0.8 0.1 0.3 0 0
4 (HI/IPE) 70 34 56 158 146 3.6 5.2 1.8 5.0 0.9 2.7
5 (CON) 71 51 46 197 164 3.3 2.8 0 0 0.9 2.7
Total 353 36 50 132 127 2.4 4.6 0.8 3.0 0.8 3.4
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 82 142 21 38 0 0 0 0 0 0
2 (LO/IPE) 70 60 58 49 77 0 0 0.2 0.4 0.4 0.7
3 (HI/DPE) 71 42 38 44 44 0 0 0.1 0.3 0.2 0.4
4 (HI/IPE) 70 56 45 88 78 0 0 1.3 1.5 1.3 1.5
5 (CON) 71 51 32 163 169 0 0 2.3 3.8 2.9 3.8
Total 353 58 73 73 103 0 0 0.8* 2.0 1.0* 2.1
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 1.0 1.9 0 0 0.2 0.4 0 0 0 0
2 (LO/IPE) 70 2.1 2.8 0 0 0.9 0.9 0 0 0 0
3 (HI/DPE) 71 1.1 0.9 0.1 0.3 1.2 1.9 0.1 0.3 0.1 0.3
4 (HI/IPE) 70 2.3 1.3 0 0 1.6 1.9 0.1 0.3 0 0
5 (CON) 71 3.0 2.4 0.1 0.3 2.4 1.9 0.4 0.5 0.1 0.3
Total 353 1.9 2.1 0 0.2 1.3 1.7 0.1* 0.3 0 0.2
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 0 0 0 0 0 0 1.9 2.8 0 0
2 (LO/IPE) 70 0 0 0 0 0 0 5.6 7.5 0 0
3 (HI/DPE) 71 0.2 0.7 0.2 0.4 0 0 4.7 4.4 0 0
4 (HI/IPE) 70 0 0 0 0 0 0 4.7 4.8 0.1 0.3
5 (CON) 71 0 0 0.1 0.3 0 0 5.2 4.2 0 0
Total 353 0 0.3 0.1 0.3 0 0 4.4 4.9 0 0.1
Group n Mean SD Mean SD Mean SD
1 (LO/DPE) 71 28 40 0.2 0.4 0.4 0.7
2 (LO/IPE) 70 75 198 1.8 4.1 0.1 0.3
3 (HI/DPE) 71 32 55 1.0 2.3 0.2 0.7
4 (HI/IPE) 70 28 33 1.1 1.8 1.2 3.7
5 (CON) 71 31 33 4.1 4.7 1.3 1.9






























Appendix B9 – Nutritional Analysis for Five Groups.  Macronutrients and 
micronutrients are given for five groups: LO/DPE, LO/IPE, HI/DPE, HI/IPE, and 
CON.  Significant differences among groups were found for total calories, energy, 
total calories from carbohydrate, total calories from protein, %calories from 
protein, total grams of protein, grams protein per kg total body mass per day, 
grams protein per kg lean mass per day, and micronutrients as indicated (* = 




Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 408 287 4.7 14.0 47 29 206 156 625 397
2 (LO/IPE) 70 411 332 0 0 84 75 247 158 797 583
3 (HI/DPE) 71 544 247 0 0 104 96 367 285 819 470
4 (HI/IPE) 70 593 311 0 0 134 75 544 332 1315 739
5 (CON) 71 680 364 0 0 165 133 876 754 1475 1113
Total 353 527 315 0.9 6.3 107 94 448* 456 1006 752
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 2509 891 0 0 0 0 99 260 0 0
2 (LO/IPE) 70 3293 1023 0.9 2.7 0.2 0.7 128 272 1.3 4.0
3 (HI/DPE) 71 3767 1221 0 0 0.4 0.7 4 4 0 0
4 (HI/IPE) 70 3980 1328 0.3 1.0 0.4 0.5 68 172 0.7 2.0
5 (CON) 71 4013 1822 0.3 1.0 0.6 0.7 30 33 0.8 2.0
Total 353 3512 1362 0.3 1.3 0.3 0.6 66 183 0.6 2.1
Group n Mean SD Mean SD Mean SD Mean SD Mean SD
1 (LO/DPE) 71 8 3 0.2 0.4 0 0 10 10 4.6 8.5
2 (LO/IPE) 70 10 5 1.0 0.9 0.6 1.7 14 11 2.6 1.6
3 (HI/DPE) 71 11 7 0.7 1.3 0 0 40 47 3.9 4.3
4 (HI/IPE) 70 10 5 1.4 1.1 0.3 1.0 46 34 5.1 2.8
5 (CON) 71 10 6 1.4 1.3 0.3 1.0 74 69 6.4 6.0












10. ANOVA Results for Nutrition Log of Five Groups 
 
Sum of Squares df Mean Square F Sig.
Between Groups 5056127.911 4 1264031.978 3.34 0.019*
Within Groups 15137635.33 40 378440.883
Total 20193763.24 44
Between Groups 88382330.89 4 22095582.72 3.324 0.019*
Within Groups 265886015.1 40 6647150.378
Total 354268346 44
Between Groups 30986.311 4 7746.578 6.878 <0.001*
Within Groups 45052.667 40 1126.317
Total 76038.978 44
Between Groups 6.93 4 1.733 10.186 <0.001*
Within Groups 6.804 40 0.17
Total 13.734 44
Between Groups 5.176 4 1.294 3.526 0.015*
Within Groups 14.682 40 0.367
Total 19.859 44
Between Groups 520052.978 4 130013.244 6.805 <0.001*
Within Groups 764218 40 19105.45
Total 1284270.978 44
Between Groups 378.889 4 94.722 4.683 0.003*
Within Groups 809.111 40 20.228
Total 1188 44
Between Groups 79425.467 4 19856.367 3.603 0.013*
Within Groups 220459.778 40 5511.494
Total 299885.244 44
Between Groups 2121.422 4 530.356 1.304 0.285
Within Groups 16271.778 40 406.794
Total 18393.2 44
Between Groups 11316.889 4 2829.222 2.077 0.102
Within Groups 54481.556 40 1362.039
Total 65798.444 44
Between Groups 153.022 4 38.256 1.377 0.259
Within Groups 1110.889 40 27.772
Total 1263.911 44
Between Groups 166.133 4 41.533 1.762 0.156
Within Groups 943.111 40 23.578
Total 1109.244 44
Between Groups 0 4 0 . .
Within Groups 0 40 0
Total 0 44
Between Groups 89.911 4 22.478 3.108 0.026*
Within Groups 289.333 40 7.233
Total 379.244 44
Between Groups 14 4 3.5 1.238 0.31
Within Groups 113.111 40 2.828
Total 127.111 44
Between Groups 2 4 0.5 0.865 0.493
Within Groups 23.111 40 0.578
Total 25.111 44
Between Groups 541.422 4 135.356 1.218 0.318
Within Groups 4443.556 40 111.089
Total 4984.978 44
Between Groups 91353.022 4 22838.256 4.779 0.003*
Within Groups 191136.889 40 4778.422
Total 282489.911 44
Between Groups 1260469.778 4 315117.444 3.987 0.008*
Within Groups 3161148 40 79028.7
Total 4421617.778 44
Between Groups 337.911 4 84.478 1.505 0.219
Within Groups 2244.667 40 56.117
Total 2582.578 44
Between Groups 4948.356 4 1237.089 1.177 0.336
Within Groups 42043.556 40 1051.089
Total 46991.911 44
Between Groups 441.022 4 110.256 1.138 0.352































Sum of Squares df Mean Square F Sig.
Between Groups 0.089 4 0.022 1 0.419
Within Groups 0.889 40 0.022
Total 0.978 44
Between Groups 0 4 0 . .
Within Groups 0 40 0
Total 0 44
Between Groups 502.578 4 125.644 1.034 0.402
Within Groups 4860 40 121.5
Total 5362.578 44
Between Groups 127.022 4 31.756 1.212 0.321
Within Groups 1047.778 40 26.194
Total 1174.8 44
Between Groups 0.889 4 0.222 0.93 0.456
Within Groups 9.556 40 0.239
Total 10.444 44
Between Groups 37.2 4 9.3 1.5 0.22
Within Groups 248 40 6.2
Total 285.2 44
Between Groups 420020.978 4 105005.244 1.165 0.34
Within Groups 3603967.333 40 90099.183
Total 4023988.311 44
Between Groups 95.333 4 23.833 0.594 0.669
Within Groups 1603.778 40 40.094
Total 1699.111 44
Between Groups 876469.244 4 219117.311 4.092 0.007*
Within Groups 2142124 40 53553.1
Total 3018593.244 44
Between Groups 42.089 4 10.522 1.393 0.254
Within Groups 302.222 40 7.556
Total 344.311 44
Between Groups 2069.689 4 517.422 1.403 0.25
Within Groups 14750.889 40 368.772
Total 16820.578 44
Between Groups 3.556 4 0.889 1.468 0.23
Within Groups 24.222 40 0.606
Total 27.778 44
Between Groups 206.089 4 51.522 2.963 0.031*
Within Groups 695.556 40 17.389
Total 901.644 44
Between Groups 7334.089 4 1833.522 0.907 0.469
Within Groups 80829.556 40 2020.739
Total 88163.644 44
Between Groups 3607.867 4 901.967 1.797 0.148
Within Groups 20077.333 40 501.933
Total 23685.2 44
Between Groups 853.2 4 213.3 1.732 0.162
Within Groups 4926 40 123.15
Total 5779.2 44
Between Groups 0.667 4 0.167 0.732 0.576
Within Groups 9.111 40 0.228
Total 9.778 44
Between Groups 1.467 4 0.367 0.5 0.736
Within Groups 29.333 40 0.733
Total 30.8 44
Between Groups 482.311 4 120.578 0.698 0.598
Within Groups 6906.667 40 172.667
Total 7388.978 44
Between Groups 246837.911 4 61709.478 1.304 0.285
Within Groups 1892481.333 40 47312.033
Total 2139319.244 44
Between Groups 167114.089 4 41778.522 3.578 0.014*
Within Groups 467117.111 40 11677.928
Total 634231.2 44
Between Groups 5172074.917 4 1293018.729 0.332 0.855
Within Groups 151726023.3 39 3890410.855
Total 156898098.3 43





























Sum of Squares df Mean Square F Sig.
Between Groups 276606.356 4 69151.589 0.289 0.883
Within Groups 9572178.444 40 239304.461
Total 9848784.8 44
Between Groups 4724.089 4 1181.022 0.656 0.626
Within Groups 72029.111 40 1800.728
Total 76753.2 44
Between Groups 4514621.644 4 1128655.411 0.359 0.837
Within Groups 125930766.7 40 3148269.167
Total 130445388.3 44
Between Groups 1491044.133 4 372761.033 0.222 0.924
Within Groups 67120765.11 40 1678019.128
Total 68611809.24 44
Between Groups 26450557.2 4 6612639.3 0.471 0.756
Within Groups 561208886.4 40 14030222.16
Total 587659443.6 44
Between Groups 2.578 4 0.644 1.611 0.19
Within Groups 16 40 0.4
Total 18.578 44
Between Groups 10.444 4 2.611 1.111 0.365
Within Groups 94 40 2.35
Total 104.444 44
Between Groups 490.533 4 122.633 0.729 0.577
Within Groups 6728.667 40 168.217
Total 7219.2 44
Between Groups 47.467 4 11.867 0.874 0.488
Within Groups 543.111 40 13.578
Total 590.578 44
Between Groups 13.911 4 3.478 1.783 0.151
Within Groups 78 40 1.95
Total 91.911 44
Between Groups 417556.978 4 104389.244 2.659 0.047*
Within Groups 1570160.222 40 39254.006
Total 1987717.2 44
Between Groups 64572.133 4 16143.033 1.366 0.263
Within Groups 472581.111 40 11814.528
Total 537153.244 44
Between Groups 26234.356 4 6558.589 0.975 0.432
Within Groups 269152.222 40 6728.806
Total 295386.578 44
Between Groups 11206.089 4 2801.522 1.121 0.36
Within Groups 99955.111 40 2498.878
Total 111161.2 44
Between Groups 116245.644 4 29061.411 1.973 0.117
Within Groups 589134 40 14728.35
Total 705379.644 44
Between Groups 97.778 4 24.444 1.168 0.339
Within Groups 837.333 40 20.933
Total 935.111 44
Between Groups 39.867 4 9.967 1.103 0.368
Within Groups 361.333 40 9.033
Total 401.2 44
Between Groups 29.867 4 7.467 0.636 0.64
Within Groups 469.333 40 11.733
Total 499.2 44
Between Groups 7867.422 4 1966.856 0.351 0.842
Within Groups 224182.222 40 5604.556
Total 232049.644 44
Between Groups 111671.467 4 27917.867 3.184 0.023*
Within Groups 350780.444 40 8769.511
Total 462451.911 44
Between Groups 0 4 0 . .
Within Groups 0 40 0
Total 0 44
Between Groups 36.756 4 9.189 2.694 0.044*
Within Groups 136.444 40 3.411
Total 173.2 44
ANOVA Results for Nutrition Logs for Five Groups cont'd.
Vit-D2(mcg)
Vit-D3(mcg)



























Sum of Squares df Mean Square F Sig.
Between Groups 50.311 4 12.578 3.681 0.012*
Within Groups 136.667 40 3.417
Total 186.978 44
Between Groups 25.867 4 6.467 1.619 0.188
Within Groups 159.778 40 3.994
Total 185.644 44
Between Groups 0.133 4 0.033 0.75 0.564
Within Groups 1.778 40 0.044
Total 1.911 44
Between Groups 24.356 4 6.089 2.525 0.056
Within Groups 96.444 40 2.411
Total 120.8 44
Between Groups 1.2 4 0.3 3 0.03*
Within Groups 4 40 0.1
Total 5.2 44
Between Groups 0.133 4 0.033 0.75 0.564
Within Groups 1.778 40 0.044
Total 1.911 44
Between Groups 0.356 4 0.089 1 0.419
Within Groups 3.556 40 0.089
Total 3.911 44
Between Groups 0.356 4 0.089 1.455 0.234
Within Groups 2.444 40 0.061
Total 2.8 44
Between Groups 0 4 0 . .
Within Groups 0 40 0
Total 0 44
Between Groups 76.133 4 19.033 0.765 0.554
Within Groups 994.667 40 24.867
Total 1070.8 44
Between Groups 0.089 4 0.022 1 0.419
Within Groups 0.889 40 0.022
Total 0.978 44
Between Groups 14949.022 4 3737.256 0.406 0.803
Within Groups 368502.222 40 9212.556
Total 383451.244 44
Between Groups 79.422 4 19.856 2.085 0.101
Within Groups 380.889 40 9.522
Total 460.311 44
Between Groups 11.778 4 2.944 0.805 0.529
Within Groups 146.222 40 3.656
Total 158 44
Between Groups 12099.778 4 3024.944 1.636 0.184
Within Groups 73948.667 40 1848.717
Total 86048.444 44
Between Groups 500153.022 4 125038.256 1.295 0.288
Within Groups 3861558.889 40 96538.972
Total 4361711.911 44
Between Groups 156.8 4 39.2 1 0.419
Within Groups 1568 40 39.2
Total 1724.8 44
Between Groups 74232.311 4 18558.078 2.365 0.069
Within Groups 313820.889 40 7845.522
Total 388053.2 44
Between Groups 2686979.867 4 671744.967 4.151 0.007*
Within Groups 6473671.111 40 161841.778
Total 9160650.978 44
Between Groups 4853868.311 4 1213467.078 2.425 0.064
Within Groups 20016412 40 500410.3
Total 24870280.31 44
Between Groups 14303300.13 4 3575825.033 2.125 0.096
Within Groups 67313494.67 40 1682837.367
Total 81616794.8 44
Between Groups 4.756 4 1.189 0.652 0.629
Within Groups 72.889 40 1.822
Total 77.644 44





























Sum of Squares df Mean Square F Sig.
Between Groups 1.778 4 0.444 1.25 0.306
Within Groups 14.222 40 0.356
Total 16 44
Between Groups 91149.111 4 22787.278 0.661 0.623
Within Groups 1378458.667 40 34461.467
Total 1469607.778 44
Between Groups 11.556 4 2.889 0.603 0.663
Within Groups 191.556 40 4.789
Total 203.111 44
Between Groups 63.333 4 15.833 0.574 0.683
Within Groups 1102.667 40 27.567
Total 1166 44
Between Groups 9.911 4 2.478 2.155 0.092
Within Groups 46 40 1.15
Total 55.911 44
Between Groups 2.089 4 0.522 0.547 0.703
Within Groups 38.222 40 0.956
Total 40.311 44
Between Groups 24253.689 4 6063.422 3.665 0.012*
Within Groups 66175.111 40 1654.378
Total 90428.8 44
Between Groups 74.8 4 18.7 0.677 0.612
Within Groups 1104.444 40 27.611
Total 1179.244 44
Between Groups 9.2 4 2.3 3.09 0.026*
Within Groups 29.778 40 0.744
Total 38.978 44
Between Groups 17.778 4 4.444 2.667 0.046*
Within Groups 66.667 40 1.667
Total 84.444 44
Between Groups 54 4 13.5 2.845 0.036*
Within Groups 189.778 40 4.744
Total 243.778 44
Between Groups 51.778 4 12.944 3.058 0.027*
Within Groups 169.333 40 4.233
Total 221.111 44
Between Groups 5.644 4 1.411 2.619 0.049*
Within Groups 21.556 40 0.539
Total 27.2 44
Between Groups 14.889 4 3.722 2.68 0.045*
Within Groups 55.556 40 1.389
Total 70.444 44
Between Groups 15.111 4 3.778 2.636 0.048*
Within Groups 57.333 40 1.433
Total 72.444 44
Between Groups 1.244 4 0.311 1.697 0.17
Within Groups 7.333 40 0.183
Total 8.578 44
Between Groups 22.8 4 5.7 2.882 0.035*
Within Groups 79.111 40 1.978
Total 101.911 44
Between Groups 25.644 4 6.411 3.223 0.022*
Within Groups 79.556 40 1.989
Total 105.2 44
Between Groups 29.2 4 7.3 2.778 0.04*
Within Groups 105.111 40 2.628
Total 134.311 44
Between Groups 68.356 4 17.089 2.613 0.05*
Within Groups 261.556 40 6.539
Total 329.911 44
Between Groups 2.756 4 0.689 2.385 0.067
Within Groups 11.556 40 0.289
Total 14.311 44
Between Groups 251.244 4 62.811 3.206 0.022*
Within Groups 783.556 40 19.589
Total 1034.8 44






























Appendix B10 – ANOVA Results for Nutrition Logs of Five Groups.  Macronutrients and 
micronutrients were analyzed with a one-way ANOVA for five groups: LO/DPE, LO/IPE, 
HI/DPE, HI/IPE, and CON.  Significant differences among groups were found for total 
calories, energy, total calories from carbohydrate, total calories from protein, %calories 
from protein, total grams of protein, grams protein per kg total body mass per day, grams 
























Sum of Squares df Mean Square F Sig.
Between Groups 15.867 4 3.967 3.466 0.016*
Within Groups 45.778 40 1.144
Total 61.644 44
Between Groups 0.089 4 0.022 1 0.419
Within Groups 0.889 40 0.022
Total 0.978 44
Between Groups 24.089 4 6.022 2.765 0.04*
Within Groups 87.111 40 2.178
Total 111.2 44
Between Groups 17.333 4 4.333 2.261 0.08
Within Groups 76.667 40 1.917
Total 94 44
Between Groups 12.222 4 3.056 3.235 0.022*













11. Tukey Post-Hoc Test for Nutrition Logs of Five Groups 
 
 
Dependent Variable (I) GROUP (J) GROUP Mean Difference (I-J) SD Sig.
HI/DPE -842.22222 289.99651 0.045
HI/IPE -968.77778 289.99651 0.015
HI/DPE -3517.55556 1215.37835 0.046
HI/IPE -4050 1215.37835 0.015
HI/DPE -56.88889 15.82064 0.007
HI/IPE -59.55556 15.82064 0.005
HI/DPE -56.11111 15.82064 0.008
HI/IPE -58.77778 15.82064 0.005
HI/DPE -0.98101 0.19442 <0.001
HI/IPE -0.89534 0.19442 <0.001
HI/DPE -0.80914 0.19442 0.001
HI/IPE -0.72348 0.19442 0.005
HI/DPE CON 0.64665 0.19442 0.015
HI/IPE CON 0.56099 0.19442 0.047
HI/DPE -228.55556 65.1587 0.009
HI/IPE -250.11111 65.1587 0.004
HI/DPE -223.33333 65.1587 0.012
HI/IPE -244.88889 65.1587 0.005
LO/DPE LO/IPE 6.88889 2.12016 0.019
LO/IPE HI/DPE -6.55556 2.12016 0.028
LO/IPE -101.77778 34.99681 0.044
HI/DPE -105 34.99681 0.035
HI/IPE -116.44444 34.99681 0.015
LO/IPE -110 32.58637 0.013
HI/DPE -115.66667 32.58637 0.008
HI/IPE -121.44444 32.58637 0.005
CON -94.22222 32.58637 0.046
LO/IPE -403.11111 132.52144 0.032
HI/DPE -420.22222 132.52144 0.023
HI/IPE -463.33333 132.52144 0.01
LO/DPE CON -345.66667 109.09028 0.023
LO/IPE CON -392.11111 109.09028 0.007
Ash(g) LO/DPE CON -6.33333 1.96576 0.02
LO/DPE CON -167.11111 50.94208 0.017
HI/DPE CON -164.55556 50.94208 0.02
Vit-D(IU) LO/DPE CON -141.77778 44.14499 0.021
LO/DPE CON -2.88889 0.87135 0.016
HI/DPE CON -2.66667 0.87135 0.03
GammaTocopherol(mg) LO/DPE CON -2.22222 0.73199 0.032
LO/DPE CON -0.44444 0.14907 0.037
LO/IPE CON -0.44444 0.14907 0.037
LO/DPE CON -670.55556 189.64398 0.009
LO/IPE CON -629.66667 189.64398 0.016
LO/DPE CON -63.66667 19.17393 0.016
LO/IPE CON -59.66667 19.17393 0.027
Isoleucine(g) LO/IPE CON -1.77778 0.60858 0.043
Leucine(g) LO/IPE CON -3 1.0268 0.043
Lysine(g) LO/IPE CON -3 0.96992 0.028
Threonine(g) LO/IPE CON -1.77778 0.56437 0.024
Valine(g) LO/IPE CON -2 0.66295 0.034
Alanine(g) LO/IPE CON -2.11111 0.66481 0.023
Arginine(g) LO/IPE CON -2.33333 0.76417 0.031
LO/DPE CON -6.22222 2.08641 0.037
LO/IPE CON -6.44444 2.08641 0.028
Glycine(g) LO/IPE CON -1.55556 0.5043 0.029
Proline(g) LO/IPE CON -2 0.69567 0.048






























Appendix B11 – Tukey Post-Hoc Test for Nutrition Logs of Five Groups.  Macronutrients 
and micronutrients were analyzed with a one-way ANOVA and Tukey HSD for five 
groups: LO/DPE, LO/IPE, HI/DPE, HI/IPE, and CON.  Table shows all significant 












































12. ANOVA Results for Total Body Composition 
 
 
Appendix B12 – ANOVA Results for Total Body Composition.  Values at baseline and 
follow-up and change between the two time points were analyzed with a one-way ANOVA 
for total body percent fat and lean mass for each intervention group (LO/DPE, LO/IPE, 
HI/DPE, and HI/IPE) and the control group (CON).  There were no significant differences 
among groups for any measure at any time point.
Sum of Squares df Mean Square F Sig.
Between Groups 187.971 4 46.99 1.413 0.247
Within Groups 1329.933 40 33.25
Total 1517.904 44
Between Groups 160.065 4 40.02 1.218 0.319
Within Groups 1314.631 40 32.87
Total 1474.696 44
Between Groups 3.256 4 0.81 1.083 0.378
Within Groups 30.073 40 0.75
Total 33.330 44
Between Groups 285.726 4 71.43 0.996 0.421
Within Groups 2869.821 40 71.75
Total 3155.547 44
Between Groups 303.170 4 75.79 1.112 0.364
Within Groups 2726.580 40 68.17
Total 3029.750 44
Between Groups 5.655 4 1.41 1.123 0.359
Within Groups 50.338 40 1.26
Total 55.994 44
Change














13. ANOVA Results for Total Thigh Composition 
  
 
Appendix B13 – ANOVA Results for Total Thigh Composition. Values at baseline 
and follow-up and percent change between the two time points were analyzed with 
a one-way ANOVA for total thigh percent fat, total thigh fat mass, and total thigh 
lean mass for each intervention group (LO/DPE, LO/IPE, HI/DPE, and HI/IPE) 
and the control group (CON).  Significant differences among groups were found for 
change in thigh percent fat, baseline thigh fat mass, and percent change in thigh fat 
mass (* = p<0.05). 
Sum of Squares df Mean Square F Sig.
Between Groups 258.477 4 64.619 2.015 0.111
Within Groups 1283.069 40 32.077
Total 1541.546 44
Between Groups 239.403 4 59.851 1.797 0.148
Within Groups 1332.065 40 33.302
Total 1571.468 44
Between Groups 17.517 4 4.379 4.432 0.005*
Within Groups 39.524 40 0.988
Total 57.041 44
Between Groups 9670387.022 4 2417596.76 2.944 0.032*
Within Groups 32845615.28 40 821140.382
Total 42516002.3 44
Between Groups 8617939.533 4 2154484.88 2.53 0.055
Within Groups 34064862.94 40 851621.574
Total 42682802.48 44
Between Groups 392.77 4 98.193 2.899 0.034*
Within Groups 1354.926 40 33.873
Total 1747.696 44
Between Groups 7420908.2 4 1855227.05 1.123 0.359
Within Groups 66079538 40 1651988.45
Total 73500446.2 44
Between Groups 8423836.3 4 2105959.08 1.248 0.306
Within Groups 67503189.5 40 1687579.74
Total 75927025.8 44
Between Groups 41.922 4 10.481 1.222 0.317


























Appendix B14 – ANOVA Results for Thigh Cross Section Composition.  Values at 
baseline and follow-up and change between the two time points were analyzed with 
a one-way ANOVA for thigh cross section percent fat, thigh cross section fat mass, 
and thigh cross section lean mass for each intervention group (LO/DPE, LO/IPE, 
HI/DPE, and HI/IPE) and the control group (CON).  Significant differences among 
groups were found for change in thigh cross section percent fat, baseline cross 
section fat mass, and percent change in cross section fat mass (* = p<0.05). 
 
Sum of Squares df Mean Square F Sig.
Between Groups 244.323 4 61.081 2.321 0.073
Within Groups 1052.579 40 26.314
Total 1296.902 44
Between Groups 232.413 4 58.103 2.025 0.109
Within Groups 1147.579 40 28.689
Total 1379.992 44
Between Groups 29.301 4 7.325 3.199 0.023*
Within Groups 91.607 40 2.29
Total 120.908 44
Between Groups 8031.022 4 2007.756 2.92 0.033*
Within Groups 27504.556 40 687.614
Total 35535.578 44
Between Groups 7372.611 4 1843.153 2.479 0.059
Within Groups 29738.333 40 743.458
Total 37110.944 44
Between Groups 1791.1 4 447.775 3.131 0.025*
Within Groups 5721.068 40 143.027
Total 7512.168 44
Between Groups 9673.189 4 2418.297 1.366 0.263
Within Groups 70791.056 40 1769.776
Total 80464.244 44
Between Groups 8844.144 4 2211.036 1.381 0.258
Within Groups 64047.556 40 1601.189
Total 72891.7 44
Between Groups 33.806 4 8.451 0.776 0.547





















15. Tukey Post-Hoc Test for Body Composition Measures 
 
 
Appendix B15 – Tukey Post-Hoc Test for Body Composition Measures.  All body 
composition measures were analyzed with a one-way ANOVA and Tukey HSD for 
five groups: LO/DPE, LO/IPE, HI/DPE, HI/IPE, and CON.  Table shows all 













Dependent Variable (I) GROUP (J) GROUP Mean Difference (I-J) SD Sig.
Change Thigh % Fat LO/DPE CON -1.922 0.469 0.002
LO/DPE HI/DPE 1205.05556 422.16191 0.05
LO/DPE HI/IPE 1233.056 427.172 0.047
%Change Thigh Fat Mass LO/DPE CON -9.11161 2.7436 0.016
Cross Section Fat Mass Baseline LO/DPE HI/DPE 35.889 12.361 0.045
Thigh Fat Mass Baseline







16. ANOVA Results for Normalized Strength and Power 
 
 
Appendix B16 – ANOVA Results for Normalized Strength and Power.  Values at 
baseline and follow-up and percent change between the two time points were 
analyzed with a one-way ANOVA for normalized isokinetic flexion and extension 
strength (ft-lbs/kg thigh lean mass), isometric strength (ft-lbs/kg thigh lean mass), 
Sum of Squares df Mean Square F Sig.
Between Groups 25.052 4 6.263 2.181 0.092
Within Groups 97.616 34 2.871
Total 122.668 38
Between Groups 13.972 4 3.493 0.873 0.49
Within Groups 136.058 34 4.002
Total 150.03 38
Between Groups 788.733 4 197.183 1.117 0.365
Within Groups 6004.345 34 176.598
Total 6793.079 38
Between Groups 86 4 21.5 3.028 0.031*
Within Groups 241.395 34 7.1
Total 327.396 38
Between Groups 71.914 4 17.979 1.635 0.188
Within Groups 373.931 34 10.998
Total 445.845 38
Between Groups 973.262 4 243.316 1.863 0.14
Within Groups 4440.122 34 130.592
Total 5413.384 38
Between Groups 49.17 4 12.293 0.998 0.422
Within Groups 418.944 34 12.322
Total 468.114 38
Between Groups 54.14 4 13.535 0.705 0.594
Within Groups 652.771 34 19.199
Total 706.911 38
Between Groups 18.396 4 4.599 0.023 0.999
Within Groups 6699.402 34 197.041
Total 6717.798 38
Between Groups 2373.228 4 593.307 2.527 0.056
Within Groups 9390.034 40 234.751
Total 11763.261 44
Between Groups 2036.95 4 509.238 1.807 0.146
Within Groups 11270.108 40 281.753
Total 13307.059 44
Between Groups 161.103 4 40.276 0.274 0.893
Within Groups 5875.067 40 146.877
Total 6036.17 44





























and right leg power (Watts/kg thigh lean mass) for each intervention group 
(LO/DPE, LO/IPE, HI/DPE, and HI/IPE) and the control group (CON).  
Significant differences among groups were found for baseline normalize isokinetic 










































17. ANOVA Results for One Repetition Maximum Testing 
 
 
Appendix B17 – ANOVA Results for One Repetition Maximum Testing.  Values at 
baseline and follow-up and percent change between the two time points were 
analyzed with a one-way ANOVA for bench press, leg press, lat pull down, and 
Sum of Squares df Mean Square F Sig.
Between Groups 5047.778 4 1261.944 0.505 0.732
Within Groups 100022.222 40 2500.556
Total 105070 44
Between Groups 7025.556 4 1756.389 0.659 0.624
Within Groups 106644.444 40 2666.111
Total 113670 44
Between Groups 61.563 4 15.391 0.96 0.44
Within Groups 641.52 40 16.038
Total 703.083 44
Between Groups 189671.968 4 47417.992 0.825 0.517
Within Groups 2298150.249 40 57453.756
Total 2487822.218 44
Between Groups 631082.031 4 157770.508 1.441 0.238
Within Groups 4379761.945 40 109494.049
Total 5010843.977 44
Between Groups 1056.238 4 264.059 2.254 0.08
Within Groups 4686.773 40 117.169
Total 5743.01 44
Between Groups 3781.615 4 945.404 0.498 0.738
Within Groups 75999.711 40 1899.993
Total 79781.326 44
Between Groups 4782.048 4 1195.512 0.518 0.723
Within Groups 92380.202 40 2309.505
Total 97162.25 44
Between Groups 85.115 4 21.279 0.14 0.966
Within Groups 6061.242 40 151.531
Total 6146.358 44
Between Groups 7573.203 4 1893.301 2.322 0.073
Within Groups 32614.369 40 815.359
Total 40187.572 44
Between Groups 16322.93 4 4080.732 3.569 0.014*
Within Groups 45729.807 40 1143.245
Total 62052.736 44
Between Groups 815.528 4 203.882 2.319 0.074
Within Groups 3517.407 40 87.935
Total 4332.935 44
























knee extension 1RM (lbs) for each intervention group (LO/DPE, LO/IPE, HI/DPE, 
and HI/IPE) and the control group (CON).  Significant differences among groups 












































18. Tukey Post-Hoc Test for Strength and Power Measures 
 
 
Appendix B18 – Tukey Post-Hoc Test for Strength and Power Measures.  All 
strength and power measures were analyzed with a one-way ANOVA and Tukey 
HSD for five groups: LO/DPE, LO/IPE, HI/DPE, HI/IPE, and CON.  Table shows 









Dependent (I) GROUP (J) GROUP Mean Difference (I-J) SD Sig.
LO/IPE CON 4.11556 1.40435 0.044
HI/DPE CON 4.71381 1.48242 0.024
Normalized 
Power 
(Right Leg) - 
Baseline





LO/DPE CON 56.56333 15.38749 0.006
Knee 
Extension 
1RM - % 
Change
HI/DPE CON 58.24444 15.93909 0.006










19. Independent Samples Test of FSR for Combined Intervention Groups vs. Control 
 
 
Appendix 19 – Independent Samples Test of FSR for Combined Intervention Groups vs. Control. Mean myofibrillar 
fractional synthetic rates (%/day) were analyzed with an independent samples t-test for the combined intervention 
groups (n=36) compared to control group (n=9). The combined intervention group FSR was significantly greater than 









Samples Comparison Assumption of Variance F Sig. t df Sig. (2-tailed) Mean Difference SE Difference
Lower Upper
Equal variances assumed 4.884 0.032* 1.831 43 0.074 12.43165 6.79042 -1.26253 26.12583
Equal variances not assumed 2.812 29.762 0.009* 12.43165 4.4202 3.40136 21.46194
95% Confidence Interval of the Difference
Independent Samples Test for Combined Intervention vs. Control
Levene's Test for Equality of Variances t-test for Equality of Means






20. Independent Samples Test of FSR for Individual Intervention Groups vs. Control 
 
 
Appendix 20 – Independent Samples Test of FSR for Individual Intervention Groups vs. Control.  Mean myofibrillar 
fractional synthetic rates (%/day) were analyzed with an independent samples t-test for each intervention group 
(LO/DPE, LO/IPE, HI/DPE, and HI/IPE) and the control group (CON). The LO/DPE group FSR was significantly 




Samples Comparison Assumption of Variance F Sig. t df Sig. (2-tailed) Mean Difference SE Difference
Lower Upper
Equal variances assumed 14.873 0.001* 2.335 16 0.033* 22.28424 9.54391 2.05206 42.51643
Equal variances not assumed 2.335 9.672 0.043* 22.28424 9.54391 0.92099 43.6475
Equal variances assumed 1.368 0.259 1.704 16 0.108 10.45798 6.13809 -2.55419 23.47015
Equal variances not assumed 1.704 12.41 0.113 10.45798 6.13809 -2.86694 23.7829
Equal variances assumed 7.171 0.017* 1.645 16 0.12 10.5513 6.41599 -3.04999 24.15259
Equal variances not assumed 1.645 12.003 0.126 10.5513 6.41599 -3.42751 24.53011
Equal variances assumed 5.129 0.038* 1.059 16 0.305 6.43308 6.07464 -6.44458 19.31073
Equal variances not assumed 1.059 12.51 0.31 6.43308 6.07464 -6.74279 19.60895
95% Confidence Interval of the Difference
FSR 3:5
FSR 4:5
Independent Samples Test for Individual Intervention Groups vs. Control









21. ANOVA Results for FSR of Intervention Groups Normalized to Control 
 
 
Appendix 21 – ANOVA Results for FSR of Intervention Groups Normalized to Control.  Myofibrillar fractional 
synthetic rates normalized to control group means were analyzed with a 2 (low vs. high total protein intake) x 2 
(delayed vs. immediate timing of supplementation) ANOVA.  There were no significant differences among groups. 
Source Type III Sum of Squares df Mean Square F Sig. Noncent. Parameter Observed Power (b)Correct d 
Model 4.862a 3 1.621 1.089 0.368 3.267 0.266
Intercept 112.894 1 112.894 75.867 0 75.867 1
Group PRO 2.148 1 2.148 1.444 0.238 1.444 0.214




0.514 1 0.514 0.345 0.561 0.345 0.088





a: R Squared = .093 (Adjusted R Squared = .008)
b: Computed using alpha = 0.05







22. Interaction Effects of Protein and Timing on FSR 
 
 
Appendix 22 – Interaction Effects of Protein and Timing on FSR.  Myofibrillar fractional synthetic rates normalized to 
control group means were analyzed with a 2 (low vs. high total protein intake) x 2 (delayed vs. immediate timing of 











Group PRO Group TIME Mean SE
Lower Bound Upper Bound
HI DPE 1.654 0.407 0.826 2.483
IPE 1.399 0.407 0.571 2.227
LO DPE 2.382 0.407 1.554 3.21
IPE 1.648 0.407 0.82 2.477
95% Confidence Interval






23. Pairwise Comparison of FSR for High and Low Protein Groups 
 
 
Appendix 23 – Pairwise Comparison of FSR for High and Low Protein Groups.  Myofibrillar fractional synthetic rates 
normalized to control group means were analyzed with a 2 (low vs. high total protein intake) x 2 (delayed vs. immediate 
timing of supplementation) ANOVA.  There were no significant pairwise comparisons between high and low total 











(I) Group PRO (J) GroupPRO Mean Difference (I-J) SE Sig. (a)
Lower Bound Upper Bound
HI LO -0.489 0.407 0.238 -1.317 0.34
LO HI 0.489 0.407 0.238 -0.34 1.317
Based on estimated marginal means
a: Adjustment for multiple comparisons: Least Significant Difference (equivalent to no adjustments).
Pairwise Comparisons of FSR for Protein Groups (HI/LO)






24. Pairwise Comparison of FSR for Delayed and Immediate Supplementation Groups 
 
 
Appendix 24 – Pairwise Comparison of FSR for Delayed and Immediate Supplementation Groups.  Myofibrillar 
fractional synthetic rates normalized to control group means were analyzed with a 2 (low vs. high total protein intake) x 
2 (delayed vs. immediate timing of supplementation) ANOVA.  There were no significant pairwise comparisons 











(I) Group TIME (J) Group TIME Mean Difference (I-J) SE Sig. (a)
Lower Bound Upper Bound
DPE IPE 0.494 0.407 0.233 -0.334 1.323
IPE DPE -0.494 0.407 0.233 -1.323 0.334
Based on estimated marginal means
a: Adjustment for multiple comparisons: Least Significant Difference (equivalent to no adjustments).
Pairwise Comparisons of FSR for Timing (DPE/IPE)






25. Univariate Tests of FSR for High and Low Protein Groups 
 
 
Appendix 25 – Univariate Tests of FSR for High and Low Protein Groups.  Myofibrillar fractional synthetic rates 
normalized to control group means were analyzed with a 2 (low vs. high total protein intake) x 2 (delayed vs. immediate 
















Sum of Squares df Mean Square F Sig. Noncent. Parameter Observed Power (a)
Contrast 2.148 1 2.148 1.444 0.238 1.444 0.214
Error 47.618 32 1.488
a: Computed using alpha = 0.05






26. Univariate Tests of FSR for Delayed and Immediate Supplementation Groups 
 
 
Appendix 26 – Univariate Tests of FSR for Delayed and Immediate Supplementation Groups.  Myofibrillar fractional 
synthetic rates normalized to control group means were analyzed with a 2 (low vs. high total protein intake) x 2 
(delayed vs. immediate timing of supplementation) ANOVA.  There were no significant univariate effects of delayed or 
immediate protein supplementation.  
 
Sum of Squares df Mean Square F Sig. Partial Eta Squared Noncent. Parameter Observed Power (a)
Contrast 2.199 1 2.199 1.478 0.233 0.044 1.478 0.218
Error 47.618 32 1.488
a: Computed using alpha = 0.05
Univariate Tests of FSR for Timing Groups (DPE/IPE)
